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IF (RUDYARD KIPLING 1865-1936) 
If you can keep your head when all about you 
Are losing theirs and blaming it on you; 
If you can trust yourself when all men doubt you, 
But make allowance for their doubting too; 
If you can wait and not be tired by waiting, 
Or being lied about, don’t deal in lies, 
Or being hated, don’t give way to hating, 
And yet don’t look too good, nor talk too wise: 
If you can dream -- and not make dreams your master; 
If you can think -- and not make thoughts your aim; 
If you can meet with Triumph and Disaster 
And treat those two imposters just the same; 
If you can bear to hear the truth you’ve spoken 
Twisted by knaves to make a trap for fools, 
Or watch the things you gave your life to, broken, 
And stoop and build ’em up with worn-out tools; 
If you can make one heap of all your winnings 
And risk it on one turn of pitch-and-toss, 
And lose, and start again at your beginnings 
And never breathe a word about your loss; 
If you can force your heart and nerve and sinew 
To serve your turn long after they are gone, 
And so hold on when there is nothing in you 
Except the Will which says to them: “Hold on!” 
If you can talk with crowds and keep your virtue, 
Or walk with kings -- nor lose the common touch, 
If neither foes nor loving friends can hurt you, 
If all men count with you, but none too much; 
If you can fill the unforgiving minute 
With sixty seconds’ worth of distance run -- 
Yours is the Earth and everything that’s in it, 
And -- which is more -- you’ll be a Man, my son! 
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INTRODUCTION 
Schizophrenia is a devastating and often debilitating mental illness characterized by symptoms 
such as hallucinations, delusional believes, disorganized thinking, loss of goal directed behaviors 
and deterioration in social functioning. For some, the disease can be relatively mild with the per-
son suffering one or several episodes with little or no lasting impairment. However, for ap-
proximately 47% of patients, schizophrenia is a disorder for life; with persistent symptoms or 
recurrent episodes associated with significant social disability. (Hegarty et al. 1994). It is an ex-
pensive illness to manage, recent estimates of total health service costs, in the United Kingdom 
(based on figures from 2004-2005) are in the order of £2 billion, making it the third most costly 
diagnostic group in Britain after (learning disability and stroke disorder) this represents 3% of 
the total health care expenditure. The economic burden however extends well beyond the health 
care system to other care organizations and public sector bodies, such as housing departments 
and the criminal justice system. Further, ‘hidden costs’ include lost income due to employment 
difficulties, typically one fifth of all persons with schizophrenia are unable to find paid work, 
resulting in huge losses to the national economy. There is also a significant burden on family 
(and friends) e.g. lost leisure time, and employment opportunities. That is, schizophrenia has 
significant health, social and economic impacts on patients, their families and the wider society 
(Hegarty et al. 1994;Knapp M et al. 2004;Mangslore R and Knapp M 2007).“Aetiological elu-
siveness” Few mental disorders have been investigated with such persistence over decades with 
such patchy results as schizophrenia. Some advances have been made and a number of genetic 
and environmental factors have been identified (discussed in this thesis) which increase the risk 
of schizophrenia however they are generally of small/modest effect and are neither necessary or 
sufficient causal components. Using epidemiology to understand the cause of diseases. Epi-
demiology is a population science. The central paradigm of classical epidemiology is that sys-
tematic analyses of the patterns of disease will provide understandings to their causes and even-
tual control. The key strategy compares and contrasts aggregated disease pattern in populations 
over TIME, between PLACE and in different (subgroups of people defined by variation in demo-
graphic and risk factor exposures) PERSONS. Consequently, classical epidemiological studies 
measure the likelihood or probability of disease at the group level that is, what happens on aver-
age in a population. A person’s risk may deviate from the estimated average. For example, the 
causal link for cigarette smoking and lung cancer is robust; however, an individual person’s risk 
may differ from the estimated relative risk (for smokers) in the population, due to specific envi-
ronmental or genetic factors, which reduce their susceptibility to the carcinogenetic effects of 
tobacco (Bhopal R. 2002). Variation in disease over time That diseases wax and wane in their 
population frequency as the result of medical /public health practice or natural causes is one of 
the axioms of classical epidemiology. Variation in disease occurs over time in populations be-
cause the characteristics of the people or their environment changes. Even if the social and 
physical environment were constant some patterns of disease over time would likely occur (of 
course much more slowly, over evolutionary time scales) for genetic changes are inevitable and 
will influence the onset and persistence of disease. Genetic changes arise from a number of 
processes including genetic drift, genetic mutation and epigenetic transmutations, which cause 
random variation in the gene frequency from generation to generation. In small populations, 
genetic drift can lead to important genetically driven disease differences however, in large popu-
lations genetic DNA (deoxyribonucleic acid) sequencing remains relatively stable over time. 
Classical epidemiological methodology assumes that changes in disease frequency within large 
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populations occurring over short time period (few decades) are almost wholly due to environ-
mental factors. Since the 1980’s there have been a substantial number of studies suggesting that 
the first admission rates of schizophrenia have declined by as much as 50% in the latter part of 
the twentieth century. (Al Mousawi and Dunstan 1998;Brewin et al. 1997;de Alarcon and Sea-
groatt 1990;Der et al. 1990;Eagles and Whalley 1985;Eagles et al. 1988;Munk-Jorgensen 
1986;Munk-Jorgensen and Jorgensen 1986;Munk-Jorgensen and Mortensen 1993;Munk-
Jorgensen et al. 1992;Oldehinkel and Giel 1995;Osby et al. 2001;Suvisaari et al. 1999). While 
others studies have found significant increase in service defined incidence rates over the same 
period.(Castle et al. 1991;Preti and Miotto 2000;Boydell et al. 2003). Variation of disease rates 
by place Similar insights into aetiology can be determined by systematically examining variation 
in the rates of disease between populations with different demographic and environmental 
characteristics. Until recently, it was a generally held view that the incidence of schizophrenia 
was uniform. Indeed the WHO Collaborative study (Sartorius N. et al. 1996) which specifically 
set out to ascertain incidence rates for schizophrenia in rural and urban areas, in developed and 
developing countries, concluded that “schizophrenic illness, occur with comparable frequency in 
different populations”. While this study was carefully executed and measured contemporane-
ously incidence in a number of different geographical areas using the same ascertainment meth-
ods, semi structured interview (PSE, present state examination) for diagnoses it may have been 
hampered by low power when comparing the narrowly defined schizophrenia. Since the publi-
cation of the WHO study a raft of studies have demonstrated spatial variation in the incidence of 
schizophrenia (McGrath et al. 2004). Real variation in time and place or artifact? For causal 
understandings of observed variation in rates of disease, the first step must be to exclude artifact 
because if the variation is an illusion then there is no epidemiological association to explain! 
(Bhopal R. 2002). 
 
Variation in the rates of disease by time and place: Artefactual explanations 
 
1. CHANCE- random fluctuation 
2. DIFFERENTIAL ERROR OF OBSERVATION: sampling and information bias 
3. VARIATION IN THE UNDERLYING SIZE & STRUCTURE OF THE POPULATION 
4. VARIATION IN HEALTH SEEKING BEHAVIOUR: this varies with level of knowledge, expec-
tations, accessibility and acceptability of health care services. 
5. DIAGNOSTIC ACCURACY: variation in and quality diagnostic facilities, level of skill and 
training  
6. VARIATION IN DIAGNOSTIC CLASSIFICATION SYSTEMS & FASHION: variation in clinical 
approaches to classification systems employed 
7. VARIATION IN CASE ASCERTIANMENT: Variation in service administration and informa-
tion systems. 
8. VARIATION IN STATISTICAL ANALYSES: Different underlying population structures or 
changes in the standard populations used in adjusting disease rates for differences in age 
and sex. 
 
Variation in person (clinical epidemiology: subgroup analyses) harnesses the inherent het-
erogeneity seen in populations. For example in a society where everyone smoked heavily, (uni-
form exposure) the classical epidemiological strategy of comparing and contrasting exposure 
would be impossible (Schunemann H J and Guyatt G H 2005) However examining the variation 
in susceptibility, onset, course and outcome of disease and the reasons behind this variation 
helps us to better understand the disease. through the systematic identification and evaluation 
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of inherited and acquired characteristics of individuals’, attributes, behaviors and exposures, 
known as risk factors (determinants). These risk factors increase an individual’s likelihood of 
developing i) a precursor of the clinical disorder ( a condition or state preceding the recognized 
onset of a disease) ii) a clinical disease or iii) a particular course and outcome trajectory for the 
disease process. Determinants rarely act in isolation to increase risk; rather their effects are cu-
mulative. Such complementary actions can be additive (the linear sum of the individual effects) 
or synergistic (interaction of effects) when individual risk factor effects are modified by particu-
lar environmental conditions, biological stochastic events or with other known risk factors. Fur-
ther, there is no reason to assume that the risk factors for the emergence of a clinical disorder 
and those influencing persistence are congruent. Evidence that the same risk factor is implicated 
in both onset and persistence of a disease (discrete major effect) could aid our understanding of 
aetiological mechanisms. However, lack of, discrete effects suggests the course of a disease is not 
pre determined and is potentially modifiable after onset. Clinical epidemiology uses this varia-
tion in risk factor profiles to generate hypotheses and develop empirically based conceptual 
frameworks (models) of disease. Identifying the risk factors operating prior to the onset of dis-
ease are fundamental to effective evidence based primary prevention, while the risk factors pre-
dicting course and outcome help identify patients at higher risk of poor outcome, so guiding the 
development of secondary and tertiary preventative strategies and interventions tailored for 
specific individual’s in clinical settings. Heterogeneity is the hallmark of schizophrenia, with 
manifest variation in risk factors for onset, symptomatology, course and outcome. Caseness: 
schizophrenia a provisional diagnostic category! Central to any epidemiological study is the 
issue of caseness. How we define the disease outcome determines the estimated rates in descrip-
tive epidemiological studies and the calculated effect sizes in analytical studies. From the 1960’s 
psychiatrists have expended much energy in improving the reliability of psychiatric diagnoses in 
general and schizophrenia in particular. This has resulted in a number of operational definitions 
of schizophrenia, which have accepted diagnostic reliability, but all vary and it is questionable 
which one should be adopted. The basic problem is that we do not know whether the concept of 
schizophrenia has any validity and even if it has, which operational definition best reflects that 
validity. (Andreasen 1995;Carlos E.Berganza et al. 2005;John S.Strauss 2005;Kendell R.E. 
1989;Kendler 1980;Kessler 2002;Liddle 1987). That schizophrenia is at best a provisional diag-
nostic category has serious implications for the epidemiological study design and interpretation 
of the results. It handicaps our research efforts and impedes our aetiological understandings 
resulting in calls for the investigation of further investigation into its validity. 
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STATEMENT OF OBJECTIVES 
The aim of the current thesis is threefold. 
 
Part 1 
Describes studies investigates the variation in incidence of psychosis (more particularly schizo-
phrenia) in time and place. 
 
Part 2 
Reviews the current literature on the variation in risk for schizophrenia by person (studies 
which examine the association of demographic and differential exposure (risk gradients) to pu-
tative risk factors with rates of schizophrenia). 
 
Part 3 
Reviews the validity of schizophrenia as a diagnostic construct and examines its diagnostic util-
ity.  
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CHAPTER 3 
Variation in the incidence of schizophrenia by place 
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CHAPTER 4 
Variation in the incidence of psychosis by area level 
social characteristics 
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Background Social disorganisation,
fragmentation and isolationhave long
beenposited as influencing the rate of
psychoses at area level.Measuring such
societal constructs is difficult.Acensus-
based indexmeasuring social
fragmentationhas beenproposed.
Aims To investigate the association
between first-admissionrates for
psychosis and area-basedmeasures of
social fragmentation, deprivation and
urban/rural index.
Method Weused indirect
standardisationmethods and logistic
regressionmodels to examineassociations
of social fragmentation, deprivation and
urban/rural categorieswith first
admissions for psychoses in Scotland for
the 5-year period1989^1993.
Results Areas characterised byhigh
social fragmentationhadhigher first-ever
admissionrates for psychosis independent
of deprivation andurban/rural status.
Therewas a dose^response relationship
between social fragmentation category
and first-ever admissionrates for
psychosis.Therewasno statistically
significant interaction between social
fragmentation, deprivation andurban/
rural index.
Conclusions First-admissionrates are
stronglyassociatedwithmeasuresof social
fragmentation, independentofmaterial
deprivation andurban/rural category.
Declaration of interest. None.
Geographical studies show that popu-
lations of areas with greater material
deprivation have higher rates of psychoses
(Dauncey et al, 1993; Harrison et al,
1995; Harvey et al, 1996; Boardman et al,
1997) and that urban areas have a greater
risk of psychoses compared with rural areas
(Lewis et al, 1992; Marcelis et al, 1998;
Mortensen et al, 1999; Allardyce et al,
2000). Also, the association with depri-
vation may apply to urban but not rural
areas (Thornicroft et al, 1993). Although
strong associations are shown for area-
based indices of deprivation and psychosis
they may not fully describe the ecological
relationship. Faris & Dunham (1939) and
Hare (1956) recognised the importance of
social disorganisation, fragmentation and
isolation in the onset of mental disorders
and more recent reports support this
proposition (van Os et al, 2000). Congdon
(1996) has proposed a census-based index
measuring anomie (social fragmentation)
and we used this to examine the relative
impact of social fragmentation, material
deprivation and urbanicity/rurality on first-
admission rates to hospital for psychosis,
using a Scottish national data-set for the
period 1989–1993.
METHOD
To allow chronological matching, we iden-
tified cases in which hospital admission
occurred during the period 1989–1993,
and used information on social factors from
the 1991 national census to calculate cate-
gories of deprivation, social fragmentation
and urban/rural classification.
Case identification
The Scottish Office Information and Statis-
tics Division collates in-patient activities
in Scottish hospitals. All psychiatric facil-
ities return a form (SMR04) for each
patient after an in-patient stay; this form
provides both demographic and diagnostic
information. During the period 1989–
1993 the main diagnoses were coded
according to ICD–9 (World Health Organi-
zation, 1978). The record linkage section of
the Information and Statistics Division
identified for this period all cases with a
discharge diagnosis of schizophrenia (code
295), schizoaffective disorder (295.6), delu-
sional disorder (297), mania (296.0, 296.2,
296.4), acute, transient or unspecified
psychotic disorder (298) or drug-induced
disorder (292.1), in which the patient had
had no previous admission (in Scotland)
for any of the above psychotic diagnoses.
We excluded patients over the age of 64
years (as there is likely to be significant
diagnostic difficulty with elderly people)
and those without a permanent address in
Scotland.
Population at risk
The population of Scotland was determined
at around 5 million (all age groups)
throughout the study period. At the 1991
census only 2.8% of the population had
been born outside of the UK. The General
Register Office of Scotland provided de-
tailed population data for the 5-year period
stratified by age, gender and postcode sec-
tor (an area with an average population of
5000 considered of sufficient size to pro-
vide fairly reliable rates for health events;
Carstairs & Morris, 1991).
Area-based measures
Area-based measures were calculated for
every postcode.
Social fragmentation
We calculated social fragmentation using
information from the 1991 census on mobi-
lity in the previous year, number of
privately rented households, single-person
households and number of unmarried
persons (Congdon, 1996). The social frag-
mentation index for each postcode sector
was calculated by adding the z scores (the
number of standard deviations above or
below the population mean when the un-
derlying distribution is normal) for each
of the four characteristics. The scores
ranged from 74.8 to 33.79. For the pur-
pose of the analysis presented here we
collapsed the index into categories, created
by quartiles. However, because there was a
strong positive skew in the distribution of
the social fragmentation scores, the upper
quartile was divided at the 90th percentile,
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creating five categories – category 1 being
the most socially cohesive area and 5 the
most socially fragmented.
Material deprivation
Material deprivation was measured using
Carstairs scores, the indicators routinely
used in Scotland (Carstairs & Morris,
1991). Carstairs scores correlate highly
with other commonly used indices of depri-
vation (Townsend 0.96, Jarman 0.83). The
scores were calculated using the 1991
census data for overcrowding, male unem-
ployment, low social class and no car. The
postcode sector scores range from 78.5
(most affluent) to 12.8 (most deprived).
The deprivation scores for each postcode
sector are transformed routinely into cate-
gories, using pre-defined cut-off scores,
which range from category 1 (most afflu-
ent) to 7 (most deprived) (McLoone, 1995).
Urban/rural index
We measured the urban/rural index using
data from the 1991 census and the official
Scottish classification (Carstairs & Morris,
1991). The degree of urbanicity is calcu-
lated for each postcode sector by adding
to the population total the population of
each directly adjacent neighbourhood:
category 1 is most urban, and category 5
and 6 are the most rural.
Analysis
Using the indirect standardisation method
we calculated standardised (first) admission
ratios by category of social fragmentation,
deprivation and urban/rural classification.
For each (10-year) age and gender band
we used both the national first-admission
rates and the rates for stratum 1 of each
social characteristic as the reference. Next,
we calculated the age/gender-adjusted
admission rates for first-ever psychosis for
each postcode sector in order to model their
dependence on social fragmentation,
adjusting for deprivation category and
urban/rural index. As there was evidence
of overdispersion in the admission rates
they could not be adequately modelled.
To overcome this the admission rate distri-
bution was dichotomised into the high-rate
quintile (rate lies within the top 20%
of admission rates) and the remainder.
Logistic regression analysis was used to
determine whether social fragmentation,
deprivation and urban/rural index were
independently associated with first
admission rates classified as ‘high’. A sensi-
tivity analysis was carried out using the
75th percentile and the 85th percentile to
check whether the actual cut-off point used
to define high rates was critical in the
interpretation of the results.
RESULTS
The SMR04-linked data-set contained 5858
cases eligible for inclusion; 20 (0.34%) had
missing or unknown postcodes and 5838
cases were therefore entered into the analy-
sis. Tables 1–6 show the standardised
admission ratios categorised according to
fragmentation (Tables 1–2), deprivation
category (Tables 3 and 4) and urban/rural
level (Tables 5 and 6). The odds ratios that
social fragmentation, deprivation and
urbanicity measures predict standardised
first-ever psychosis admission rates are
shown in Table 7.
Univariate analysis showed a very
significant association for social frag-
mentation category, deprivation category
and urban/rural index with ‘high rate’ post-
code sectors. In the adjusted model this
very significant association remained for
social fragmentation only. There was no
significant interaction between social frag-
mentation, deprivation and the urban/rural
index in the model.
The model is a good fit to the data
(Hosmer–Lemeshow test, P¼0.78) and the
results are essentially the same using the
75th and 85th percentiles as the cut-off
for defining high admission rate.
DISCUSSION
Main findings
Social fragmentation
This study suggests that areas characterised
by high social fragmentation have higher
first-ever admission rates for psychosis
independent of deprivation and urban/rural
status. There is a clear monotonic gradient
in the relationship between social fragmen-
tation and first-ever admission rates for
psychosis. The odds that a postcode from
the most fragmented category has a high
admission rate is 12.8 (95% CI 5.7–28.9)
times the odds for a postcode from the least
fragmented areas.
We are unaware of any recently pub-
lished work exploring rates of psychosis
with composite measures of social fragmen-
tation. Faris & Dunham (1939) recognised
urban areas with high rates of psychiatric
morbidity to be characterised by social dis-
integration, excessive residential mobility,
ethnic conflict, communication breakdown
and lack of consensus. Social isolation
leading to mental health inequality was
suggested by Hare (1956), who found an
Table 1 Standardised admission ratios for social fragmentation (using national rates as reference)
Social fragmentation category1 Expected cases
n
Observed cases
n
Standardised admission ratio
Ratio (95% CI)
1 1858.15 1434 0.77 (0.73^0.81)
2 1605.92 1466 0.91 (0.87^0.96)
3 1149.25 1219 1.06 (1.00^1.06)
4 655.31 932 1.42 (1.33^1.51)
5 491.56 787 1.60 (1.49^1.71)
1. Category1, most socially cohesive; category 5, most socially fragmented.
Table 2 Standardised admission ratios for social fragmentation (using category1as reference rate)
Social fragmentation category1 Expected cases
n
Observed cases
n
Standardised admission ratio
Ratio (95% CI)
1 1434 1434 1 ^
2 1243.16 1466 1.18 (1.12^1.24)
3 890.97 1219 1.37 (1.29^1.44)
4 576.9 932 1.84 (1.78^1.90)
5 376.25 787 2.09 (1.95^2.24)
1. Category1, most socially cohesive; category 5, most socially fragmented.
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ecological correlation with single-person
households in Bristol and rates of first
admission for schizophrenia. A more
recent study has shown area-based mea-
sures of single and divorced residents to
be associated with higher first-contact
rates for psychosis, independent of a
number of neighbourhood social and
demographic characteristics and individual
measures of age, gender and marital status
(van Os et al, 2000). Thornicroft et al
(1993) demonstrated that in urban areas
the proportion of unmarried people and
the proportion of people living alone were
strongly correlated with admissions for
psychosis.
Material deprivation
Our results are consistent with previous
work demonstrating an association between
admissions for psychosis and population-
based measures of material deprivation
(Harrison et al, 1995; Boardman et al,
1997; Koppel & McGuffin, 1999). We
show this association to hold for first-
admission data also. Adjustment for social
fragmentation and urbanicity in our logistic
model weakened the association. Although
Thornicroft et al (1993) found an associa-
tion between deprivation and service utili-
sation rates for psychosis in south Verona
(an urban area), there was no relationship
in the same study with deprivation in the
rural area of Portogruaro. However, we
found no interaction of deprivation and
urban/rural terms in our model, i.e. the
effect of deprivation does not vary across
urban/rural categories. We studied all
postcodes in Scotland, allowing examin-
ation of rural areas heterogeneous for
material and social deprivation. The 11
rural districts in the Italian study might
have been too similar to detect any associa-
tion in this relatively small area.
Urban/rural variation
The urban/rural differences in admission
rates for psychoses demonstrated in this
study have been well documented in
previous studies (Marcelis et al, 1998;
Mortensen et al, 1999; Allardyce et al,
2001). However, we have not shown a sta-
tistically significant variation in admission
rates with urbanicity after adjustment for
social fragmentation and deprivation. It is
therefore possible that deprivation and
social fragmentation are important expla-
natory factors in the urban effect seen in
previous studies.
Methodological considerations
Data-set and admission rate calculations
The SMR04 data-set provides national,
comprehensive (100% coverage) infor-
mation for in-patient care over three
decades in Scotland. The usefulness of such
a data-set depends on the accuracy of its
information, and despite earlier criticism
(Kendrick & Clarke, 1993) the quality of
the SMR04 data is now considered good
(Harley & Jones, 1996). The quantity
of the data should reduce the effect of
variation in local coding practices, but
some variation due to regional differences
may remain; we have used the broad diag-
nostic category ‘psychosis’ to calculate
first-ever admission rates as it is likely to
have the greatest diagnostic consistency
(Allardyce et al, 2001).
We examined admission rates from the
fine-grain level of postcode sectors and
have offset the possible disadvantage of
low numbers by taking admissions over a
5-year period and using a dichotomised
outcome measure. Admission rates reflect
only the met demand for in-patient care,
and it is possible that areas with better
community facilities and day hospital pro-
vision will use fewer beds; however, this
assumption is not supported for psychosis
(Jarman et al, 1992; Flannigan et al,
1994). In Scotland during the period of
study, there was no specific day care alter-
native to admission for people with severe
mental illness.
Measures of area-based exposures
The area-based measures of deprivation
and social fragmentation were generated
from aggregation of census-based variables.
The census is the only source of objective
and uniform data for the entire population
and therefore any proxy measure is con-
strained by the data available from it. As
a sound conceptual base for either social
fragmentation (social cohesion) or depriva-
tion is lacking, there is no absolute
underlying theory in the selection of
variables used in the aggregate scores
(Carr-Hill, 1988). The demographic factors
we used to measure fragmentation –
namely non-married adults, one-person
households, population turnover and pri-
vate renting – may not in themselves be
Table 3 Standardised admission ratios for deprivation (using national rates as reference)
Deprivation category1 Expected cases
n
Observed cases
n
Standardised admission ratio
Ratio (95% CI)
1 328.11 225 0.69 (0.60^0.78)
2 806.51 661 0.82 (0.76^0.88)
3 1266.07 1101 0.87 (0.82^0.92)
4 1457.97 1377 0.94 (0.89^0.99)
5 880.59 985 1.12 (1.05^1.19)
6 633.65 840 1.33 (1.24^1.41)
7 387.28 649 1.68 (1.55^1.80)
1. Category1, most affluent; category 7, most deprived.
Table 4 Standardised admission ratios for deprivation (using category1as reference rate)
Deprivation category1 Expected cases
n
Observed cases
n
Standardised admission ratio
Ratio (95% CI)
1 225 225 1 ^
2 558.09 661 1.18 (1.09^1.27)
3 880.35 1101 1.25 (1.18^1.32)
4 1019.05 1377 1.35 (1.28^1.45)
5 618.00 985 1.59 (1.49^1.69)
6 478.33 840 1.76 (1.64^1.87)
7 272.70 649 2.38 (2.20^2.56)
1. Category1, most affluent; category 7, most deprived.
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valid indicators of social fragmentation, or
may adequately measure social fragmenta-
tion in some areas but not in others. For
example, in urban areas the combination
of young, single people living in non-family
households may not measure disorganised
communities but rather communities with
young professionals or students (Congdon,
1996). Similarly, the individual census vari-
ables chosen may reflect deprivation in
some areas better than others. For example,
overcrowding is an almost exclusively
urban phenomenon and is likely to be irre-
levant in identifying deprivation in rural
areas. Lack of a car may be an indicator
of deprivation in an urban context, but pos-
session of a car in rural areas may be almost
a necessity. In rural areas car ownership is
highly correlated with remoteness rather
than socio-economic group (Midwinter et
al, 1988).
As a population census is only per-
formed every 10 years in the UK, it is more
than possible that an area’s characteristics
may change during this time with obviously
no concomitant change in the census
aggregated score. However, as we have
analysed data from the period 1989–1993,
area-based measures and admission data
are chronologically matched.
There is no universally accepted defini-
tion of ‘rural’. Characteristics may include
open spaces, green scenery, agricultural
activities, remoteness and lack of people.
Most published work has used quantitative
definitions of ‘urban/rural’, but as there
is no point on the continuum from large
agglomerations to small clusters or
scattered dwellings where ‘urban’ disap-
pears and ‘rural’ begins, the division
between urban and rural population will
always be arbitrary. Despite these method-
ological limitations, area-based measures
are increasingly used in public health
research and practice (Smith & Hart,
1999).
It is unlikely that any area, however
small, will be totally homogeneous for
exposure levels of deprivation, social frag-
mentation and urban/rural characteristics.
This is especially so if the geographical
categorisation is logistical, as in postcode
sectors. However, in Scotland postcode sec-
tors are more socioculturally homogeneous
than elsewhere in the UK (Reijneveld et al,
2000). Although area-based measures may
not apply equally to all individuals within
an area, all these individuals are exposed
to living in a neighbourhood with (for
example) low social fragmentation or high
Table 5 Standardised admission ratios categorised by urban/rural index (using national rates as reference)
Urban/rural category1 Expected cases
n
Observed cases
n
Standardised admission ratio
Ratio (95% CI)
1 1553.33 1883 1.21 (1.16^1.27)
2 970.77 1208 1.24 (1.17^1.32)
3 1828.30 1641 0.90 (0.85^0.94)
4 1245.77 966 0.78 (0.73^0.82)
5, 6 162.02 140 0.86 (0.72^1.01)
1. Category1, most urban; category 6, most rural.
Table 6 Standardised admission ratios categorised by urban/rural index (using category1as reference rate)
Urban/rural category1 Expected cases
n
Observed cases
n
Standardised admission ratio
Ratio (95% CI)
1 1883 1883 1 ^
2 1177.68 1208 1.03 (0.97^1.08)
3 2216.92 1641 0.74 (0.72^0.76)
4 1512.88 966 0.64 (0.60^0.68)
5, 6 188.62 140 0.74 (0.62^0.87)
1. Category1, most urban; category 6, most rural.
Table 7 Odds ratios for area measures of social fragmentation, deprivation and urbanicity predicting ‘high’
first-admission rates for psychosis
Unadjusted Adjusted
Odds ratio P Odds ratio P 95% CI
Social fragmentation category1 50.001 50.001
1 1.00 1.00
2 4.10 4.29 2.04^9.05
3 5.09 5.34 2.52^11.32
4 11.38 9.38 4.30^20.46
5 20.37 12.84 5.71^28.88
Deprivation category2 50.001 0.014
1 1.00 1.00
2 1.71 1.44 0.44^4.76
3 2.16 2.03 0.64^6.43
4 2.88 2.43 0.78^7.55
5 4.16 3.40 1.06^10.88
6 8.31 4.58 1.39^15.09
7 15.80 5.29 1.49^18.75
Urban/rural category3 50.001 0.177
1 1.00 1.00
2 0.84 0.93 0.50^1.73
3 0.31 0.60 0.32^1.09
4 0.21 0.43 0.22^0.85
5 0.35 0.51 0.21^1.26
6 0.55 0.62 0.29^1.32
1.Category1, most socially cohesive; category 5, most socially fragmented.
2.Category1, most affluent; category 7, most deprived.
3.Category1, most urban; category 6, most rural.
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deprivation levels. Social characteristics
such as social fragmentation in our society
are likely to have profound effects on
health and yet are incompletely captured
and described by individual approaches to
measurement.
Ecological study design
This is an area-based study comparing
groups rather than individuals, allowing
the ecological effects of constructs concep-
tualised at the group/area level, such as
social fragmentation, deprivation and
urban/rural categories, to be demonstrated.
A study with both individual and ecological
information would allow us to look at the
person–environment interaction, which
would be very informative; however,
data at the individual level were not
available.
Finally, standardised (first) admission
ratios may not be the best way of compar-
ing morbidity in different geographical
areas, because each subgroup is adjusted
to a different standard. These ratios are,
however, fairly robust with respect to the
violation of the assumption of proportion-
ality (Court & Cheng, 1995). This method
has the advantage over direct standard-
isation in that it has a smaller variance.
The wide confidence intervals that
would be generated by other methods of
standardisation would cause difficulty in
interpreting the results and might be
misleading. We have complemented the
standardised admission ratios analysis with
a logistic regression model.
Clinical implications
Association does not imply causality.
Living in a socially fragmented deprived
area may precipitate a first episode of
psychosis (social causation hypothesis);
alternatively, individuals predisposed to
psychosis may drift into or out of or be
left in areas (social selection). It is also
possible that some other variable might
be confounding the effect and the depriva-
tion and social fragmentation indices
are simply proxy measures. Our study
suggests, whatever the underlying mechan-
ism, that both material deprivation and
social fragmentation are likely to influence
first-admission rates for psychosis at area
level. However, we found social frag-
mentation to have the greatest effect.
The observed health inequalities appear to
be mediated by both material deprivation
and social fragmentation. Deprivation
scores such as Carstairs indices are often
used to measure health inequalities between
areas, but our results suggest that this
would not fully describe the ecological re-
lationship and that other measures of socie-
tal influences should be explored if we wish
to clarify and tackle this inequality.
We are unable to determine whether
the area-based measures operate at the
individual (compositional) or at the macro-
environmental (contextual level). Further
studies with individual and area-based
measures of social fragmentation and
deprivation and the onset of psychosis
would clarify the relative importance of
the personal and area characteristics.
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CHAPTER 5 
Variation in the rates of psychosis by area level social 
characteristics: A systematic review 
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Review: The Wider Social Environment and Schizophrenia
Judith Allardyce1,2 and Jane Boydell3
2Department of Clinical Research, Crichton Royal Hospital,
Dumfries DG1 4TG, Scotland; 3Divison of Psychological
Medicine, Institute of Psychiatry, Denmark Hill, London SE5
8AF, UK
Rates of schizophrenia differ significantly between groups
defined at the social level, eg, urban/rural comparisons,
neighborhoods, and ethnic minority status. While earlier
studies were not able to determine if the social environment
influenced the development of schizophrenia (causation) or
whether individuals at risk aggregated in adverse social
environments (selection), the recent development of multi-
level modeling should inform this debate. To date, there are
few examples of multilevel analyses in schizophrenia re-
search; however, the small number of studies suggest that
there may be a neighborhood social contextual effect
that influences rates of schizophrenia and other psychotic
disorders.
Further research is urgently required to progress our
knowledge of how individuals, their genes, and the neighbor-
hoods they live in, interact with each other. Studies need to
use well-specifiedmultilevel models, and until then, we should
remain cautious in our interpretation of such findings.
Key words: schizophrenia/psychosis/multi-level/
ecological/deprivation/social cohesion/ethnic minority
status
Introduction
The last decade has witnessed a shift from individualistic
approaches in chronic disease epidemiology to the ex-
ploration of a wider set of risk factors, defined at levels
higher (eg, families, neighborhoods, countries, or cultural
context) and lower (eg, genetic or molecular) than the
person. With this has come a rapid growth in studies ex-
amining the influence of the shared social environment
on health.1,2
The study of schizophrenia has only recently started to
reflect this methodological transition, due to the accre-
tion of evidence showing consistently higher incidence
rates for schizophrenia in urban as compared with rural
areas with a dose-response relationship, possibly pointing
toward a social causation rather than a social drift expla-
nation for the observed urban-rural gradient.3 However,
growing up in an urban area is a proxy environmental
risk factor, and the correlates of this urban exposure, act-
ing to increase the risk of schizophrenia, require elucida-
tion. At an ecological level a neighborhood’s social and
economic structure may be an important explanatory fac-
tor for this urban effect.4
The social environment varies widely and systemati-
cally across neighborhoods, along the dimensions of dep-
rivation, residential stability (eg, tenured housing and
migration), family structure (eg, living alone), and ethnic
composition.5 Social stratification by place is inherent
and pervasive,6,7 and many health outcomes vary across
them.8 This ecological perspective is not new in schizo-
phrenic research; as far back as 1939, Faris and Dunham9
demonstrated differential rates of schizophrenia across
city zones in Chicago, with the highest rates in areas char-
acterized by high ethnic conflict, residential mobility, and
social disorganization. Later studies from Bristol10 and
Nottingham11 demonstrated similar associations. How-
ever, we abandoned ecological studies concentrating
our effort on individual approaches in the 1970s; with
the demonstration that schizophrenia was a biological
brain disorder, we thought that its causes, effective treat-
ments, and prevention strategies would also be biological
and lie at the individual level and assumed that differen-
tial rates across neighborhoods were due to social (selec-
tion) drift.12
In this review, we describe the current state of published
research examining neighborhood-level social environ-
mental factors and schizophrenia. Studies were included
(see Appendix) if (1) they were published after 1995, a pe-
riod where multilevel modeling were established; (2) the
area measured was the ‘‘neighborhood’’ or geographi-
cally defined small area; (3) outcomes were rates of psy-
chosis or schizophrenia; and (4) there was an area-level
measure of social context. Only 13 studies fulfilled these
criteria. Deconstructing a neighborhood’s social environ-
ment in a way that is susceptible to scientific inquiry is
difficult; we have chosen to organize this review around
1Towhomcorrespondenceshouldbeaddressed;tel:44-1387-244000,
fax: 44-1387-257735, e-mail: j.allardyce@clinmed.gla.ac.uk.
Schizophrenia Bulletin vol. 32 no. 4 pp. 592–598, 2006
doi:10.1093/schbul/sbl008
Advance Access publication on July 18, 2006
 The Author 2006. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved.
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the classical social area dimensions (stratifications) seen
in neighborhoods such as (1) deprivation; (2) community
organizational structure, ie, family composition and
housing characteristics which support stable neighbor-
hoods; and (3) ethnic composition.
Area-Level Measures of the Social Environment and
Their Relationship to Rates of Schizophrenia
Deprivation
Ecological studies have consistently found a relationship
(not necessarily linear) between derivation and incidence
of psychosis13 first admission rates for schizophrenia,4,14
prevalence of schizophrenia,15,16 and admission rates for
schizophrenia.17–20 The majority of these studies have
used only aggregate-level data, reflecting their primary
aim of assessing whether area measures of deprivation
(used to determine formulas for national funding) can ef-
fectively predict use of mental health services. They de-
scribe the association but do not explain it. They do
not differentiate between ‘‘compositional’’ effects (aggre-
gations of persons each with increased individual risk)
and ‘‘contextual’’ explanations where the features of
the social (or physical) environment of the neighborhood
influence the health of those exposed to it (either in ad-
dition to or in interaction with individual risk factors).
With the recent development of multilevel (hierarchi-
cal) statistical modeling, it is now possible to tease out
the effects of individual-level risk factors and neighbor-
hood contextual effects. The first study to examine both
individual and neighborhood deprivation data15 on prev-
alence rates of schizophrenia showed that both individual
characteristics and area-level deprivation were indepen-
dently and significantly related to rates of schizophrenia.
However, further analyses of the same data set16 includ-
ing a specific measure of individual-level deprivation
(household income) attenuated and rendered the neigh-
borhood deprivation effect nonsignificant. The attenua-
tion was due solely to individual deprivation indicators.
Further studies have shown a similar attenuation in the
neighborhood effect of deprivation after adjustment of
individual-level risk factors (and other neighborhood
measures).21,22
‘‘Controlling away’’ the neighborhood deprivation ef-
fect could be (1) individuals predisposed to schizophrenia
aggregating in deprived areas; (2) it may be that an indi-
vidual’s deprivation status is a function of neighborhood
social characteristic not adequately captured by depriva-
tion indices, eg, social disorganization; and (3) method-
ological artifact, area deprivation, is not conceptualized
independently of the individuals living in the area.23 This
may be overcome by using income/deprivation distribu-
tion or inequality measures rather than deprivation indi-
ces.24 One study has examined the relationship of
inequality and schizophrenia.25 They found that (social)
inequality was not associated with higher incidence rates
for schizophrenia except in the most deprived electoral
wards, after controlling for individual ethnic minority
status and area derivation. However, they did not mea-
sure individual social economic status, so it may be that,
in the deprived/high inequality areas where there is likely
to be very high concentrations (as compared with areas
with less disparity) of deprived people, the contextual
effect may have been overestimated.
Neighborhood Organization (levels of disorganization)
To date, most studies have used objective measurements
of disorganization, generated from single or composite
(Social Fragmentation index [SFI]) aggregates of the cen-
sus variables—unmarried, 1-person household, popula-
tion turnover, and private rents.
Two studies have shown that area measures of SFI have
a strong influence on rates of psychosis4 and schizophre-
nia18 independent of area-level deprivation and ethnic
composition. Another cross-sectional study from Sweden
used subjective survey methods and found higher rates of
schizophrenia in areas characterized by high levels of dis-
order, fear of crime, and victimization.26 These studies
had no individual-level data and, therefore, could not ex-
amine whether this is a contextual effect of the neighbor-
hood. There are 2 published studies using multilevel
analyses to explore organizational structure of neighbor-
hoods. In Maastricht, single people were at greatest risk of
schizophrenia in neighborhoods with smaller proportions
of single people, ie, individual risk was conditioned on the
neighborhood organization.22 The second study from the
United States16 found residential mobility (population
turnover and rented accommodation)–predicted preva-
lence of schizophrenia independent of area deprivation,
ethnic composition, and individual social economic sta-
tus. It is possible that important individual risk factors,
eg, family histories, which were not controlled for, con-
found these results. Finally, we cannot assess the direction
of this association, social disorganization might increase
the risk of schizophrenia or possibly the social behavior
of people with schizophrenia may increase the social dis-
organization in the areas where they live.
Ethnic Composition (minority status)
Again, we find a strong ecological relationship between
proportion of people from an ethnic minority in an area
and its rate of service use16,18,21 which is attenuated
when individual-level ethnicity is adjusted for.16,21
When people with a particular characteristic live in an
area where this characteristic is less common, we observe
higher rateofmental illness.27 Boydell etal21 examinedthis
with regard to ethnicity and found incidence rates of
schizophrenia to increase in ethnic minority groups as
the proportion of ethnic minorities in the locality fell;
this association has recently been replicated (not yet pub-
lished).28 Further work is required, including measures of
individual-level social disadvantage. It may be interesting
Environmental Factors in Schizophrenia: The Wider Social Environment and Schizophrenia
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to measure how minority groups are integrated/segregated
in a neighborhood, along with subjective measures of how
they perceive their environment, to clarify what aspect of
the social experience (eg, discrimination) increases risk.
Is There Evidence of Contextual Neighborhood Effect?
Multilevel modeling is a recent advancement, but the ini-
tial findings are promising and suggest that high rates of
psychosis in the most socially disorganized areas (rather
than the most deprived areas) are contextual neighbor-
hood effects. Individual risks of psychosis for minorities’
groups seem to be conditioned on neighborhood ethnic
density. These findings need to be replicated and study
designs developed to extend the hypothesis of a neighbor-
hood contextual influence.
Social cohesion may be the concept, which bridges these
2 neighborhood effects. Both may reflect populations that
are generally less likely to form stable neighborhood ties,
residential mobility impeding bonding in disorganized
area, while people from minority groups may be more vul-
nerable to discrimination, perceived alienation, and
anomie when they are a smaller minority. A socially co-
hesive area has richly endowed stocks of social capital
(features such as levels of interpersonal trust, norms of
reciprocity, and mutual aid, which act as resources for
individuals and facilitate collective action).29,30 Social
capital may be a protective factor for development of
schizophrenia, though the potential mechanisms for this
effect need to be developed. Social capital may work as
a ‘‘buffer’’ modulating stress and dopamine regulation,
mechanisms in the development of psychosis,31 or through
psychological mechanisms; areas of low social capital may
promote development of persecutory attribution styles,
which in people with a genetic liability, may eventually
manifest as a fully blown psychotic episode.32 Further re-
search using more sophisticated measures of the social en-
vironment33,34 examining its effect across the life course, at
different aggregation levels, and using well-specified mul-
tilevel models should help elucidate the influence of the
wider social environment on schizophrenia.
Appendix
Search Strategy
The studies included in this review were identified by key-
word searches MEDLINE, EMBASE, PsychINFO, and
Science and the Social Science Citation Index using com-
binations of the keywords ‘‘schizophrenia’’ OR ‘‘psycho-
sis’’ AND ‘‘neighbourhood,’’ ‘‘ecological,’’ ‘‘multi-level’’,
‘‘hierarchical’’, ‘‘socioeconomic factor’’ ‘‘socioeconomic
deprivation’’ ‘‘deprivation’’ ‘‘material deprivation’’, ’’so-
cial disadvantage’’ ‘‘inequality’’ ‘‘poverty’’ ‘‘social cohe-
sion’’ ‘‘social disorganisation’’, ‘‘social fragmentation’’,
‘‘social capital’’ ‘‘residential mobility’’ ‘‘ethnicity’’. T
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CHAPTER 6 
Variation onset of schizophrenia by person 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
van Os J & Allardyce J 2009 
Presented are extracts from: The Clinical Epidemiology of Schizophrenia, in Kaplan & Sadock’s 
Comprehensive Textbook of Psychiatry (Ninth Edition) Lippincott & Wilkins Publications: esti-
mated publication date November 2009. 
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RISK FACTORS FOR THE ONSET OF SCHIZOPHRENIA 
Genetic Risk: Indirect evidence from epidemiological studies (1;2) 
Family studies compare the morbid risk (the proportion of affected to unaffected relatives, usu-
ally adjusted for variation in non-affected participants time-at-risk) for probands with schizo-
phrenia, to the morbid risk in the general population or demographically matched control 
groups. Results from a systematic review of the studies published during the period 1980-2003, 
found the first-degree relatives of probands to have a higher morbidity risk for schizophrenia as 
compared to the relatives of controls. Estimates ranged from 2-9% (in studies which adjusting 
for time at risk using Weinberg, Strömgren or Kaplan Meier methods) compared to a morbid risk 
in the relatives of controls of about 0.5%. The effect varied according to the diagnostic classifica-
tion employed in the study, broader definitions of schizophrenia, such as Research Diagnostic 
Criteria, tending to show larger estimated effects than the narrower definitions employed post 
DSM III and studies using control groups unscreened for psychiatric disorder showed more con-
servative estimates. There was also evidence of clinical heterogeneity, with the relatives of early-
onset cases having a higher morbid risk compared to the relatives of late onset cases. Further 
studies have examined familiar aggregation for categorical subtypes, symptom dimensions de-
rived from factor analysis and individual symptoms. The findings are inconsistent and show 
significant methodological heterogeneity; there is nevertheless some support for higher morbid 
risk for schizophrenia associated with negative symptoms and the disorganization dimension / 
hebephrenic subtypes. Most family studies have investigated morbid risk in first-degree rela-
tives; the few studies of second and third degree relatives suggest an increase in risk with in-
creasing relationship closeness, the structural form of which may not be linear. 
Adoption studies: Most children inherit their genetic characteristics and early rearing environ-
ment from the same biological parents. Adoption provides an opportunity to disentangle these 
genetic and rearing effects. Evidence from adoption studies have primarily come from 1) An 
adoptee’s family study using the Danish national linked data set, comparing rates of schizophre-
nia in the adoptive and biological families of adoptees with schizophrenia. Results reported over 
the last 30 years (using different diagnostic criteria) consistently show the biological relatives to 
be at a higher risk of schizophrenia than the adoptive relatives, who have a similar estimated 
risk to the rest of the general population. 2) The second strategy compares the rates of schizo-
phrenia in adopted away children, for parents with and without a diagnosis of schizophrenia. 
Early studies using this methodological approach consistently demonstrated higher rates of 
schizophrenia in the adopted away offspring of affected mothers, compared to the rates in the 
offspring of the unaffected controls. An ongoing Finnish study has improved on these earlier 
methodologies by identifying larger samples, using standardized interviews with home assess-
ments and DSM operationalised diagnostic criteria. Its results support the early findings, show-
ing a morbidity risk in the adopted away offspring of mothers with schizophrenia of 5.1%, as 
compared with 1.6% in the adopted away offspring of control mothers. 
Twin studies: examine the concordance rates for monozygotic (identical) twins (assumed to 
inherit all their genes in common) with those of dizygotic (non-identical) twins (who on average 
share around 50% of their genes). Such studies further assume that twin pairs are equally ex-
posed to environmental risk factors for schizophrenia. Statistical combination of the published 
studies that used DSM IIIR criteria to define caseness, estimated pooled concordance rates of 
50% in monozygotic twins and 4.1% in the dizygotic pairs, the pooled estimates of concordance 
for studies using different diagnostic classification systems are actually very similar. The con-
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cordance rate for monozygotic twins was higher in twins with an early rather than a late onset of 
schizophrenia. Twin studies investigating classical schizophrenia subtypes show higher 
monozygotic concordance rates for the hebephrenic subtype compared to the paranoid type. 
Combination twin and family studies find the risk for schizophrenia in the offspring of the iden-
tical and unaffected twin to be the same as that seen for the offspring of the affected twin. 
Specificity of Heritability 
Relationship to subclinical-psychoses phenotypes: Clinicians have long recognized that some 
close relatives of patients with schizophrenia, though never frankly psychotic, display symptoms 
and signs similar to the pathological experiences seen in the clinical disorder. Some are attenu-
ated forms of the positive/disorganized symptoms of schizophrenia (odd behavior, odd speech, 
muddled thinking, loose associations, ideas of reference, magical thinking, suspiciousness and 
illusions) while others resemble the negative symptoms (social isolation, aloofness, guardedness 
poor rapport). The DSM classification system has combined these quasi-psychotic (schizotypic) 
features under the diagnostic category; schizotypal personality disorder. As schizotypal, schiz-
oid, and paranoid personality disorders are found to co-occur they have been grouped together 
under the rubric Cluster-A personality Disorder within the manual. Family studies measuring 
lifetime prevalence for DSM cluster-A personality disorders (some studies have also included 
avoidant personality disorder) in first-degree relatives of patients with schizophrenia (and other 
psychotic disorders including psychotic bipolar disorder) find rates in the relatives of the pro-
bands (range: lifetime prevalence 2.8% – 8.2%) that are 2-4 times the rates found in the control 
families. The significant heterogeneity in estimated lifetime prevalence is primarily due to 
methodological differences. Adoption and twin studies confirm this familiar aggregation. Nega-
tive-schizotypic features (and associated neuro-cognitive impairments) are more prevalent than 
positive schizotypic features in the relatives of patients with schizophrenia. Further, studies 
investigating the correlation of (factor analytically derived) ‘pathological’ symptom dimensions 
(positive negative and disorganized) in patients with their corresponding (factor analytic de-
rived) non-pathological’ schizotypal dimensions in the clinically well relatives, have consistently 
shown correlation of the negative ‘pathological’ dimension and negative schizotypal dimension, 
suggesting a discrete genetic liability effect across ‘pathological’ and ‘non-pathological’ negative 
symptoms. Less clear is the association of ‘pathological’ disorganized and positive symptom di-
mensions and their corresponding schizotypic dimensions. The familiar co-aggregation of 
‘pathological’ and attenuated schizotypal symptoms suggests that their may be a single contin-
uum of liability across the schizotypic features and ‘pathological’ psychotic symptoms. 
Relationship to other psychotic disorders & bi-polar disorder: Family and adoption studies of 
schizophrenia have generally shown an excess of risk in biological relatives, not only for schizo-
phrenia, but also for a broad range of psychotic disorders, such as schizophreniform, schizoaffec-
tive, delusional, atypical, delusional disorders. Less accepted is the possible familiar co-
aggregation of bipolar disorder and schizophrenia in families, stemming primarily from the lim-
ited and conflicting data available from family studies of bipolar disorder, which have been in-
terpreted to support the disorder ‘breeding true’. However, schizoaffective disorder occurs at 
similarly increased rates in the families of probands with schizophrenia and bipolar disorder, 
and family studies of schizoaffective disorder demonstrate increased risk for both schizophrenia 
and bipolar disorder, suggesting at least some genetic non-independence. These studies do not 
help us elucidate the nature of this shared liability. A possible explanation would be an underly-
ing continuous common liability for all psychotic disorders. A twin study from Finland tested the 
hypotheses that affective disorders and other psychotic disorders represented an intermediate 
threshold on a liability continuum shared with schizophrenia. The results did not support a sin-
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gle continuum liability model, though the investigators did not compare alternative hybrid mod-
els. However, a further study investigated both common liability (shared genetic effects) and 
disorder specific liability models, using the Maudsley twin data set. The researchers relaxed the 
normal hierarchical diagnostic approach, so allowing within person co-morbidity of schizophre-
nia schizoaffective and manic syndromes. Independent and common pathway models were used 
to compare the associations of the syndrome pairs and found that for schizophrenia and mania, 
the model encompassing both shared (common) and syndrome-specific genetic effects fitted the 
data best, while for schizoaffective disorder the shared genetic effect model was sufficient to 
explain the associations. These results suggest that transmission may operate through a set of 
susceptibility genes specific to schizophrenia, and another set specific to bipolar disorder, while 
a third set of shared (common) effects acts across the three syndromes. Interpretation of these 
studies must be tentative; findings are preliminary and somewhat crude (based on additive and 
static models of genetic liability) and further replication is required. These codicils not with-
standing, the evidence point towards a model of liability, which incorporates a common (shared) 
genetic susceptibility for psychosis, and concomitant separate schizophrenia-specific liability. 
There have been substantially fewer studies examining the risk of non-affective and non-
psychotic Axis 1 disorders in the relatives of probands with schizophrenia; the current weight of 
evidence however suggests little or no familiar association. 
Genetic Model of Liability for Schizophrenia (3) 
The family, adoption and twin studies discussed above provide irrevocable evidence for the in-
volvement of a major genetic component in the liability for schizophrenia. However, the familiar 
distributions are inconsistent with simple Mendelian modes of inheritance (single major locus) 
and are more compatible with a oligo/polygenetic mode of inheritance. One possible model is 
the polygenetic threshold model, which assumes the risk of schizophrenia is due to additive ef-
fects of multiple small genes, at different loci. However, the polygenetic threshold model does not 
adequately account for the exponential rise in risk of schizophrenia observed with increasing 
familiar closeness, which is more consistent with (at least some) epistasis (an interactive effect 
between 2 or more genes , such as suppression or alteration of the expression of one gene by 
another locus). Nonetheless, the monozygotic/dizygotic twin correlations are significantly lower 
than would be expected with a full epistatic model. Therefore, it is more likely that both genetic 
and environmental factors contribute to the development of schizophrenia. The mechanisms by 
which these factors interact to influence risk remains unclear, but will probably involve the 
complex interplay of both additive and interacting genes, environmental factors and gene-
environment interactions (genetic moderation of environmental factors and environmental 
moderation of gene expression), which are continuously distributed within the population. Fur-
ther, this model of risk may vary across individuals, families or clinically defined subgroups of 
the disease, depending on the specific risk factors active within the person at different stages of 
development. If we accept this probabilistic model of risk transmission then environmental risk 
factors appear to be necessary complementary components in the development of schizophre-
nia, in many if not all cases. 
Gene-environment interaction (4;5) 
Traditional epidemiological risk factor methodologies measure the linear association of envi-
ronmental exposures to risk for onset and persistence of schizophrenia. Such studies (discussed 
below) demonstrate that people respond differently to the same environmental exposure. Some 
individuals seem to have a low risk of developing the disorder as a result of an environmental 
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exposure, while others are more vulnerable, or in some circumstances person’s with increased 
liability for a disorder seem to have a higher exposure frequency to noxious environmental 
agents, as compared with the general population. Variation in genotype may in part, account for 
this heterogeneity, two of the most often studied gene-environment relationships are 1) Gene-
environment correlation: A genotype may increase the likelihood of a person becoming ex-
posed to an environmental risk factor. For example, biological parents not only determine a 
child’s genotype but also provide their early rearing environment; or a child’s temperament (at 
least partially genetically determined) influences how he or she selects and/or shapes their en-
vironment. 2) Gene-environment interaction (synergism): Posits that instead of inheriting a 
disease state per se, a person actually inherits a set of genetic susceptibility factors, which act to 
moderate the effects of (causal) environmental exposures. If this assumption is correct, inte-
grated epidemiological approaches, which examine the joint influence of genes and environment 
on the risk for schizophrenia, will improve the accuracy and precision of the measured risk es-
timates and the predictive power of environmental risk factors. 
ENVIRONMENTAL RISK FACTORS FOR THE ONSET OF SCHIZOPHRENIA 
A number of environmental factors are statistically associated with an increased risk for onset of 
schizophrenia. Evidence of association however, does not equate to causality. Decisions regard-
ing causation require deductive judgments. In order to aid this logic, causal criteria have been 
developed (6) (Textbox 1). This chapter uses the most frequently applied criteria to structure 
the review of the current evidence for the risk factors for the onset of schizophrenia, however it 
is important to stress that these criteria should not be used in a mechanistic fashion, as all have 
exceptions and are useful at best as a framework for thought.  
RISK FACTORS OPERATING DURING “EARLY DEVELOPMENT” 
Paternal Age 
Recently, several large population based cohort studies from Israel, USA, Denmark and Sweden 
have provided strong evidence linking advanced paternal age to the risk of schizophrenia in the 
offspring. Strength of the association: The association is strong, independent and the findings 
consistent. There is a higher risk of schizophrenia (around 3-4 times) in the offspring of fathers 
who are older than fifty, at the time of conception, compared to the offspring of fathers in their 
early twenties. The small variation of estimated effect size across studies reflects methodological 
differences, with higher associations found in studies of patients with narrowly defined schizo-
phrenia. Dose-Response Relationship: Nearly all studies have found a dose-response relation-
ship, with the risk increasing across consecutive age-bands. The functional form of this associa-
tion has not established but there is some evidence for a slightly increased risk of schizophrenia 
in younger fathers (under 20) with J-shaped associations having been suggested. Temporal As-
sociation: exposure clearly predates diagnosis of schizophrenia. Consistency of findings & po-
tential sources of confounding and bias: All the cohort studies have estimated broadly similar 
strengths of association and while adjustment for known risk factors have been made, there may 
be residual confounding by a factor currently unidentified, which directly increases the risk of 
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TEXTBOX 1: CAUSAL CRITERIA  
 
1. Strength of the association 
The argument states that strong associations are more likely to be causal, because if they could be explained by 
another factor the effect of the confounder would have to be even stronger than the observed association. While 
weaker associations are more likely due to ‘noise’ and bias It is important to remember that measures of associa-
tion (eg relative risk for odds ratios) are a characteristic of the sample under study and depends on the relative 
prevalence of other causal factors. 
 
2. Dose-response relationship (biological gradient) 
Defines a unidirectional trend in disease frequency with increasing levels of exposure; however, this is neither 
necessary or sufficient for causality as the presence of an unadjusted confounder will also show a gradient. Further, 
some causal relationships show single jumps (thresholds).  
 
3. Temporal association 
This is a  sine qua non for causality. Requires that for a factor to be considered causal it must precede the disease, 
this is irrefutable, however it does not provide evidence for or against causation when the cause is present prior to 
onset of the disorder.  
 
4. Consistency of findings 
Is the repeated observation of an association in different populations under different circumstances. However, lack 
of consistency does not rule out a causal association because some risk factors only produce effects under certain 
situations where a complement of causes are present (or have been present). Consistency can only really be as-
sessed after the relevant details of the causal mechanism are understood. 
 
5. Specificity of effect 
This is still emphasised in psychiatric epidemiology, perhaps due to the continual nosological debates regarding 
classification of disorders. However, there are no good grounds to refute a causal interpretation of an exposure 
because it is related to multiple effects or disease outcomes. 
 
6. Biological plausibility 
Plausibility is important however, biologically plausible hypotheses can be constructed which are later found to be 
erroneous and vice versa causal associations can be dismissed due to current knowledge or belief systems. 
 
7. Coherence 
Related to biological plausibility and therefore similar problems, the association should not conflict with what is 
known of the natural history and biology of the disease. 
 
8. Experimental evidence 
Commentators are unclear what is meant by experimental evidence, wither it was evidence coming from labora-
tory work or human experiments such as removal of an exposure. However this is a test for causality rather than a 
criterion. 
 
9. Analogy 
Analogy may provide a source for more elaborate hypotheses about the associations but does not falsify a hypothe-
sis. 
 
Critique of the causal criterion 
With the exception of temporality none of the above situations can be viewed as a necessary or sufficient criteria 
for determining wither an observed association is causal. Causal inference cannot be deduced with certainty.  
 
schizophrenia and is also associated with paternal age. Specificity of effect: The association is 
stronger for narrowly defined schizophrenia compared to non-affective psychosis supporting 
relative specificity for schizophrenia within the spectrum of psychosis. Association with age at 
onset: no evidence for an association between age of first admission and paternal age has been 
demonstrated. Evidence of Gene-environment interactions: There is a stronger association 
between paternal age and schizophrenia in people without a family history (7). This observed 
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pattern of effect lends support for two genetic theories. The first and most likely is that advanc-
ing paternal age results in accumulation of de novo mutations in the germ cells of older fathers, 
or secondly advancing paternal age interferes with the DNA-methylation process of gene ex-
pression.  
SEASON OF BIRTH (8;9) 
Excess winter birth in people who later develop schizophrenia is a robust epidemiological find-
ing, at least in the Northern Hemisphere. It is likely to be a ‘proxy’ indicator for some seasonally 
fluctuating environmental factor. The most popular hypotheses relate to seasonal variation in 
exposure to inter-uterine viral infections around the time of birth, or variation in light, tempera-
ture/weather or external toxins. Strength of the association: There is a statistically significant 
but small effect associated with winter birth and later development of schizophrenia, a meta-
analysis of Northern hemisphere studies, estimated a pooled odds ratio of 1.07 (95% confidence 
interval 1.05-1.08). Dose-response Relationship: the effect size increases with latitude (though 
there are fewer studies from the lower latitudes of the Northern hemisphere in the pooled 
analyses) until about 50 degrees latitude, where it then starts to fall, suggesting a nonlinear in-
verted U shape association, this may in part be explained by methodological heterogeneity 
across studies. Temporal Association: exposure clearly predates diagnosis of schizophrenia 
Consistency of findings & potential sources of confounding and bias: The studies from North-
ern hemisphere countries consistently show excess winter births in people with schizophrenia, 
however the effect seems to be greater for those born in urban as compared to rural settings. A 
meta-analysis of studies carried out in the southern hemisphere did not find an effect for season 
of birth (pooled odds ratio 1.04, 95% confidence interval 0.99-1.08). Further pooled analyses of 
individual patient data, found a significant association with deficit syndrome schizophrenia (a 
group defined by primary enduring negative symptoms) and summer birth thus the season of 
birth effect pattern seems to differ across groups of patients with different clinical characteris-
tics. Specificity of effect: Studies examining season of birth association to other psychiatric con-
ditions are small and their findings inconsistent. The largest and most robust study, carried out 
in Denmark did not find an association with season of birth and development of bipolar disorder 
suggests some specificity of effect for schizophrenia (spectrum) disorder as compared with bi-
polar disorder. Association with age at onset: Few studies have looked at age of onset in rela-
tion to seasonality of birth in people with schizophrenia, the largest study to date found higher 
rates of winter births in patients who developed schizophrenia later in life, most studies are 
underpowered to investigate this issue. Evidence of Gene-Environment Interactions: Little 
information is currently available. Indirect support comes from a recent study In Puerto Rico, of 
25 families with at least two siblings who were diagnosed with schizophrenia, affected relatives 
were more likely to have been born in the winter months, as compared to their unaffected family 
members, suggesting further research on interaction between winter birth and underlying ge-
netic liability may be productive. 
PREGNANCY AND BIRTH COMPLICATIONS (10;11) 
There are a large number of published studies demonstrating some relationship between preg-
nancy and birth complications and the development of schizophrenia. Strength of the associa-
tion: The literature suggests pregnancy and birth complications have a small effect on the risk of 
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later development of schizophrenia. Meta-analytic studies have estimated a pooled odds ratio of 
2.0 (95% confidence intervals 1.6-2.4) for patients with schizophrenia having a history of preg-
nancy and birth complications compared with non-affected controls. The term ‘pregnancy and 
birth complications’ covers a broad range of pre and peri-natal events but even a large system-
atic review of prospective population-based studies (period 1995-2001) was unable to identify 
one individual complication or unifying mechanism. The investigators found three main catego-
ries of obstetric complication to have significant estimates, i) abnormal fetal growth and devel-
opment: low birth weight, congenital malformations and small head circumference. ii) Complica-
tions of pregnancy: bleeding, pre-eclampsia, diabetes and rhesus incompatibility. iii) Complica-
tions of delivery: asphyxia, uterine-atony and emergency cesarean section. Taken together, they 
seem to implicate an increased risk of hypoxia. Dose-response Relationship: Studies to date 
have mostly been underpowered to uncover variation in effect size (odds ratio) across groups 
ordered by degree of exposure to pregnancy and birth complications. One population based-
cohort study from Helsinki used continuous measures and found an effect gradient of increasing 
risk with decreasing birth weight, length at birth and placental weight (controlled for family 
history of schizophrenia) and The National Collaborative Perinatal Project found risk increased 
when multiple hypoxia-associated complications were present. However, it is difficult to inter-
pret these gradients while the underlying mechanism remains elusive. Temporal Association: 
exposure clearly predates diagnosis of schizophrenia, though fetal growth retardation may be an 
early indicator of aberrant neurodevelopment. Consistency of findings & potential sources of 
confounding and bias: The associations for individual obstetric complication with later devel-
opment of schizophrenia are mostly negative and inconsistent; however, statistically pooled 
estimations suggest a modest effect with the broad category of pregnancy and birth complica-
tions. There is methodological heterogeneity with a discrepancy in the estimated effects for case 
control studies (that generally show stronger associations) and cohort studies. The most likely 
explanation for this is selection and information bias, in the of case control studies. Pregnancy, 
birth and neonatal complications do not act independently of each other; however, current stud-
ies are underpowered to detect interactive effects. There have been few studies examining dif-
ferential effect of pregnancy and birth complications and symptom dimensions or subtypes of 
schizophrenia. A small study from Poland found pregnancy and birth complications to be signifi-
cantly more frequent in patients with prominent negative symptoms compared with patients 
with prominent positive symptoms. Specificity of effect: A recent systematic review of preg-
nancy and birth complications and bipolar disorder, estimated the pooled odds ratio for expo-
sure to pregnancy and birth complications and later development of bipolar disorder to be 1.01 
(95% Confidence interval 0.76-1.35) compared to controls, 1.13 (95% confidence interval 0.64-
1.99) compared with patients with unipolar disorders and 0.61 (95% confidence interval 0.39-
0.95) compared with people who later developed schizophrenia. Furthermore, a Danish National 
Register based study did not find fetal growth indicators to be associated with the development 
of bipolar disorder. This suggests some specificity for schizophrenia (spectrum) disorder among 
psychiatric conditions. Association with age at onset: a meta-analytic study reanalyzed indi-
vidual patient data from 11 case-control studies of adult onset schizophrenia, the pooled odds 
ratio was 1.52 (95% confidence intervals 1.04-2.2) for patients with earlier age of onset (under 
22) for broadly defined pregnancy and birth complications compared with the later onset group. 
Further analysis divided the age distribution into quartiles and found a gradient of association 
across age groups (adjusted for study design). However, two cohort studies of childhood onset 
schizophrenia have not found stronger effects in very early onset cases. Evidence of Gene-
environment interactions: Indirect evidence comes from a population based cohort study in 
Helsinki, which found that a history of fetal hypoxia was associated with increased structural 
brain abnormalities (reduced grey matter and increased ventricular size) among schizophrenia 
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patients and their non-affected siblings, but not among controls at lower genetic risk for the dis-
order. Moreover, the effect size was greater for patients compared to the unaffected siblings, 
suggesting that while they show some sensitivity to the ‘schizophrenia-promoting’ effects of 
hypoxia there is a quantitative difference in this sensitivity. Gene-environment correlation: 
Evidence from a meta-analytic study of pregnancy and birth complications in children born to 
parents with schizophrenia found individuals with schizophrenia to have an increased risk of 
obstetric complications, low birth weight and poor neonatal condition. The risk is greater for 
mothers with schizophrenia but is not confined to mothers with onset prior to delivery or to the 
births of the children who develop schizophrenia themselves later in life. These findings possibly 
reflect a gene environment correlation where by the genetic liability for schizophrenia in the 
parent increases the likelihood of social adversity which is associated with obstetric complica-
tions. 
OTHER PUTATIVE PRENATAL RISK FACTORS 
Emerging evidence from ecological studies suggests that a number of other prenatal factors may 
have a weak association with the later development of schizophrenia Prenatal infections (12). 
A series of studies have found higher rates of schizophrenia in people exposed to the 1957 influ-
enza pandemic during the second trimester of their gestation. This is not a fully replicated find-
ing and remains controversial. A study from New York City found a 10-20% increased risk for 
schizophrenia in people who had serologically confirmed prenatal rubella exposure, while fur-
ther studies have implicated prenatal exposure to toxoplasmosis, polivirus and other common 
respiratory infections. The effect may be in part due to cytokines and chemokines, which medi-
ate host response to infection. Rhesus Incompatibility There is some evidence that rhesus in-
compatibility increases the risk of developing schizophrenia; this may not be through the direct 
toxic effect of hyperbilirubinemia on the developing brain, but rather via maternal-fetal geno-
type incompatibility effects. Prenatal stress: There may be higher rates of schizophrenia in the 
offspring of mothers who experienced significant levels of stress during pregnancy, such as the 
death of a spouse, living through a natural disasters or military invasions. Famine during preg-
nancy: Nutritional deficiency in pregnancy may also increase the risk of schizophrenia in off-
spring. A two-fold increase in rates of schizophrenia was found in the children of mothers who 
were exposed to the Dutch famine, during early gestation. These putative environmental risk 
factors all require further replication. 
RISK FACTORS OPERATING DURING CHILDHOOD AND ADOLESCENCE 
Urban birth & upbringing (13;14) 
Over twenty studies have demonstrated an association between urban living and rates of 
schizophrenia and non-affective psychosis. Strength of the association: Generally, studies show 
a two-fold increase in risk of schizophrenia in urban as compared to rural settings. Dose-
response Relationship: The weight of evidence supports a risk gradient, with unidirectional 
increasing rates of schizophrenia with increasing levels of urbanicity. Temporal Association: 
There is compelling evidence suggesting that elevated rates of schizophrenia in urban areas are 
not due to social drift during the prodrome (reverse causation). It is urban exposure prior to the 
onset of the disorder, which seems to be more important rather than the level of exposure at the 
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time of illness onset. A case register study from The Netherlands demonstrated an increased risk 
of schizophrenia for people born in urban areas irrespective of where they were living at the 
time of presentation, while those living in urban areas were only at increased risk if they had 
also been born within an urban area. Furthermore, a Danish study measured the effect of cumu-
lative urban exposure on risk of schizophrenia and found the first fifteen years of life were the 
most critical. Analyses from the same cohort further suggest that people conceived (including 
period of gestational development) in urban areas but reared in less urban areas may be at 
higher risk of schizophrenia (15). This phenomenon of increased risk seen when there is a mis-
match between in-utero developmental environments versus environment in adult life is recog-
nized in other chronic complex diseases, such as cardiovascular disease. Consistency of findings 
& potential sources of confounding and bias: The findings are consistent with similar effect 
sizes seen across studies from different geographical areas. The effect is not confounded by 
other known risk such as pregnancy and birth complications and is present after controlling for 
socio-demographic variables. Specificity of effect: Most analyses have examined the association 
of urban living within the broad psychosis category rather than specific diagnoses. Studies, 
which have compared across diagnostic categories, have found the risk to be relatively specific 
for schizophrenia (spectrum) disorders compared to bipolar disorder. Association with age at 
onset: Few investigators have examined this, but those that have consistently find an earlier age 
of onset in people exposed to urban upbringing. Evidence of gene-environment interactions: 
Studies investigating family history and urban exposure support a possible interaction with ge-
netic liability. For example in the Danish cohort, those without a family history of schizophrenia 
had a much smaller risk of schizophrenia (0.054% increase risk, per unit change of urbanicity) 
compared to those with a family history (0.22% increase in risk, per unit change of urbanicity). 
Could group level social processes account for the urban upbringing effect? 
Growing up in an urban environment is a proxy environmental risk factor. Recent research has 
started to examine the social and economic structure of neighborhoods as a possible explanation 
for this effect. The social environment varies widely and systematically across dimensions of 
material deprivation, neighborhood organization (social fragmentation) and ethnic composition. 
Deprivation: Studies have consistently found a relationship (not necessarily linear) between 
material deprivation and risk of schizophrenia, though study design has generally been cross 
sectional therefore the direction of the relationship can not be assessed, and could be accounted 
for by people drifting into more deprived areas before presenting to clinical services. Social 
Fragmentation/social cohesion: Ecological studies have consistently shown area level social 
fragmentation to influence strongly the rates of schizophrenia. A small number of recent studies 
have examined levels of social cohesion and found neighborhoods richly endowed with stocks of 
social capital (interpersonal trust, norms of reciprocity, mutual aid) to have reduced rates of 
psychosis independent of material deprivation. Ethnic density: is an area level characteristic, 
defined as the percent composition (in a particular geographical area) of people with a given 
ethnicity, and has been found to be protective. That is, the higher the area ethnic density the 
lower the rates of schizophrenia for the ethnic group under study, independent of area measures 
of deprivation. Taken together these reports suggest a possible neighborhood level social proc-
ess influencing the risk of schizophrenia, which will require further elaboration and replication. 
MIGRATION (16) 
Many studies have reported increased rates of schizophrenia in migrants, especially among the 
second-generation born in the new homeland. Increased risk is found among African Caribbean 
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and black African immigrants to the UK; Surinamese Dutch-Antillean and Moroccan immigrants 
to The Netherlands; Australian, African and Greenland immigrants to Denmark and Greek immi-
grants to Belgium. Strength of the association: A meta-analysis of incidence studies (published 
between 1970-2003) found a higher risk of schizophrenia in almost all immigrant groups com-
pared with the majority population. Although the pooled effect size suggested a three-fold in-
crease in risk, there was evidence of systematic heterogeneity across studies, which could not be 
accounted for by variation in study design. Analyzing first and second-generation migrants sepa-
rately found a pooled relative risk of 2.7 (95% confidence intervals 2.3-3.2) for the first genera-
tion and a higher pooled relative risk of 4.5 (95% confidence intervals 1.5-13.1) for the second 
generation. There was also a higher risk of schizophrenia in migrants from developing countries, 
however the most conspicuous finding was the increased risk associated with being black, with a 
pooled relative risk of 4.8 (95% confidence interval 3.7-6.2). Dose-response Relationship: mi-
grant status is a binary exposure; one is either a migrant or one is not. Therefore, a dose-
response association will only be testable after the underlying mechanism operating to increase 
the risk is established. Temporal Association: The selective migration of people at increased 
risk of schizophrenia is possible (reverse causation). However, this does not explain the in-
creased risk, apparent in groups who migrated on mass, such as the Surinamese mass migration 
to the Netherlands. Further, it cannot explain the increased risk found in the second-generation 
immigrants. Consistency of findings & potential sources of confounding and bias: Increased 
risk of schizophrenia in migrant groups is a replicated and consistent finding. The validity of this 
finding has been intensely debated, however. Increased rates do not appear to be explained by 
psychiatrists diagnosing schizophrenia differently in migrant groups, differential service use or 
under-enumeration, which may have hampered some of the earlier studies. Poor obstetric care 
in migrant mothers has also been muted as an explanation but there is no evidence to support 
this view. The few published studies examining migrant status across dimensions or subtypes of 
schizophrenia have not detected any differential associations between migrant group and the 
majority population. Finally, studies mostly from the United Kingdom have found the risk of 
schizophrenia to vary across different ethnic groups. The African Caribbean and black African 
groups in England are at higher risk than the Asian group, as are the Surinamese and Moroccan 
groups compared to the Turkish group in the Netherlands. Specificity of effect: The association 
is not specific to schizophrenia with rates of non-affective and bipolar disorder also higher in 
migrants. A large cohort study in the UK (AESOP) found a 7-fold increase in mania among Afri-
can-Caribbeans and black Africans compared to the majority group and a two-fold increase in 
mania among other migrant groups. Association with age at onset: There is no difference in the 
age of onset in migrant groups as compared to the majority population. Evidence of Gene-
environment interactions: Family studies of schizophrenia have found a differential morbid 
risk for schizophrenia in the relatives of UK born African Caribbean probands (15.9%) compared 
with the rates in the relatives of white probands (1.8%) which suggests a possible gene-
environment interaction. 
CANNABIS USE (17) 
There is little doubt that cannabis intoxication is associated with transient psychotic symptoms 
in some individuals, furthermore case control studies have consistently demonstrated higher 
rates of cannabis use among patients with schizophrenia as compared with controls. However, 
controversy remains about whether cannabis is a risk factor for the development of schizophre-
nia or other psychotic disorders. There are only a few prospective studies examining prior can-
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nabis use and subsequent development of schizophrenia (or other psychotic disorders) but 
more studies have examined broadly defined psychotic outcomes, such as positive or negative 
symptoms and their associated disability. Strength of the association: The best evidence for an 
association between cannabis use in adolescence and subsequent development of schizophrenia, 
come from a study of Swedish conscripts who were followed up over a 27 years period (18). 
Cannabis use prior to conscription was associated with higher rates of schizophrenia, estimated 
odds ratio of 1.5 (95% confidence interval 1.1-2.0) after adjusting for potential confounders 
such as disturbed behavior, low IQ, urban upbringing and poor social adjustment. Further, a 
meta-analysis of prospective cohort studies found similarly high rates of broadly defined psycho-
sis outcome (either psychotic disorder or psychotic symptoms and associated disability) in peo-
ple who had ever used cannabis compared with no-users, pooled odd ratio of 1.41 (95% confi-
dence interval 1.20-1.65). There are a number of small studies examining association of canna-
bis use with symptom dimensions or subtypes of schizophrenia; most have found no association 
with negative symptoms and cannabis exposure. Dose-response Relationship: In the Swedish 
conscript study, the effect size increased with frequency of cannabis use and this is a consistent 
finding in the studies, which used the broader definition of psychosis outcome. Temporal asso-
ciation: It is possible that people with an emerging psychosis or schizophrenic prodrome start 
using cannabis to reduce their distressing symptoms (reverse causation) and this cannot be fully 
discounted. However, investigators have generally screened and excluded people who may be 
experiencing early psychotic symptoms at the start of the prospective studies. Specificity of ef-
fect: Studies examining cannabis use and the subsequent development of other psychiatric con-
ditions are small and their findings inconsistent. The evidence to date suggests some specificity 
of effect for schizophrenia and non-affective psychosis; however, it is too early to call. Consis-
tency of findings & potential sources of confounding and bias: The association with prior can-
nabis use and subsequent psychosis is a consistent finding across studies. Adjusting for other 
drug abuse, known risk factors of schizophrenia and socio demographic variables attenuates the 
effect but it remains statistically significant. Association with age at onset: One study to date 
has examined the age of onset and prior cannabis use (retrospectively assessed after onset of 
psychosis). It found males who used cannabis during adolescence had a significantly lower age 
of onset. Evidence of Gene-environment interactions: A family study of adolescents with acute 
psychosis found a ten-fold increase in the morbid risk for schizophrenia in relatives of probands 
who tested positive for cannabis use, compared to the relatives of probands who tested negative 
for cannabis. Furthermore, there is evidence that a specific functional polymorphism in the cate-
chol-O-methyltransferase (COMT) gene moderates the effect of adolescent cannabis use. Indi-
viduals homozygous for the COMT valine allele of this polymorphism are more likely to exhibit 
psychotic symptoms and develop schizophreniform disorder in adult life after exposure to can-
nabis but this adverse effect is not evident in individuals homozygous for the COMT methionine 
allele. Cannabis use itself is not associated with the COMT valine or methionine allele, suggesting 
an underlying gene-environmental interaction, (rather than a gene-environment correlation) is 
operating to increase risk. 
STRESSFUL LIFE EVENTS & EARLY CHILDHOOD TRAUMA 
Stressful life events: many studies report an excess of stressful life events, in the few weeks 
prior to the onset of psychotic and affective disorders. While these life events may precipitate, 
the disorder, there is some evidence to suggest they reflect a concatenation of stressful life 
events over a more sustained period before the onset of psychosis. However, it is difficult to es-
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tablish wither increased stress is a cause or a consequence in the development of psychotic dis-
order. This is difficult to disentangle with traditional risk factor methodologies; on the other 
hand, gene-environmental interaction designs may be a more fruitful way of exploring the effect 
of stress. For example, a study from Greece found stress related to army induction resulted in 
increased risk of psychotic symptoms but that the specific functional polymorphism in the COMT 
gene (mentioned above) moderated this effect, as individuals homozygous for the COMT valine 
allele of this polymorphism were more likely to exhibit psychotic symptoms than individuals 
homozygous for the COMT methionine allele. Early childhood trauma: describes a range of se-
vere adverse experiences including sexual, physical and emotional abuse and neglect. There are 
now a modest number of population based studies suggesting that the risk of psychotic experi-
ences is increased in those exposed to early childhood trauma. However, wither childhood 
trauma is a risk factor for schizophrenia remains controversial and open to question due to a 
number of conceptual and methodological issues which will require further study. 
PRE-MORBID VULNERABILITY INDICATORS/MARKERS 
Pre-morbid indicators: Early Developmental Abnormalities (11) 
As a group, individuals who develop schizophrenia as adults are more likely to manifest subtle 
motor/language, cognitive abnormalities during childhood and adolescence compared with in-
dividuals who do not develop schizophrenia. There does not appear to be any association be-
tween developmental abnormalities and prenatal insults, suggesting they may be indicators of 
genetic liability. Early Developmental Motor Abnormality: A series of large birth cohort stud-
ies, have consistently found evidence for delays in attainment of developmental milestones for 
pre-schizophrenic children. Abnormalities in motor milestones are most conspicuous before the 
age of two, while receptive language abnormalities are most prominent between the ages of five 
and fifteen. The relationship between the age of acquiring motor/language milestones and risk 
of schizophrenia appears to be linear, making a possible ‘developmental sub group’ unlikely. 
Furthermore, severe motor/language abnormalities tend to predict an earlier age of onset for 
schizophrenia. A study from Philadelphia, found increased rates of motor and language abnor-
malities, not only in the children who later developed schizophrenia, but also in their siblings 
who remained unaffected, suggesting manifest motor abnormalities may be markers of underly-
ing genetic liability. The early emerging motor and language deficits appear to be relatively spe-
cific for schizophrenia (or spectrum disorder). Early Developmental Cognitive Performance: 
As a group, children who later develop schizophrenia, score lower on standardized measures of 
intelligence compared to their unaffected counterparts throughout childhood however, the dif-
ference widens around the ages of about four to seven. Studies, which compared affected and 
unaffected siblings, found the pre-schizophrenic children had a lower IQ compared to their unaf-
fected sibling. This deviance in cognitive impairment seems to be relatively specific for schizo-
phrenia (spectrum) disorder and is not present in bipolar disorder. Twin and family studies 
have shown that the alterations in adult cognitive performance seen in patients and their first-
degree relatives are markers for schizophrenia genetic liability. It is likely that the developmen-
tal cognitive alterations similarly reflect the influence of genetic factors associated with schizo-
phrenia. Early developmental social/emotional impairment: As a group, the children who 
later develop schizophrenia are more likely to show signs of subtle social maladjustment, for 
example, poor relationships with other children, social isolation, lone play and social anxiety as 
compared to their peers. However, these subtle social markers are common among children who 
later develop a broad range of different psychiatric disorders. Predictive Power: While devel-
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opmental abnormalities are common in children who later develop schizophrenia, many pre-
schizophrenic children have normal developmental histories which results in low sensitivity 
(the ability to predict children who will later develop psychosis correctly). Furthermore, they 
are relatively prevalent in the general population (estimated at around 15%) which conse-
quently reduces their specificity (the ability to correctly predict children who will not develop 
psychosis) which in turn makes them poor predictors of future schizophrenia (positive predic-
tive power estimates range from 3%-5%). Developmental abnormalities may be most useful as a 
possible measurable indicator of genetic liability for schizophrenia 
Pre-morbid indicators: psychopathology/vulnerable mental states 
Childhood psychiatric disorders 
The Dunedin Multidisciplinary Health and Development study is a longitudinal follow up of a 
representative birth cohort of 1037 children born in Dunedin, New Zealand during the year 
(1972-73). Its strength lies in the fact that it has sequentially assessed not only childhood devel-
opmental indices, but also serially collected self-reported psychopathology (ages 11, 13, 15, 18 
and 21 years) with further psychiatric interviews having been carried out at age 11 and 26 
years. Investigators first examined diagnoses given to individuals across the follow-up period 
and found over half of those who had been given a major DSM-IV diagnosis at age 26 had also 
been given a diagnosis at age 11-15 and three quarter had been given a diagnosis before age 18 
years. Generally, there was child-to-adulthood syndrome-continuity found for anxiety, depres-
sion and antisocial disorders. However, no such syndrome-continuity was evident for adult 
schizophreniform disorder, which was preceded by a number of different childhood disorders, 
including anxiety, depression, conduct/oppositional disorder and attention deficit hyperactivity. 
This group of juvenile diagnoses did not specifically predict adult psychotic disorder but were in 
fact the harbingers of many different adulthood psychiatric illnesses. Predictive Power: Such 
findings clearly demonstrate significant psychopathology prior to adult onset psychosis. How-
ever, the juvenile categorical diagnoses are demonstrably poor discriminators for what adult 
psychiatric disorder a child is likely to develop in the future. 
Subclinical psychotic experiences 
Subclinical psychotic experiences predict later development of psychotic disorders: Evidence 
that subclinical psychotic experiences may be vulnerability markers (or even precursors) for the 
later development of psychotic disorders comes (again) from The Dunedin Multidisciplinary 
Health and Development study. In further analyses, the investigators examined whether self-
reported delusional beliefs and hallucinatory experiences at age eleven would predict schizo-
phreniform psychiatric disorder, fifteen years later (age 26 years) (19). By age 11 years, nearly 
fifteen percent of the total cohort reported some psychotic experience. Children were grouped 
according to the strength/frequency of their psychotic experiences (at age 11 years): the major-
ity of children had no psychotic symptoms (control group (n=654)), an intermediate group had 
weak symptoms (n=95) and small proportion had symptoms described as strong (n=12). At age 
26 years, 2% of the controls had a diagnosis of schizophreniform disorder, compared with 9.5% 
in the weak and 25% in the strong-symptom-groups. Early psychotic experiences specifically 
increased the risk for schizophreniform disorder moderately in the weak-symptom-group (odds 
ratio 5.1, 95% confidence interval 1.7, 18.3) and strongly in the strong-symptom-group (odds 
ratio 16.4, 95% confidence interval 3.9-67.8), compared to controls. While 25% of the strong-
group had developed schizophreniform disorder, a further 70% (although not fulfilling the full 
diagnostic criteria for schizophreniform disorder) still reported some psychotic symptoms (per-
sistence of pre-clinical psychotic experiences) at age 26 years and 90% had occupational and so-
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cial difficulties. The strong-symptom-group also manifest impairments in motor, language and 
cognitive ability, suggesting the pervasive and persistent psychotic experiences may be indica-
tors of an underlying ongoing psychotic process, reflecting increased genetic liability. The weak-
symptom-group on the other hand did not have such prominent developmental abnormalities, 
though they had significant receptive language impairment, suggesting a weaker genetic liability. 
Replication of this transition over time from subclinical psychotic experiences to full-blown psy-
chotic disorder comes from a longitudinal general population study in The Netherlands (The 
Netherlands Mental Health Survey and Incidence Study; NEMESIS). In order to identify new 
cases of subclinical psychotic experiences the cohort was followed up for one year. Individuals 
who reported subclinical psychotic experiences at the 1-year assessment, but not at baseline 
were considered incident cases. Next, a second-wave follow up (over 2 years) allowed the risk of 
transition of subclinical to clinical psychotic disorder (both affective and non-affective psycho-
sis) in the incident case group to be compared with the risk in the group of individuals with no 
clinical or subclinical psychotic experiences (controls). The incident cases were at significantly 
higher risk of developing psychotic disorders compared to the controls (odds ratio 65.1, 95% 
confidence interval 19.4-218.1) and the positive predictive value over 2 years was 8%. There 
was a dose-response relationship in the association between the number of subclinical psychotic 
experiences and the transition to clinical psychosis going from a risk of around 30 in individuals 
who had only one subclinical psychotic experience (odds ratio 27.3, 95% confidence interval 
5.2-143.6) to a much higher risk in individuals who had multiple subclinical experiences (odds 
ratio 211.2, 95% confidence interval 51.6-864.1). Characteristics of the subclinical psychotic 
experiences & transition to psychosis: In both the Dunedin Cohort and the Nemesis study, 
transition from subclinical to clinical psychotic disorder was higher in individuals characterized 
by stronger (persistent) subclinical psychotic experiences. In the Nemesis study, transition was 
also partly dependent on the emotional context of the subclinical psychotic experience. Most 
subclinical psychotic experiences are self limiting and transitory: Emerging evidence from 
general population studies show that subclinical psychotic experiences are relatively common 
(prevalence of around 15%). However, most are brief, self-limiting developmental phenomena. 
The reasons why approximately 15% of children have subclinical psychotic experiences during 
development and the others do not, is not fully established, but it may in part reflect the shared 
genetic liability for psychosis continuously distributed in the general population (20). Towards 
a dynamic model of psychosis evolution: proneness-persistence-impairment hypothesis. In 
two large independent general population samples, NEMESIS and EDPD (The early developmen-
tal health and incidence survey), investigators examined the hypothesis that these relatively 
common, subclinical developmental psychotic experiences could become abnormally persistent 
when synergistically combined with known risk factors for onset of psychotic disorders (the 
study used cannabis, urban upbringing and developmental trauma). Over a follow-up period of 
three years, the studies found the rates of subclinical psychotic experiences, which persisted to 
be relatively low, 26% (NEMESIS) and 31% (EDSP), however rates of persistence increased pro-
gressively with higher baseline doses of exposure to known risk factors. This suggests that envi-
ronmental determinants of psychotic disorders may in part operate by driving up the rates of 
subclinical psychotic experiences, which become persistent in individuals with a genetic liability 
for psychosis. A dynamic model of psychosis evolution or proneness-persistence-impairment 
model may best conceptualize this trajectory from developmental expression of psychosis liabil-
ity (transitory subclinical psychotic symptoms) to more intrusive persistent subclinical psy-
chotic symptoms to significant impairment and dysfunction and the eventual onset of psychotic 
disorder. Such a model provides a framework for the further investigation of the ontogenesis of 
psychotic disorders. Predictive power: The psychosis-proneness persistence-impairment-model 
of psychosis offers a possible insight into the underlying mechanism for development of psycho-
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sis. However, a positive predictive power of around 40% for persistent subclinical symptoms 
ability to estimate onset of future psychotic disorders is still too low to be useful as general 
population screening test.  
NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA 
The broad neurodevelopmental hypothesis: Posits that schizophrenia is the behavioral out-
come of subtle deviances in early brain development, the full effect of which is not manifest until 
adolescence or early childhood. There is convincing evidence for the broad neurodevelopment 
model, in agreement with the epidemiological findings for prenatal risk factors and developmen-
tal abnormities reviewed in this chapter. Children who later develop schizophrenia also have 
higher rates of minor physical anomalies indicative of subtle disruption of ectoderm develop-
ment e.g. craniofacial and dermatoglyphic anomalies and neurological soft signs. Further evi-
dence is the absence of inflammatory reactions in the brains of people with a diagnosis of 
schizophrenia. While earlier histological studies implicated abnormal neuronal migration during 
corticogenesis, this was not been borne out with further investigation. However, reduced neu-
ronal size, dendritic arborisation and spine density, in the cortex and hippocampus is a consis-
tent finding across studies. Such findings are important and support a neurodevelopmental 
model when put in the context of a burgeoning realization that ultra-structural refinement at the 
synapse is shaped by patterns of environmental input, which occur across the life span, and 
seems to have functional significance. Such plasticity in the connectivity of neurons is thought to 
underlie new learning and the development of new schemata and mental skills. Lag between 
exposure to environmental risk factors and onset of schizophrenia: There is generally a long 
latency period between exposure (before adulthood) to known risk factors and onset to schizo-
phrenia. Such a delayed effect is consistent with a causal model where the environmental risk 
factor increases a person’s liability, but the full manifestation of the disorder requires the addi-
tion or interaction of other complementary (gene or environmental) causal components. Several 
susceptibility genes for schizophrenia appear to have specific developmental correlates that 
influence brain development across the life course and it is possibly this variable expression, 
which forms the basis for the widespread subtle developmental delays and subclinical psychotic 
experiences seen years before the onset of schizophrenia and later emergence of the full-blown 
disorder. More over it could potentially help explain the broad variation in age of onset of 
schizophrenia. Epigenetic Hypothesis Suggests that the onset of schizophrenia is influenced not 
only by the additive or interactive action of static gene and environmental factors, but via epige-
netic dysregulation of gene activity. This model fits well with the familiar (non Mendelian) fea-
tures of schizophrenia and it is likely that epigenetic strategies will develop the underlying 
mechanisms of the phenotypic differences in monozygotic twins discordant for schizophrenia. 
Unlike DNA (Deoxyribonucleic acid) sequencing which usually remains stable over time epige-
netics refers to the regulation of gene expressions that are controlled by heritable but poten-
tially reversible changes in DNA methylation and chromatin structure. Epigenetic aberrations 
(epimutations) may originate from three sources acting individually or in combination 1) inher-
ited through the germline. 2) influence of environmental factors acting across different devel-
opmental stages 3) generated via biological stochastic events. Such epigenetic modification of 
DNA and chromosomal proteins may have a significant impact on regulation of gene expression 
via age and hormone dependent neorochemical changes rather than the structural changes to 
the brain. Recent studies suggest that this may be a useful model to btter understand develop-
mental aspects of schizophrenia. A twin case study, of two pairs of monozygotic twins (one pair 
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concordant for schizophrenia the other discordant) found a higher degree of DRD2 (dopamine 
D2 receptor) methylation in the lymphocytes of the affected co-twin as compared to the unaf-
fected twin. Furthermore, the affected twin in the discordant pair was epigenetically more simi-
lar to the unrelated affected twins than they were to their own unaffected co-twin. Such epige-
netic studies may further our understanding of how abnormally expressed (developmental) 
genes affect the developmental of the psychosis phenotype. 
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Defining caseness: Is schizophrenia a valid diagnostic 
construct? 
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The DSM V planning process is currently underway and it
has once again ignited the debate about the validity of the
schizophrenia diagnosis. In this paper, we review the psy-
chometric literature examining the evidence for discontinu-
ity between schizophrenia and normality and the distinction
between schizophrenia and other psychotic disorders. We
conclude by proposing potential alternative approaches to
refining the classification of psychosis.
Key words: psychosis/schizophrenia/classification/
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Introduction
Worldwide, the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV) definition
of schizophrenia is the most influential in clinical practice
and research.1 Its clear criterion-based definition facili-
tates diagnostic agreement (reliability) and communication
among practitioners, including comparable statistical
reporting of incidence and prevalence rates.2 It has
high clinical utility, providing nontrivial information
about course, outcome, and likely treatment response.3,4
However, does this make schizophrenia a valid diagnostic
construct?
Clinical usefulness is embedded in the established cri-
teria for nosological validation.5–8 A diagnosis is consid-
ered useful if its antecedent, biological, social, prognostic,
or treatment correlates provide substantial information
not contained within the syndrome’s definition.6,9 If
we accept this conflation of utility and validity DSM-
IV schizophrenia is indeed a robust construct, a model
for conceptualizing complex clinical experience, guiding
clinical management and predicting outcome.
Clinical utility, however, does not provide information
about the fundamental nature and structure of schizophre-
nia; it does not answer the basic taxonic question ‘‘are the
correlations of observed clinical characteristics, corrobora-
tive of underlying latent phenotypic dimensions (continu-
ous distributions), latent categories (composed of one or
more class or subdisorder, each with its own phenotypic
presentation) or a mix of the two?’’10 That is, usefulness
does not provide information on the construct validity
of schizophrenia.11 If our definition of schizophrenia
does not represent a ‘‘real’’ construct in nature, then it
will not delineate the true pathology and causal mecha-
nisms underlying psychosis; it will obfuscate etiology.
The developers of DSM-IV carefully point out that there
is no assumption that each category is a discrete entity.
However, they provide an operational definition of schizo-
phrenia presenting the disorder as a condition qualitatively
different fromhealth (discontinuity betweennormality and
schizophrenia) and qualitatively different from the other
diagnoses (discontinuity between schizophrenia and the re-
lated diagnostic categories described in the classification
system). Below, we review the evidence for this and discuss
alternative approaches to the classification of psychosis.
The distribution of Psychosis in the General Population
Mounting evidence suggests that, in fact, there are no dis-
crete breaks (demarcations) in the distribution of mani-
fest (positive) symptom indicators of psychosis; delusions
and hallucinations seem to have a continuous distribu-
tion in the general population.12–24 Prevalence estimates,
in nonclinical samples, range from 4%12 to 17.5%21 (with
methodological differences likely to explain much of this
variability) and results from a longitudinal study using
the British National Psychiatric Morbidity Survey data
found that 4.4% of the general population reported
incident symptoms at 18-month follow-up.24 These rates
are not a reflection of unidentified cases ‘‘hidden’’ in the
community because only a very small proportion of those
reporting positive psychotic symptoms fulfilled diagnos-
tic criteria for DSM nonaffective psychosis.15,21
How should we interpret this skewed continuum of
positive psychotic symptoms? It may be an artifact,
caused by measurement error; the use of lay interview
or self-report methods may lower symptom recognition
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thresholds, so studies are measuring psychosis-like expe-
riences, not necessarily related to the clinical features of
a true latent category or disease entity. However, even if
there is measurement variance between the symptoms eli-
cited in the general population and those from clinical
samples, this may be informative, given the fact that psy-
chosis-like symptoms can be conceived as indicators of
psychosis proneness, ‘‘clinical psychosis’’ emerging
(with higher than expected probability) from the pool
of those with psychotic-like features.19,25–27
The skewed continuum may be indicative of a latent
continuous pathology in the general population. This is
consistent with the prevailing view that schizophrenia
has a multifactorial etiology where many different genes,
which are neither necessary or sufficient causes, and of
small effect, interact with each other andwith environmen-
tal risk factors to cause the disorder, different combina-
tions of risk factors resulting in a gradation of exposure
and associated range of presentations from normal
through to the clinical disorder. Published work supports
this postulated continuity in the risk factor profiles
for community-reported symptoms and schizophrenia,
though much of the evidence comes from cross-sectional
studies where the direction of the associations cannot be
determined for exposures that vary over the life course.
One study has suggested that there may be some differen-
ces in risk factor profiles for psychotic symptoms and clin-
ical psychosis,24 though this may in part be a consequence
of using current urban residence as a proxy for urban birth
and upbringing. If this finding is replicated, it would sug-
gest discontinuity of risk factor profiles, though at a differ-
ent point (threshold) on the indicator continuum than that
suggested by the DSM-IV definition of schizophrenia.
These findings throw into doubt the assumption that
schizophrenia exists as a discrete disease entity (categori-
cal latent variable). The requisite population-based stud-
ies, using appropriate structural statistical analyses, eg,
finitemixturemodeling (and its derivates)28,29 or coherent
cut kineticmethods30 havenotbeen carriedout, so it is still
possible that a dichotomous latent construct could under-
lie the skewed distribution of psychosis indicators.10,31
The above approach uses delusions and hallucinations
as indicators for the latent (continuous or categorical)
construct schizophrenia. It remains possible that they
are nothing more than epiphenomena or nonspecific sur-
face symptoms, not core to the pathological process or
perhapsevenend-stagemanifestationsof schizophrenia.32
If this is the case, then positive psychotic symptoms may
not provide adequate coverage of the latent construct
whether it exists as a category or dimension in nature.
Schizophrenia: A Disorder Distinct from Other
Psychosis?
The symptoms used to characterize schizophrenia do not
define a specific syndrome. Rather, the concept allows
a number of different combinations so that many permu-
tations of the defining symptoms are possible (ie, it is
a polythetic definition). These symptoms are also found
commonly in the other categories of psychosis described
in DSM-IV.33 Recent studies using psychopathological
dimensions (correlations of symptoms determined by fac-
tor analysis) suggest that the diagnostic entities are sim-
ilar with regard to the key symptom dimensions of
psychosis.4,34–36 There is, however, variation in the di-
mensional profiles of different diagnostic categories in
that individuals with a diagnosis of schizophrenia score
higher in the positive, negative, and disorganized factors,
while patients with affective diagnoses score higher in the
manic and depressive dimensions and lower in the nega-
tive and positive dimensions.4,37 This seems to suggest
a quantitative variation in symptom dimension scores
across current diagnostic categories rather than qualita-
tive differences. The factor solutions across studies have
been broadly consistent demonstrating a 5-factor solu-
tion for psychosis—manic, depression, disorganized,
positive, and negative (though there may be conflation
of the disorganized and negative dimensions in first-onset
samples),38 reproducibility of this structure strengthens
the findings. The true latent structure of psychopathol-
ogy is still to be clarified, eg, latent class analyses
(LCAs) demonstrate similar indicator profiles to those
determined by exploratory factor analysis (EFA),39,40
confusing our understanding at the latent level. However,
the overlapping co-occurrence of dimensions may be in-
dicative of underlying shared risk factors, which are
quantitatively rather than qualitatively distinct and con-
tinuously expressed. The ambiguous schizoaffective cat-
egory may simply be the result of trying to demarcate,
where in reality no latent discontinuity exists. Reasonable
doubt exists about the true latent structure of the psycho-
sis spectrum; therefore, the true appearance of psychosis
in nature has yet to be determined.
Alternative Approaches to the Classification of Psychosis
Refinement of the Diagnostic Category (subtyping)
The clinical heterogeneity of DSM–IV schizophrenia
could be reduced by refinement of the current definition,
narrowing the concept, to describe more homogenous
symptom clusters or subgroups.41,42 One putative cate-
gorical subtype is the ‘‘deficit syndrome,’’ characterized
by enduring primary negative symptoms.43 Association
studies support the clinical usefulness of this sub-
group44–50 but tell us little about its construct validity.
Does it truly exist in nature as a discrete disease entity
(as its definition assumes) or are its observed associations
with external validators the result of comparing high
scoring individuals with those scoring low on a latent
(negative) dimension? If negative symptoms are associ-
ated with other important variables in the clinical, neuro-
cognitive, social, or biological domain, any comparison
J. Allardyce et al.
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of individuals high vs those low in negative symptomswill
yield significant group differences regardless of whether
or not the true latent structure of negative symptoms is
purely dimensional. A recently published study, using co-
herent cut kinetics, suggests that there may be a latent
level discontinuity in negative symptoms within (chronic)
schizophrenia, with an estimated base rate of 28%–36%.51
The author’s were unable to compare this empirically de-
fined construct with that of deficit syndrome because they
had not rated deficit symptoms in their sample. Further
support for a possible discrete negative subcategory of
schizophrenia comes from a study which used a surface
data reduction method (principal components analysis
[PCA]) to identify dimensions of psychopathology and
found the negative factor scores were bimodally distrib-
uted in people with a diagnosis of schizophrenia.4 If the
PCA factor does represent a latent dimensional construct
(which is not necessarily the case), then this suggests
a quantitative discontinuity in the negative dimension.
An important limitation of this approach, however, is
the use of chronic clinical samples because this can lead to
artificial truncation of the symptom severity distribution,
which can distort the results by violating the conditional
independence assumption needed to obtain unbiased
estimates.30,52,53
Dimensional Representations
Another approach that has been used extensively to re-
duce the clinical heterogeneity seen in schizophrenia is
by statistically identifying psychopathological dimen-
sions (groups of symptoms which occur together more
often than would be expected by chance alone) using fac-
tor analyses. Individuals can then be defined by how high
or low they score on the different dimensions, which may
coexist. This methodology assumes that the underlying
latent structure of psychopathology is continuous. A
3-factor solution has consistently been found in schizo-
phrenia, and when affective symptoms are included, a
further 2 factors are identified, namely depressive and
mania/excitement.54 Expanding this method to include
more broadly defined functional psychosis have generally
extracted similar 4- or 5-factor solutions.38,55–58 Differen-
tial associations are consistently found across the symp-
tom dimensions with clinically relevant variables.4,37,59–61
Analyses comparing dimensional representations with
the traditional diagnostic categories show the dimensions
to be more useful at predicting clinical course and treat-
ment needs, though the difference in the discriminative
power may be rather small.4,59,62 Thus, dimensions
seem to add to the information contained within the di-
agnostic systems, providing assessments that are more
detailed and likely to be important particularly in clinical
research.
Both these alternative methods for classification (sub-
types and dimensions) use latent variable modeling to tap
into the underlying structure of psychopathology. How-
ever, the approach to date has important limitations.
Taxonic analyses have rarely been carried out, prior to
the LCA or EFA. Therefore, the decision about which
statistical method to use has not been empirically driven
but rather reflects the researcher’s epistemological stance.
If a latent class (taxon) is identified, external analyses (as-
sociation studies) can be carried out on this subsample
of individuals to determine secondary thresholds (sub-
groups). Failure to restrict these analyses to the taxonic
group will introduce unnecessary imprecision into the
search for secondary thresholds. On the other hand, if
no taxon is identified, it is appropriate to use factor anal-
yses or multidimensional scaling to generate symptom
scores, which can be used in external (association) anal-
yses to define diagnostic thresholds. It is important to re-
member that a latent class can be extracted as a strong
factor in EFA (30). Kessler has proposed a 3-tiered ap-
proach for the use of structural analyses in the develop-
ment of psychiatric classification systems.52
Search for More Proximal Indicators of Psychosis
The current definition of schizophrenia and the alterna-
tive approaches discussed in this article depend heavily
on symptoms and signs that are probably somewhat dis-
tal to the underlying pathoetiology. Integration of defin-
ing characteristics, more proximal to the pathological
process underlying schizophrenia, is likely at some point
in the future (reviewed in accompanying articles in this
issue). Potentially informative, alternative indicators of
psychopathology are the development of standardized
and validated functional clinical tests for psychological
dysfunction (dysfunctional modules).63 A modular con-
cept of psychopathology is grounded in experimental
psychological theory, and depends on amodel where psy-
chological behavior and brain structure constitute a mo-
lar system, made up of identifiable microsubsystems of
elementary psychological functions, with corresponding
neuronal circuits, distributed networks,64 or processing
streams. A series or hierarchy of dysfunctional modules
would then provide a detailed and individual character-
ization of an individual patient.
Conclusion/Recommendations
Two main diagnostic issues arise. First, it is essential to
know how the psychosis phenotype or phenotypes exist in
nature, in order to study its causes and outcomes. Second,
a decision needs to be made about how to derive a useful
diagnostic construct from the natural phenotype or phe-
notypes, so that patients can be usefully identified and
treated.
In the short term, there is considerable need for de-
scriptive and latent variable approaches to determine
how psychosis is distributed in the general population.
The Validity of Schizophrenia and Alternative Approaches to the Classification of Psychosis
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Identification of naturally occurring taxons, and/or con-
tinuous dimensional representations of psychopathology,
and their associated course and outcome over time may
be clinically very useful.
In the longer term, these descriptive approaches will no
doubt be complemented by studies of putative etiological
or pathophysiological indicators. However, until this
time, the aim of any revision of our classification system
should be to optimize clinical utility. The emerging
evidence seems to demonstrate that models using both
categorical and dimensional representations of psychosis
are better discriminators of course and outcome than ei-
ther model independently. Currently, the most useful ap-
proach to classification seems to be the complementary
use of categorical and dimensional representations of
psychosis.
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Abstract
In this paper, we discuss the conceptual background for including a dimensional component to the DSM V diagnoses for 
psychoses. We review the evidence for a continuous distribution of psychosis like symptoms in the general population and 
summarise the research validating the clinical usefulness of psychopathological dimensions. We conclude that diagnostic 
models using both categorical and dimensional representations of psychosis have better predictive validity than either model 
independently. Dimensions do not appear to be diagnosis specifi c so a fl exible scoring of dimensions across all psychotic 
and major affective disorders may be potentially more informative than a system where categorical diagnoses are kept 
artifi cially dimension-specifi c. Copyright © 2007 John Wiley & Sons, Ltd.
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phenotype.
The current Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV) classifi ca-
tion of psychosis stems directly from the systematic 
clinical observations of Kraepelin (1919), Bleuler (1911) 
and Schneider (1959) who worked in the large asylums 
of Western Europe during the late nineteenth and early 
twentieth century. These institutions provided care for 
people with severe and debilitating conditions. There 
are at least two potentially important limitations to a 
classifi cation system derived from such a selective case 
sample. First, your clinical experience would be of 
severe cases in need of treatment, you would under-
standably conceptualize psychosis as a discrete disease 
entity, as a categorical construct, distinct from normal-
ity. This, however, may not refl ect the true distribution 
of psychosis at the population level.
Second, the observed pattern of psychopathological 
co-occurrence may actually refl ect symptoms, which 
are independent risk factors for hospital admission 
becoming conditionally dependent in the institutional 
setting, a phenomena known as Berkson’s fallacy (bias). 
A community study has shown that positive and nega-
tive symptoms are both independently associated with 
need for care (Maric et al., 2004). Such additive effects 
could infl ate the positive/negative co-occurrence in 
hospital settings, indicating that the current con-
ceptualization of schizophrenia as a unitary entity 
with high co-occurrence of positive and negative 
psychopathological domains may in part be the result 
of Berkson’s bias.
Similar fi ndings apply to the bipolar disorder con-
struct. A general population study has demonstrated 
independent associations of manic and depressive 
symptoms, with need for care; while symptom co-
occurrence was 17% in individuals known to services 
it was only 7% in those not in the secondary health 
care system. These independent effects may well infl ate 
depression/mania co-occurrence in institutional set-
tings (Regeer et al., in press).
There is no doubt that the work of Kraepelin, Bleuler 
and Schneider respectively (and the classifi cation 
systems which evolved from their insights), has greatly 
facilitated the acquisition of the knowledge we now 
have about psychosis. However, the walls of the asylum 
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confi ned their observations, perhaps obscuring the true 
nature of the psychosis phenotype.
Distribution of psychosis in the general population
The clinical defi nitions of psychosis may represent only 
a minor, possibly biased sample of the total psychosis 
phenotype present in the general population. This is 
consistent with the prevailing view that psychosis has 
a multi-factorial aetiology (similar to that seen in other 
chronic disorders such a diabetes and cardiovascular 
disease) where many different genes, which are neither 
necessary or suffi cient causes, and of small effect, 
interact with each other and with environmental risk 
factors (Jones and Cannon, 1998). It can be shown that 
such different combinations of risk factors must result 
in a gradation of exposure and associated range of dif-
ferent expressions from normal through to clinical psy-
chosis (continuum hypothesis). Mounting support for 
the continuum hypothesis comes from studies examin-
ing (1) the distribution of psychotic symptoms and psy-
chotic proneness in the general population; (2) the 
pattern of genetic and non-genetic risk factor profi les 
in non-clinical and clinical samples; (3) the transition 
from sub-clinical to clinical states over time (up to 25% 
in the largest prospective study to date (Poulton et al., 
2000)).
The distribution of the positive symptoms of psycho-
sis, delusions and hallucinations, seem to have a con-
tinuous distribution in the general population (Eaton 
et al., 1991; Janssen et al., 2003; Johns et al., 2004; 
Kendler et al., 1996; King et al., 2005; Olfson et al., 
2002; Peters et al., 1999; Poulton et al., 2000; Tien, 
1991; van Os et al., 2000a; van Os et al., 2001; Verdoux 
et al., 1998; Wiles et al., 2006; Spauwen et al., 2003). 
Prevalence estimates, in non-clinical samples, range 
from 4% (Eaton et al., 1991) to 17.5% (van Os et al., 
2000a) (with methodological differences likely to 
explain much of this variability). High rates do not 
appear to be secondary to measurement error due to 
self-report interview techniques, as high rates are also 
reported using non self-report interviews by clinicians 
(Poulton et al., 2000; Spauwen et al., 2003). These rates 
also are not a refl ection of unidentifi ed cases ‘hidden’ 
in the community, as only a very small proportion of 
those reporting positive psychotic symptoms fulfi lled 
diagnostic criteria for DSM non-affective psychosis 
(Kendler et al., 1996; van Os et al., 2000a). That the 
psychosis phenotype is much more prevalent than pre-
viously thought is also supported by recent work 
showing that the lifetime prevalence of psychotic dis-
order, when multiple sources are taken into account, 
exceeds 3%, much higher than the traditional 0.6% 
(Perala et al., 2007). Studies of schizotypy (a personality 
trait characterized by a proneness to psychotic-like 
experiences) suggest that it is a quantitative rather than 
a qualitative trait, on a continuum from normality, 
through eccentricity, different combinations of schizo-
typal characteristics, to fl orid psychosis. Factor analyses 
of schizotypy extract three or possibly four dimensions: 
aberrant perceptions and believes, introvert/anhedonia 
and conceptual disorganization (a factor solution some 
consider to be similar to that found in schizophrenia). 
This work suggests that psychosis proneness is a multi-
dimensional continuous construct (Gruzelier, 1996; 
Mata et al., 2003; Vollema and van den Bosch, 1995).
Mood disturbance similarly appears to have a 
continuous distribution in the general population. 
Sub-threshold depression and (hypo)mania, defi ned as 
the experience of distinct periods of depressive or 
(hypo)manic symptoms, which do not fulfi ll the 
DSM-III-R/IV diagnostic criteria appear to be common 
(Angst and Gamma, 2002; Cuijpers et al., 2004) with 
prevalence rates of up to 13% for depression, and 9% 
for hypomania (Angst and Merikangas, 1997; Angst 
et al., 2003).
Evidence from longitudinal and cross-sectional 
studies of risk factors in general support a continuity of 
risk profi les for subclinical and clinical psychosis 
(Chapman et al., 1994; Kwapil et al., 1997; Peters et al., 
1999; van Os et al., 2000a; van Os et al., 2001; Verdoux 
et al., 1998). However, one study has demonstrated 
some differences, which will require further evaluation. 
Partly, these differences may be due to study design; for 
example, the study measured the effect of current urban 
residence on psychotic symptoms, in elderly individuals 
who are likely to have moved many times and are at 
very low risk of developing incident psychotic symp-
toms, rather than studying urban birth/upbringing in 
young individuals who are most at risk for psychotic 
symptoms (Wiles et al., 2006).
Finally, longitudinal studies suggest that clinical 
psychosis emerges, from the pool of those with psy-
chotic-like features, with a much higher than expected 
frequency (Bebbington and Nayani, 1995; Chapman et 
al., 1994; Hanssen et al., 2005; Poulton et al., 2000). 
Non-clinical manic symptoms also appear to represent 
risk indicators for future clinical manic episodes (Regeer 
et al., 2006). Interestingly, the probability of developing 
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incident bipolar disorder is substantially higher (approx-
imately 7%) in individuals with both subclinical manic 
and psychotic symptoms (Kaymaz et al., 2006).
These studies suggest, that both manic and psycho-
sis phenotypes occur as part of a continuum from nor-
mality through to full-blown clinical disorders, that is, 
they are fundamentally dimensional in nature.
Superimposing categorical diagnoses on latent con-
tinuous constructs results in loss of information, but 
this practice may yield useful short-hand approxima-
tions to facilitate communication among clinicians. 
Potential problems arise, however, if the categories are 
arbitrary or generated from samples with selection bias 
(e.g. from the severe end of the spectrum or institu-
tional settings), where they potentially ‘misrepresent’ 
the underlying patho-aetiology. This is likely to impede 
our further understanding of the causes and correlates 
of psychosis. It may in part explain the current lack of 
replicable fi ndings in the genetic and biological study 
of schizophrenia and bipolar disorder.
It is important to keep in mind that although a 
continuum of psychosis and bipolarity may exist, the 
diagnosis of need for care and the decision to treat 
always will remain dichotomous. Need for care results 
from the interaction between continuous phenotype 
and the person in terms of, for example, coping, social 
support, and the level of comorbid developmental 
impairment
Clinical psychosis: discrete category or 
psychopathological dimensions
Categories of psychoses defi ned in DSM-IV refl ect his-
torical notions of severe mental illness observed in 
institutionalized clinical settings. As discussed earlier, 
such settings may infl ate the co-occurrence of symp-
toms, obscuring their true latent nature and generating 
spurious categories. The different psychotic diagnoses 
overlap in their pre-morbid risk factors, clinical presen-
tations, management needs and outcomes (Murray 
et al., 2004). This lack of discrimination casts doubt as 
to how clinically useful the categorical classifi cation 
systems used today are (McGorry et al., 1998; Toomey 
et al., 1997), and has resulted in a search for alternative 
representations of psychoses. One approach is to iden-
tify psychopathological dimensions (groups of symp-
toms which occur together more often than would be 
expected by chance alone) using exploratory factor 
analyses (EFA). Individuals can then be defi ned by how 
high or low they score on the different dimensions, 
which may co-exist. The initial work in this area exam-
ined the factor structure of the diagnostic category of 
schizophrenia and found evidence for a three-factor 
solution (Bilder et al., 1985; Liddle, 1992, 1987; Peralta 
et al., 1992), extracting positive, negative and disorga-
nized factors. The disorganization factor is the most 
unstable and least replicable of the three dimensions. 
However, a two-factor solution does not adequately rep-
resent the symptom correlations (Peralta et al., 1994) 
and the three factor solution may in fact represent 
higher order factors of many more fi rst order dimen-
sions (Peralta and Cuesta, 1999). A fi ve-factor solution 
with additional manic and depressive dimensions is 
found when measures of affective symptoms are included 
(Lindenmayer et al., 2004). When samples are expanded 
to include the full spectrum of psychoses, broadly 
similar fi ve-factors solutions are found, (Dikeos et al., 
2006; Kitamura et al., 1995; Lindenmayer et al., 2004; 
McGorry et al., 1998; McIntosh et al., 2001; Murray 
et al., 2005; Ratakonda et al., 1998; Serretti et al., 2001; 
Serretti and Olgiati, 2004), though there may be confl a-
tion of the disorganized and negative dimensions espe-
cially in fi rst onset samples (McGorry et al., 1998). It 
seems that the dimensions generated from established 
cases of psychosis provide reasonably replicable, stable 
solutions in a variety of settings, diagnostic groups and 
patient samples; however the factor structure may be 
less stable around the time of presentation (Drake 
et al., 2003).
The clinical validity of dimensional representations 
of psychosis
Nosological constructs such as psychopathological 
dimensions should be useful, that is, provide non-trivial 
information about course, outcome and likely treat-
ment response (Kendell, 1989). A number of studies 
have examined the association of psychopathological 
dimensions with various clinically signifi cant charac-
teristics. The most consistent fi nding is a strong asso-
ciation of the negative dimension with indicators of 
poor (chronic deteriorating) course (Dikeos et al., 2006; 
Hollis, 2000; Marengo et al., 2000; van Os et al., 1996; 
Wickham et al., 2001). The disorganization factor also 
predicts poor outcome but this is a weaker and less 
consistent fi nding. The associations of other dimen-
sions are inconsistent and markedly attenuated after 
adjustment for diagnosis (Dikeos et al., 2006).
A more informative method of assessing the useful-
ness of the dimensional approach is to compare the rela-
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tive contribution of the dimensional factor scores and 
diagnostic categories in predicting the variability of 
clinically signifi cant characteristics. Such studies con-
sistently show the dimensional representations to be 
more useful at predicting clinical course and treatment 
needs, though the difference in the discriminative power 
may be rather small (Dikeos et al., 2006; Peralta et al., 
2002; Rosenman et al., 2003; van Os et al., 1996).
One study has shown that while factor scores add to 
the predictive power of the diagnostic categories, the 
diagnostic categories did not increase the predictive 
power of the dimensional scores. This seems to suggest 
that the current diagnoses may partition symptom 
dimensions appropriately. However, models using both 
categorical and dimensional representations have better 
discriminative validity, suggesting that the most power-
ful approach to classifi cation is the complementary use 
of both categorical diagnoses and dimensional scores 
(Dikeos et al., 2006).
Practical example
The following clinical example illustrates how con-
comitant categorical and dimensional assessment may 
facilitate patient-care. A 45-year-old man with a 20-year 
history of bipolar I disorder, presents with mild hypo-
manic symptoms; reduced need for sleep (2–3 hours less 
than usual per night), bright and cheerful affect, 
increased energy, and subjectively feels very productive 
at work. He has worked as an insurance agent manager 
of a large company for 10 years, where he is regarded 
as a conscientious, focused, calm, and task-oriented 
employee. At interview, he describes plans to reorga-
nize the branch and carry this model throughout the 
company. This expansive mildly grandiosity does not 
meet criteria for delusional thinking, but may be on a 
continuum with delusional grandiose thought. Use of 
a dimensional measurement would alert the clinician 
to offer appropriate intervention to avert manic relapse 
which, if unmanaged, would escalate over a few days. 
His thought content would move to not only changing 
his branch, but also going to the head offi ce to tell them 
how to run the company and telling them he should be 
CEO. This is one example for the mood case of mania. 
Similar examples could readily be drawn for patients 
diagnosed with schizophrenia, mania, or depression.
Potential limitations of a dimensional approach
To date, with different studies suggesting different 
numbers of factors or variations in factor composition, 
there is no defi nitive model for the symptom dimen-
sions of psychosis, though the fi ve-factor model com-
prising positive, negative, disorganized, manic and 
depression dimensions is increasingly being considered 
to have internal validity. Most exploratory factor ana-
lytical studies have used chronic or mixed stage samples, 
however; if there are psychopathological changes during 
the course of a disorder (Fenton and McGlashan, 1991; 
Eaton et al., 1995; Peralta and Cuesta, 2001), samples 
with different distributions of ‘stage of disorder’ will 
yield different symptom dimensions depending on the 
dominant stage studied. For example, there is no study 
in the current literature examining the predictive 
validity of symptom dimensions in fi rst-episode cases of 
psychosis.
The current diagnostic categories facilitate diagnos-
tic agreement (reliability) and communication among 
practitioners (Kendell and Jablensky, 2003) and it may 
be that the introduction of dimensional measures could 
threaten this. However, what is being proposed initially 
is a dimensional measure that will complement the 
categorical diagnosis, perhaps generated from rating 
scales known to have relatively high inter-rater agree-
ment – for example, the Positive and Negative Syn-
drome Scale (PANSS) (Kay et al., 1987). Symptom-rating 
scales are now used routinely in clinical settings to 
monitor treatment response and relapse and to assess 
remission. The introduction of a formal dimensional 
measure in the classifi cation system would hopefully, 
coordinate and optimize this use.
It is important to decide over which diagnostic cat-
egories we measure any proposed psychotic dimensions. 
The revised classifi cation system could be organized 
around the presence/absence of psychosis. However, it 
is quite possible that psychotic symptoms are not fun-
damental core features of the underlying diseases, but 
rather, non-specifi c, perhaps even end-stage manifesta-
tions of a number of different pathological processes 
(Goldman-Rakic, 1995). Crow (1990) has suggested 
that there exists an aetio-pathological continuum 
across schizophrenia, schizoaffective disorder, and 
affective illness, and a recent study of patients with 
psychotic and non-psychotic bipolar disorder and 
schizophrenia found a specifi c association between 
neurogulin 1 core-at-risk haplotype and ‘manic’ forms 
of schizophrenia and ‘bipolar’ forms of schizophrenia 
supporting a biological continuum (Green et al., 2005). 
The literature suggests that substantial ‘hidden bipolar-
ity’ would be found in patients with unipolar depression 
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if a mania dimension were additionally scored in the 
course of the diagnostic process (Benazzi and Akiskal, 
2003; Cassano et al., 2004), and negative symptoms 
have been demonstrated in patients with bipolar disor-
der (van Os et al., 2000b). The fl exible scoring of 
dimensions across all psychotic and major affective dis-
orders potentially could be more informative than a 
system where categorical diagnoses are kept artifi cially 
dimension-specifi c.
Conclusion/recommendations
It is essential that we understand how the psychosis 
phenotype or phenotypes exist in nature, in order to 
study their determinants and outcomes. Further eluci-
dation is likely to come from studies using descriptive 
and latent variable methodologies to identify funda-
mental categorical subtypes and/or continuous dimen-
sions of psychopathology. In the future, it is likely these 
descriptive approaches will be complemented by the 
inclusion of putative aetiological or pathophysiological 
indicators.
An ever-increasing number of published studies con-
tinue to examine dimensional approaches in schizo-
phrenia and bipolar disorder. Dimensions are not 
diagnosis-specifi c, yet current categorical diagnoses 
require dimensional specifi city. In the psychosis litera-
ture, affective and non-affective dimensions have been 
identifi ed in people with psychosis, whereas in indi-
viduals with major mood syndromes, psychotic versus 
non-psychotic domains have been studied. A more pro-
ductive approach may be to study dimensionality across 
all mood and psychotic syndromes.
The current evidence supports the complementary 
use of both categorical and dimensional representa-
tions of psychosis. Diagnostic models using both cate-
gorical diagnoses and dimensions have better predictive 
validity than either model independently, and fl exible 
scoring of dimensions across all patients with psychotic 
and major affective disorders is likely to be especially 
informative.
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CHAPTER 9 
Diagnostic Utility: categorical and dimensional 
representations of psychosis comparison of their 
discriminate validity with known risk factors. 
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j Abstract Objective To describe symptom dimen-
sions of psychosis using detailed psychopathological
information from epidemiologically defined incident
cases which include the full spectrum of functional
psychosis across all age ranges. Then, assess the
comparative usefulness of the dimensional and cate-
gorical representations of psychosis in discriminating
between demographic and pre-morbid risk factors.
Method A total of 464 incident cases of psychosis
assessed with OPCRIT (Operational Checklist for
Psychotic Symptoms) were included in an exploratory
factor analysis. Using Regression analyses we mod-
elled the associations of the dimensional and cate-
gorical representations of psychosis with antecedent
validating variables and compared the subsequent
models using the likelihood ratio test. Results Factor
analysis produced five-symptom dimensions, manic,
disorganisation, depressive, delusional and auditory
hallucinatory symptoms, explaining 58% of the total
variance. Different dimensions were differentially
associated with the pre-morbid risk factors. Neither
the dimensional nor the categorical representations
on their own were sufficient to explain associations
with the antecedent validating variables. Conclu-
sion Neither the dimensional or the diagnostic rep-
resentation of psychosis was superior in
discriminating between known risk factors, combin-
ing dimensional measures with categorical diagnoses
will probably be more informative in determining the
causes and correlates of psychosis.
j Key words first episode psychosis – exploratory
factor analyses – dimensions – classification systems
– premorbid risk factors
Introduction
The different psychotic diagnoses overlap in their
pre-morbid risk factors, clinical presentations, man-
agement needs and outcomes. This lack of discrimi-
nation casts doubt as to how clinically useful the
categorical classification systems used today are [23,
42], and has resulted in a search for alternative rep-
resentations of psychoses. One approach is to identify
psychopathological dimensions (groups of symptoms
which occur together more often than would be ex-
pected by chance alone) using exploratory factor
analyses (EFA). Individuals can then be defined by
how high or low they score on the different dimen-
sions, which may co-exist.
To date there is no definitive model for the
symptom dimensions of psychosis, different studies
suggesting different numbers of factors or variations
in factor composition. These inconsistent findings
may be due to differences in methodology [31], most
EFA work having studied chronic or mixed stage
samples however, if there are psychopathological
changes during the course of a disorder [13, 15, 31],
samples with different distributions of ‘stage of dis-
order’ will yield different symptom dimensions
depending on the dominant stage studied. In addition
the majority of work has examined patients within the
traditional diagnostic categories, particularly schizo-
phrenia, however the dimensions described do not
appear specific to any one category. [22, 33]. There-
fore, to develop our understanding of the dimensional
representation of psychosis we need to study symp-
toms at specific stages and across the range of psy-
chotic diagnoses.
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Important in the design of an EFA is the choice of
variables to include in the study. Concept driven
instruments are likely to produce dimensions which
reflect their underlying constructs, to avoid this bias
recent studies have used OPCRIT (The Operational
Checklist for Psychotic Disorders) [6, 7, 25, 28, 30, 35–
37] which has no theoretical assumptions underlying
its design and covers a comprehensive range of psy-
chopathology, including affective symptoms. Finally,
classification systems should be useful, that is provide
non-trivial information about biological, social,
prognostic and treatment correlates and we should
evaluate competing systems using these associations.
[19, 34]
Aims of the study
(1) To describe symptom dimensions using detailed
psychopathological information rated on OPCRIT,
from incident cases of psychosis. (2) Assess the
nosological usefulness of the symptom dimensions by
modelling their associations to demographic and pre-
morbid risk factors. (3) Examine the comparative
usefulness of the dimensional and categorical repre-
sentations of psychosis in discriminating between
demographic and pre-morbid risk factors.
Methods
j Sample
Catchment area
Dumfries and Galloway is a geographically well-defined area in
South-West Scotland. It has a stable population of around 147,000,
of whom 99.5% are white. Psychiatric services are provided by one
hospital and its associated community services. There is little or no
private health care.
Patient identification
Case ascertainment has been described in detail elsewhere [1].
Briefly, we identified all patients who came in to contact with
psychiatric services in Dumfries and Galloway over a 20-year per-
iod (1979–1998) who were given a clinical diagnosis of schizo-
phrenia, schizoaffective disorder, delusional disorder, mania, drug
induced psychotic disorder; acute, transient or unspecified psy-
chotic disorder. Patients were excluded if they were not resident in
Dumfries & Galloway, had presented previously with a psychotic
episode out with the study period or had a demonstrable medical
condition, which would account for their symptoms.
Patient characteristics
A total of 464 patients had a first episode of psychosis during the
study period. There were 210 (45.26%) males and 254 (54.74%)
females with a median age at presentation of 36 (inter-quartile
range 25–55). Males and females showed a significant difference in
the age of onset, the median age for males was 33 and for females it
was 39.5 (Mann–Whitney, p < 0.001)
Assessment of psychopathology
j Symptom ratings
The case records which were recognised to be com-
prehensive and above average at the most recent
Royal College of Psychiatrists training approval visit
and contain medical, informant, nursing, social work
and occupational therapy notes and all correspon-
dence for the 464 patients identified as having a first
episode of psychosis were examined and OPCRIT was
completed. OPCRIT is a checklist containing 90 items,
exploring socio-demographic information, for psy-
chotic and affective symptoms (we used binary
(present/absent) ratings for the EFA). It was designed
with case note review in mind and it has an associated
computer algorithm allowing classification with dif-
ferent diagnostic systems. OPCRIT has established
reliability [21, 24, 44] and is a convenient, widely used
and validated assessment tool [4, 9]. Two experienced
psychiatrists working independently (JA, GM) com-
pleted the OPCRIT checklist for the year of presen-
tation and were blind to the clinically coded diagnosis.
j Selection of symptoms for entry into factor analysis
We excluded items from OPCRIT not related to
phenomenology, or where it would be difficult to
determine if they were primary or in fact, secondary
to medication (initial/middle insomnia, excessive
sleep, reduced concentration, slowed activity, loss of
energy, increased appetite, weight gain/loss). Items
that could make the factor analytic procedures com-
putationally unstable and therefore unreliable were:
excluded when their variance was close to zero (cat-
atonia, incoherent speech, diurnal variation, loss of
pleasure, excessive self-reproach, early morning
wakening, delusions of guilt, delusions of poverty,
increased sociability, negative formal thought disor-
der, lack of insight) or when reliability was poor
(primary delusions): used to create composite vari-
ables where there was high collinearity (a). Thought
alienation: thought broadcasting, thought insertion
and thought withdrawal) (b) blunted affect and flat-
tened affect (c) Third person auditory hallucinations,
thought echo and running commentary voices). There
were 28 items entered into the EFA (see Table 1).
j Reliability of opcrit ratings
Good inter-rater reliability for OPCRIT generated
ICD10 and DSM IV diagnosis of schizophrenia has
been demonstrated for this sample [1]. The raters (JA,
GM) independently scored 45 randomly selected cases
to calculate a kappa statistic of agreement for indi-
vidual items.
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Exploratory factor analysis
j Statistical procedure for fitting the common factor
model on the tetrachoric correlation matrix
It is appropriate to use EFA to identify the latent
symptom dimensions underlying psychotic presenta-
tions. EFA is based on the common factor model,
which assumes that a variable in a battery of measured
variables is a linear function of one or more common
factors and one unique factor. Common factors are
latent constructs that influence more than one vari-
able and account for the observed correlations seen
among them. The Unique factor (with a specific and
an error component) influences only one variable and
does not account for observed correlations. The
common factor model estimates the pattern of asso-
ciation between the common factors and each variable
and indexes them as factor loadings. As the OPCRIT
symptom scale was of a binary nature, factor analyt-
ical methods appropriate to this type of were applied
using TESTFACT 4 computer programme [45]. We
did a principal factor analysis with communality
iterations on the tetrachoric correlation matrix of the
28 OPCRIT derived psychopathological ratings.
j Determination of the number of factors to extract
Determination of the number of factors to include in
the model was guided by the scree test. The basic
rationale for the scree test is that the battery of vari-
ables is measuring a limited number of factors well
and a larger number of trivial, specific and error
factors less well. Thus, the prominent factors account
for most of the variance whereas the other factors are
quite numerous but small [16]. By computing the
eigenvalues for the correlation matrix and plotting
them in descending value along the ordinate with the
eigenvalue number as the abscissa, a straight edge can
then be laid across the bottom portion of the eigen-
values where they form an approximately straight
line. The point where the eigenvalue plot curves above
the straight line formed by the smaller values gives the
number of factors [8]. Review of the clinical mean-
ingfulness and interpretability of the factors extracted
and the reproducibility of these factors complemented
the scree test.
j Factor rotation to aid interpretation
To aid interpretation of the solution, factors are ro-
tated in multidimensional space to find a solution
with the best simple structure (i.e., where each factor
is defined by a subset of variables that have large
loadings relative to the other variables and in where
each variable loads highly on only a subset of com-
mon factors). Two forms of factor rotation were used
(1) Promax, which allows factors to be oblique (cor-
related), which we consider the appropriate method
(2) Varimax, which produces orthogonal (uncorre-
Table 1 5-factor solution (with promax rotation)
Kappa co-efficient
Inter-rater reliability Manic Disorganised Depressive Delusional
Auditory
hallucinations Communality
Bizarre behaviour 0.87 0.33 0.49 0.07 )0.20 0.20 0.43
Excessive activity 0.84 0.86 )0.05 0.03 0.22 0.02 0.79
Reckless activity 0.62 0.80 )0.04 )0.08 0.16 )0.05 0.66
Distractibility 0.54 0.80 0.21 )0.14 0.10 0.06 0.71
Reduced need for sleep 0.76 0.77 )0.27 0.20 0.19 0.20 0.78
Agitated behaviour 0.61 0.76 0.01 )0.44 )0.15 0.12 0.80
Speech difficult to understand 0.80 0.13 0.86 0.04 0.15 )0.07 0.78
Positive formal thought disorder 0.88 )0.25 0.85 0.31 0.15 )0.11 0.92
Pressured speech 0.87 0.70 0.02 0.24 0.19 )0.16 0.61
Thoughts racing 0.78 0.77 )0.07 0.14 0.10 )0.02 0.63
Inappropriate affect 0.91 0.02 0.63 0.02 0.16 )0.01 0.42
Elated mood 0.83 0.81 0.01 0.03 0.14 )0.16 0.70
Irritable mood 0.81 0.81 )0.10 )0.28 0.01 )0.10 0.75
Dysphoria 0.78 0.04 )0.13 )0.90 0.11 )0.18 0.87
Suicidal ideation 0.73 )0.04 )0.02 )0.70 )0.03 )0.03 0.55
Persecutory delusions 0.87 )0.23 )0.09 )0.02 )0.71 )0.03 0.56
Well organised delusions 0.69 )0.25 )0.27 0.12 )0.81 )0.14 0.82
Increased self-esteem 0.76 0.73 0.17 0.09 )0.01 )0.22 0.61
Grandiose delusions 0.69 0.67 0.29 0.10 0.19 )0.03 0.57
Delusions of influence 0.69 )0.33 0.19 0.07 )0.28 )0.01 0.23
Bizarre delusions 0.70 )0.02 0.53 )0.03 0.15 0.07 0.31
Widespread delusions 0.86 )0.17 )0.02 0.07 )0.73 )0.02 0.57
Delusions of passivity 0.88 )0.16 0.39 )0.10 0.08 0.17 0.22
Abusive/accusatory voices 0.70 )0.23 )0.17 )0.07 0.24 0.68 0.61
Other hallucinations 0.67 )0.25 0.17 )0.33 0.15 )0.24 0.28
Restricted or blunted affect 0.70 )0.54 0.33 )0.16 0.17 )0.11 0.46
Thought alienation 0.81 )0.15 0.34 )0.16 )0.19 0.18 0.20
Third person auditory hallucinations 0.92 )0.08 )0.01 0.24 0.05 0.96 0.98
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lated) factor solution has been extensively used in
previous published studies. We wished to determine
wither the choice of rotational method significantly
effects the factor solution.
j Examination of the stability of the factor solution
A prime criterion for any rotated factor solution is
that it should produce the same factors when random
sets of individuals are drawn from the underlying
population. If it cannot, the solution is of no value
[16]. To assess the stability of the obtained factor
solution we randomly split the sample in two and
factor analysed the halves separately. We then as-
sessed the congruence of the solutions using Pearson
product moment and one-way random effects intra-
class correlation co-efficients for the loadings in the
corresponding factors.
j Factor score estimation and the distribution of
dimensions within diagnostic classes
For each patient we generated (1) OPCRIT derived
diagnoses for The International Classification of Dis-
eases, 10th revision (ICD-10) [46], Research Diag-
nostic Criteria (RDC) [38] and The Diagnostic and
Statistical Manual of Mental Disorders, 4th edition
(DSM-IV) [3] and (2) factor score estimates for each
factor. An individual was considered to have scored
‘high’ on a particular dimension if their score was
above the upper tertile. ‘High’ score profiles were
created for each diagnostic category.
j The relationship of dimensions and categories to
known premorbid risk factors
Using STATA statistical programme, release 9 [39],
we fitted a series of linear/logistic regression models,
with each pre-morbid validator as the dependent
variable (1. gender, 2. age at presentation, 3. marital
status, 4. unemployment at presentation, 5. poor pre-
morbid work adjustment, 6. poor pre-morbid social
adjustment 7. Drug and alcohol misuse within one
year of onset of symptoms, 8. identified psychosocial
stressor, 9. family history of schizophrenia in first or
second-degree relatives and 10. family history of other
psychiatric disorders severe enough to warrant
referral to specialist services) and the dimensional
scores as the independent variables.
We repeated these analyses, entering the diagnostic
categories (DSM IV) as independent variables and
again, with both dimensional and categorical sche-
mata (the full model) as independent variables. Using
the Likelihood ratio test we compared the series of
analyses containing the full model with models con-
strained by dropping the categorical and the dimen-
sional components in turn. [18].
Results
j Reliability of the opcrit ratings
All symptom ratings showed a good to excellent
agreement except distractibility, which showed mod-
erate agreements (Table 1). Similarly, satisfactory
agreement was shown for the demographic and risk
factors which all had a kappa above 0.7 except for
psychosocial stressor (0.64) [2].
j Factor structure
There were eight factors with eigenvalues greater than
unity; the scree test suggested a 5-factors solution,
explaining 58% of the variance but 4, 5 and 6 factor
solutions were examined. The 5-factor solution made
most substantive sense and is presented in detail here.
Varimax and Promax rotated solutions gave similar
results (Promax solution presented) (Table 1). The
factors were mildly correlated (Table 2) and were
predominately univocal (items only load highly on to
one common factor). Factor 1 is aligned to the manic
symptoms of psychosis with principal loadings for
excessive activity (0.86), reckless activity (0.80), dis-
tractibility (0.80), reduced need for sleep (0.77), agi-
tated behaviour (0.76) pressured speech (0.70),
thoughts racing (0.77), elated mood (0.81), irritable
mood (0.81), increased self-esteem (0.73) and mood
congruent grandiose delusions (0.67). Restricted/
blunted affect ()0.54) had an opposite (negative)
substantial loading i.e., a reverse relationship with the
positively loaded ‘‘manic’’ symptoms. Factor 2 in-
cluded features of ‘disorganisation’ with the principal
loadings; speech difficult to understand (0.86), posi-
tive formal thought disorder (0.85) inappropriate af-
fect (0.63) in conjunction with bizarre behaviour
(0.49) and bizarre delusions (0.53). Factor 3 we have
described as a ‘depression factor’ with agitated
behaviour ()0.44) dysphoria ()0.71) and suicidal
ideation ()0.81) loading on to it. All substantial
loading on this dimension (and factor 4) are negative;
this does not refer to the polarity of the constructs by
themselves, but rather the sign is relational to the
other loadings on that factor. It would be quite valid
to reverse all signs on this factor (and the signs of the
correlations between factors) to aid interpretation
[16]. Factor 4, included the ‘non-bizarre/non-mood
Table 2 Factor correlations for analysis shown in
Manic Disorganised Depressive Delusional hallucinations
Manic 1.000
Disorganised )0.129 1.000
Depression 0.207 )0.323 1.000
Delusional 0.339 )0.259 0.275 1.000
hallucinations )0.296 0.320 )0.362 )0.292 1.000
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congruent delusional symptoms’; persecutory delu-
sions ()0.71), well organised delusions ()0.81),
widespread delusions ()0.73). Factor 5 was a second
positive factor consisting of ‘auditory hallucinations’
abusive/accusatory/persecutory voices (0.68) and the
composite variable of third person auditory halluci-
nations; thought echo and running commentary
(0.96).
j Stability of factors across split halves of the sample
The Pearson’s product moment and the one-way
random effects intra-class correlation for factor
loadings across the two halves produced almost
identical results therefore we have only reported the
Pearson’s correlation. The 5-factor solution produced
the most similar results across the two halves, with
factor loading correlations of 0.95, 0.73, 0.74, 0.89 and
0.62 (p < 0.001).
j Opcrit generated diagnoses
The commonest diagnoses were schizophrenia and
unspecified disorders, the proportions varied
depending on the classification system used (Table 3).
j Distribution of dimensions within dsm
classification system
The results were similar for the three diagnostic sys-
tems (only DSM classification shown). Between the
different DSM diagnostic categories, the median fac-
tor scores differed significantly (Kruskal–Wallis test,
p < 0.001) as did the proportions of individuals
scoring above the upper tertile for the different fac-
tors (symptom dimensions). For example, in the
manic diagnostic category a high proportion scored
above the upper tertile on the factor 1 ‘manic’
dimension while individuals diagnosed with depres-
sion all scored high on the Factor 3 ‘depressive
dimension’. However, within diagnostic categories
there was also considerable within-group variation
and overlap between categories (Table 4).
j Association of dimensions to known premorbid risk
factors
There was no significant association between any
dimension and gender. Age at presentation was sig-
nificantly associated with disorganisation, depressive
and delusional dimensions (adjusted for gender),
disorganisation showing the strongest association
(estimated regression co-efficient = )8.50; p-va-
lue < 0.001 95% CI )10.08, )6.91), with the F test of
linear restriction showing it to be significantly dif-
ferent from the association between age at presenta-
tion and the other dimensions (p < 0.001).
Disorganisation was also significantly associated with
being single at presentation (OR = 1.35, p = 0.002,
95% CI 1.11, 1.63), unemployed at onset of symptoms
(OR = 1.35, p = 0.02, 95% CI 1.12, 1.64), having poor
premorbid work adjustment (OR = 1.64, p = 0.001,
95% CI 1.33, 2.01) and poor premorbid social
adjustment (OR = 1.25, p = 0.04, 95% CI 1.01, 1.53),
while an inverse relationship was demonstrated with
the manic dimension for these risk factors; single
(OR = 0.69, p < 0.001, 95% CI 0.56, 0.84), unem-
ployed (OR = 0.73, p = 0.003, 95% CI 0.59, 0.90) poor
premorbid work adjustment (OR = 0.62, p < 0.001,
95% CI 0.47, 0.81) and poor premorbid social
adjustment (OR = 0.53, p < 0.001, 95% CI 0.39, 0.72).
No other dimensions were significantly associated
with these risk factors except the delusional dimen-
sion which was inversely related to poor premorbid
social adjustment (OR = 0.72, p < 0.01, 95% CI 0.57,
0.91). Only the depressive dimension was significantly
associated with drug /alcohol use within the first year
of symptoms (OR = 1.53, p = 0.003, 95% CI 1.15,
2.01) and presence of psychosocial stressors at pre-
sentation (OR = 1.61, p < 0.01, 95% CI 1.13, 2.30). It
was also associated with family history of other psy-
chiatric disorders (OR = 1.31, p = 0.03, 95% C.I 1.03,
1.66) as was the manic dimension (OR = 1.30,
p = 0.02, 95% CI 1.04, 1.62). Finally, there were no
significant associations between any dimension and a
family history of schizophrenia.
Neither the dimensional model (the set of dimen-
sional scores) nor the categorical model (the set of
diagnoses) was sufficient to explain the associations
Table 3 Distribution of opcrit generated diagnoses
Diagnosis
DSM-IV ICD-10 RDC
N (%) Median age Percent male N (%) Median age Percent male N (%) Median age Percent male
Schizophreniform 89 (19.2) 33 43.8 – –
Schizophrenia 113 (24.4) 33 54.0 304 (65.5) 34 51 278 (59.9) 36 49.3
Mania 67 (14.4) 39 38.8 51 (10.1) 37 39.2 58 (12.5) 40.5 37.9
Major Depression 9 (2) 42 11.1 4 (0.9) 28.5 25 9 (1.9) 37 33.3
Delusional disorder 32 (6.9) 72.5 31.3 – –
Unspecified 140 (30.4) 35.5 49.3 104 (22.4) 28.5 32.7 63 (13.8) 37 45.3
Schizoaffective 3 (0.7) 31 33.3 1 (0.2) – – 53 (11.4) 33 35.9
Not classified 11 (2.4) 65 27.3 – 2 (0.43) 23 0
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with all the pre-morbid variables (Table 5). None of
the posited models were significantly related to gen-
der, family history of schizophrenia or family history
of other psychiatric disorders. The set of dimensions
was an adequate model of association for single at
presentation and alcohol/drug misuse within the first
year of onset. However, the categorical model was
more informative for poor social adjustment and
unemployment at presentation. The full model (both
sets of data) best represented the association of age at
presentation, poor work adjustment and presence of a
psychosocial stressor i.e., neither the dimensional or
categorical model was sufficient on their own.
Discussion
j Findings
In a population-based study of patients during the
first year of a psychotic disorder we have shown a
symptom structure composed of 5 dimensions;
‘mania’, ‘disorganisation/bizarre’, ‘depression’, ‘non-
bizarre/non-mood congruent delusions’ and ‘auditory
hallucinations,’ which explains 58% of the total vari-
ance. This solution was replicated when EFA were
carried out on randomly split halves of the sample.
Although diagnostic categories had different symp-
tom dimension profiles, these did not relate precisely
to the diagnoses of psychoses in the currently used
classification systems. Symptom dimensions showed
different and distinct profiles of associations with
known pre-morbid risk factors i.e., individual
dimensions were able to discriminate between known
risk factors. Our results indicate that using both the
dimensional and categorical models of psychosis was
more informative in terms of sensitivity to variation
in demographic and risk factor profiles than either
model independently.
j Methodological considerations
Before interpreting our findings, we must consider
potential limitations. Symptoms and risk factors were
identified via case note review, although this is not the
best way to detail clinical variables, the case notes
were comprehensive and well maintained. The 2 rat-
ers were experienced psychiatrists demonstrating
good inter-rater reliability for both individual item
ratings and diagnostic categories. We used OPCRIT,
to cover a wide range of psychopathology and
demographic information, however not every symp-
tom or known risk factor with a theoretical relation-
ship to psychosis could be included, OPCRIT does not
have a broad range of anxiety, catatonic or negative
symptoms. A few candidate items had low variability,
Table 5 Contribution of dimensional and categorical models in the associations with premorbid risk factors
Dependent variable in logistic/linear model Comparison of full model with model
constrained by dropping the categorical
diagnoses
Comparison of full model with model
constrained by dropping the dimensions
Premorbid risk factor Likelihood ratio statistic p-value Likelihood ratio statistic p-value
Gender 10.68 0.06 4.44 0.49
Age at presentation 22.78 <0.001 86.14 <0.001
Single at presentation 8.20 0.15 15.38 <0.01
Unemployed at presentation 13.63 0.02 10.25 0.07
Poor work adjustment 15.61 <0.01 15.35 <0.001
Poor social adjustment 19.25 <0.001 2.59 0.76
Alcohol/drugs misuse 6.06 0.19 18.92 0.002
Psychosocial stressor 12.90 0.02 18.07 0.002
Family History schizophrenia 6.25 0.28 6.37 0.27
Family psychiatric history 1.84 0.76 8.67 0.12
Table 4 The Proportion of individuals within DSM categories scoring above the upper tertile on symptom dimensions
Manic
N (%)
Disorganised
N (%)
Depression
N (%)
Delusional
N (%)
Hallucinations
N (%)
Schizophrenia 21 (19) 57 (50) 26 (23) 25 (22) 39 (35)
Schizophreniform 21 (24) 42 (47) 32 (36) 23 (26) 42 (47)
Manic 62 (93) 16 (24) 17 (67) 47 (70) 22 (33)
Major depression 3 (30) 1 (10) 10 (100) 5 (50) 3 (30)
Delusional disorder 1 (3) 0 4 (13) 4 (13) 1 (3)
Unspecified 44 (31) 38 (27) 38 (27) 38 (27) 44 (31)
(11 cases, which were unclassified and 2 schizoaffective cases, were excluded from this analysis)
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which could reflect the chart review method, with
clinicians perhaps failing to record all symptoms,
however studies using face-to-face interviews have
found similarly low prevalence for items such as in-
sight [11]. Finally, we created composite items where
symptoms showed high collinearity. With regard to
pre-morbid functioning we used overall measures,
however better discrimination may have been
achieved if information on different domains of these
validators were available [27]. The EFA solution has
moderate communalities (average 0.59) and moderate
over-determination of factors (one factor only having
2 items), however the large sample size should be
adequate to produce accurate estimations under these
conditions [14] replication of the structure using split
half samples strengthens the EFA findings. Finally,
multiple statistical tests were conducted to explore the
relationship between dimensions and demographic
risk factors this could theoretically result in a Type 1
error, however no adjustment for multiple tests have
been used, as the a priori hypothesis was that differ-
ential associations would be present and adjustment
could potentially result in important differences being
deemed non-significant [32].
j Symptom dimensions
Affective symptoms loaded on to two distinct ‘manic’
and ‘depression’ domains. This is consistent with
findings from previous studies of psychoses rated
using OPCRIT [25, 30, 36, 37] and in studies of recent
onset psychosis. [23, 28]. The negative symptom
blunted/flattened affect loaded on to this dimension
in the opposite orientation to the manic symptoms,
similar to another recent study [23].
The second ‘disorganisation’ factor’ is also sup-
ported in the literature [17]. However, this has gener-
ally been associated with a negative domain, which we
did not identify separately. It is possible that this is due
to OPCRIT taking a narrow view of negative symptoms,
focusing on negative formal thought disorder, re-
stricted affect and blunted affect. This narrow view is,
however stressed in the literature as it increases the
chance of only primary negative symptoms being
elicited rather than those secondary to positive symp-
toms or medication [10]. We excluded negative formal
thought disorder in this study as it had a low preva-
lence, which in part may be consequent on the case note
review methodology, as clinician’s tend to document
only prominent and severe poverty of speech. However,
previous studies have found the symptoms of ‘blunting
of affect’ and ‘inappropriate affect’ (both present in our
study) to best discriminate between negative and dis-
organised syndromes while ‘negative formal thought
disorder’ was a poor discriminator [5, 41]. Also, pre-
vious studies using OPCRIT have identified negative
factors within mixed stage/chronic samples, where
negative symptoms have a higher prevalence [6, 30]. In
order to examine the issue of negative symptoms in
relation to the disorganisation factor, a post-hoc anal-
ysis was carried out in which associations between the
dichotomous measures of negative symptoms (blunt-
ing/restricted affect) and, jointly, the five dimensions
were assessed. This revealed significant associations
with all five dimensions, but the odds ratio was stron-
gest by far for the disorganisation dimension
(OR = 7.5, 95% CI 4.2, 13.1) and significantly stronger
than the OR with the depressive dimension (v2 = 5.3,
p = 0.02), the hallucinations dimension (v2 = 32.3,
p < 0.0001), the mania dimension (v2 = 42.8,
p < 0.0001) and the delusion dimension (v2 = 36.7,
p < 0.0001). Therefore, the disorganisation factor
identified in this study to a degree, taps into the nega-
tive symptom domain, and with time, the dynamics of
these associations may come more to the fore. Apart
from the negative symptoms of blunted/restricted af-
fect, we also found bizarre delusions (including
schneiderian first rank delusions) to load moderately
on to this dimension. In this first episode sample, there
seems to be a clinically distinct dimension of disorga-
nisation/bizarre delusions, which includes elements of
both Bleulerian and Shneiderian constructs.
Most EFA studies suggest a unitary positive
symptom dimension; however, not all studies of re-
cent onset psychosis have found this single factor.
[12, 28, 43]. We have found delusions to load on to
three factors; bizarre delusions loading with the dis-
organisation symptoms; mood congruent delusions
with the affective dimensions and finally persecutory
and systematised delusions loading on a discrete
dimension; suggesting potentially different underly-
ing psychopathological mechanisms for different
forms of delusion. Auditory hallucinations have
loaded on to a separate dimension, this segregation of
delusions and hallucinations has been reported
previously [26, 41].
j Relationship of symptom dimensions to clinical
diagnostic categories
Diagnostic categories differed in their factor score
profiles however; there was considerable overlap be-
tween categories. For example, disorganisation/bi-
zarre is more common in DSM-IV schizophrenia
(50%), but was not uncommon in other forms of
psychosis. For example, 25% of patients diagnosed
with mania scored in its top tertile. Similarly, 24% of
the subjects diagnosed with DSM-IV schizophrenia
scored in the highest tertile for the mania dimensional
scores. The range of scores in each diagnostic cate-
gory also indicates considerable intra-group varia-
tion. The mildly correlated factor solution and the
observed overlap between categories on their factor
score profiles suggests that symptom dimensions do
not define classes of patients but co-exist within
individuals.
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j The association of dimensions and categories to
known pre-morbid risk factors
There was a differential association between dimen-
sions and risk factors e.g., the disorganised factor was
strongly associated with younger age of onset, single
status, unemployment and poor pre-morbid work and
social adjustment. On the other hand, increasing
scores in the manic dimension increased the proba-
bility of being married, employed and having good
pre-morbid work and social adjustments. Manic and
depressive dimensions were both associated with
family history of psychiatric disorders (other than
schizophrenia). Previous studies exploring the rela-
tionship between symptom dimensions and a family
history of psychosis have been inconsistent showing
either no or only weak associations. [7, 25, 29]. We
did not find an association between any of the
dimensions (or diagnoses) and a family history of
schizophrenia, this result is consistent with findings
from family studies, showing family history of non-
affective psychosis throughout the spectrum of
affective and non-affective psychosis [20].
Finally, neither dimensional or categorical models
alone could best predict associations with pre-morbid
risk factors, rather concomitant use of both repre-
sentations provided significantly more information
than either one system independently. The concurrent
use of alternative representations of psychopathology
has been proposed [40] and our finds support this
assertion.
This dimensional model of first episode psychosis
requires further validation using neurobiological
strategies and prognostic variables nonetheless the
results presented here support the idea that it is useful
to conceive psychosis as overlapping symptom
dimensions, each associated with a range of under-
lying and different risk factor profiles. However, in
this study, the concomitant use of both dimensional
and categorical models of psychosis was more sensi-
tive to variations in demographic and risk factors
than either model independently; combining dimen-
sional and categorical representations of psychosis is
likely to be most informative in elucidating the causes
and correlates of psychosis.
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CHAPTER 10 
Diagnostic Utility: categories and dimensional 
representations of psychosis comparison of their 
discriminate validity with 5-year outcome 
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ABSTRACT 
Background & Aims: The American Psychiatric Association’s Diagnostic and Statistical Manual 
of Mental Disorders (DSM) is under revision and the inclusion of a dimensional measure of 
symptoms to improve clinical usefulness is being considered, however, the predictive power of 
symptom dimensions is not yet established. Few studies have examined dimensional relation-
ships with outcome and there are currently, no published follow-up studies of dimensions gen-
erated from first- episode psychosis samples. This study adds to the current literature by exam-
ining the usefulness of symptom dimensions and DSM IV categorical diagnoses (derived from 
incident cases of psychosis) in predicting 5-year outcome. Methods: From 379 incident cases of 
psychosis, outcome, measured using individual descriptors of symptom course/disability and 
‘classes of outcome’ (generated using finite mixture modeling)- from longitudinal information 
covering the initial five years from presentation, were regressed onto 3 competing explanatory 
models i) complementary model using diagnoses and dimensions ii) diagnoses only iii) dimen-
sions only. Results: The explanatory models using information from both dimensions and diag-
noses had better predictive power. For the 3 outcome classes the complementary model (di-
mensions and diagnoses) had a pseudo R-squared of 0.24, while the model with factor scores 
only had a pseudo R-squared 0.16 and diagnoses only model a pseudo R-squared of 0.19. This 
difference was statistically significant, Likelihood ratio test (LRT) statistic for the dimensions 
only model = 36.26, p value <0.001 and Diagnoses only model LRT= 63.13, p value 
<0.001).Conclusion: The complementary use of DSM IV diagnoses and dimensional (factor) 
scores, adds significantly to the predicative power of the DSM diagnoses. Diagnoses seem to be 
more useful than dimensions around the time of presentation, while dimensional representa-
tions may provide added information at follow up. Keywords: schizophrenia, psychosis, classifi-
cation, diagnoses, dimensions. 
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INTRODUCTION 
Despite significant advances in our knowledge of the neuroscience underpinning mental disor-
ders, substantial gaps in genetic and pathophysiological understandings remain, which hinder 
the development of an aetiological-based classification system, corroborated by specific biologi-
cal markers 1. Consequently, outcome remains an important criterion for validating psychiatric 
diagnoses 2-5. Valid, useful diagnoses will have good predictive power and provide clinically rele-
vant information about course, outcome and likely treatment response. 
The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders 
(DSM) is currently under revision and the possibility of introducing a dimensional or qualitative 
component to improve clinical usefulness, is under consideration, 6 however the predictive 
power of symptom dimensions is not yet established. Few studies have examined dimensional 
relationships with course and outcome and to date, there are no published follow-up studies of 
dimensions generated from first- episode psychosis samples. 
We therefore report a study comparing the prognostic usefulness of symptom dimensions and 
DSM IV categorical diagnoses, derived from incident cases of psychosis. Outcome is a multidi-
mensional construct, comprising inter-linked domains relating to; symptom course, longitudinal 
social disability and treatment 7-10. In order to take account of these associations, results are pre-
sented for outcome measured by i) individual descriptors of course and outcome and ii) classes 
(typologies) of outcome generated using finite mixture modeling (a multivariate reduction tech-
nique) – from longitudinal information covering the initial five years from presentation. 
METHODS 
Catchment area 
Dumfries and Galloway (D&G) is a geographically well-defined area in South-West Scotland. It 
has a stable population of around 147,000, of whom 99.5% are white. Psychiatric services are 
via one hospital and its associated community services. There is little or no private health care. 
Baseline patient identification & characteristics 
Case ascertainment has been described in detail elsewhere 11. Briefly, all patients were identified 
who came into contact (in-patients, day patients, out patients, domiciliary assessments and in-
formal out-of-hour contacts) with psychiatric services in Dumfries and Galloway over a twenty- 
year period (1979-98) and who were given a clinical diagnosis of schizophrenia, schizoaffective 
disorder, delusional disorder, mania, drug induced psychotic disorder; acute, transient or un-
specified psychotic disorder. Patients who were not residents of Dumfries & Galloway, who had 
experienced psychotic symptoms prior to the study period or had a clear organic cause for their 
symptoms, were excluded. 464 patients had a first episode of psychosis during the study period. 
There were 210 (45.26%) males and 254 (54.74%) females with a median age at presentation of 
36 (inter-quartile range 25-55). Males and females showed a significant difference in the age of 
onset, the median age for males was 33 and for females it was 39.5 years (p<0.001) 
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Baseline assessment of psychopathology 
Psychopathological assessment has been described in detail previously 12-14. Briefly, two experi-
enced psychiatrists, working independently, used the OPCRIT checklist 15 to rate the presence 
and absence of symptoms from the case records (which included medical, informant, nursing, 
social work, occupational therapy notes and all correspondence) for the first year from presen-
tation. Good inter-rater agreement was demonstrated for both the individual symptom meas-
ures (kappa ranged= 0.69-0.92) and DSM IV diagnoses (kappa = 0.79) generated using the asso-
ciated diagnostic algorithm OPCRIT 3.4. 
A exploratory principal factor analysis on the tetrachoric correlation matrix with promax rota-
tion of first year OPCRIT ratings was carried out and identified five latent dimensions (mildly 
correlated), explaining 58% of the variance. Affective symptoms loaded on to two distinct 
‘manic’ and ‘depression’ factors. A third factor predominately consisted of disorganised symp-
toms, which also included moderately loaded negative symptoms and a fourth, positive symp-
tom factor. Delusions loaded on to three factors; bizarre delusions with the disorganisation 
symptoms; mood congruent delusions with the affective dimensions but widespread systema-
tised delusions loading on a discrete fifth dimension. This factor structure was replicable, with 
the solutions from random split-halves of the sample being highly correlated. The four-factors 
manic, depressive, positive and disorganised/negative are consistent with factor analytical stud-
ies of recent onset psychosis 16; a separate delusional dimension has similarly been reported in 
other studies using instruments allowing for multiple measures of delusional ideation 17, 18. Fac-
tor scores were calculated for each individual for the five dimensions 14 
Tracing exercise 
The Local Regional Ethics Committee and the Privacy Committee of Information and Statistical 
Division (ISD) Scotland approved the follow up study. A Careful tracing exercised was carried-
out; over a 2-year period (2004-2005), using the D&G medical records department; the General 
Register Office, Edinburgh (for births, deaths and marriages); the National Health Service (Scot-
land) Central Registrar and the current electoral role for Scottish wards. 422 (91%) of the incep-
tion cohort were traced, 133 (32%) had died and the median time from presentation was 11.82 
years (inter quartile range 6.67- 18.41 years). Once traced, subjects each received a letter intro-
ducing the study, followed by a visit from a research worker who explained the purpose of the 
study and asked for their consent. 
Clinical outcome & social disability assessment 
Where possible, multiple sources of information including patient interviews, careful systematic 
review of case notes and supplementary information from health professionals involved in day-
to-day patient care and family members were used in order to complete a lengthy assessment 
battery. For the purpose of the analyses presented in this paper, ratings were used for the first 5 
years of follow-up, from two sources. First, a slightly modified version of the WHO Life Chart 
Schedule (LCS) 19, 20 which rates outcome across four domains of i) overall psychotic symptom 
duration, severity and periodicity coded by a single rater (JA), ii) treatment, iii) residency, iv) 
purposeful activity domains, rated by research workers demonstrating good reliability (pairwise 
agreement >0.8 for all items used in the analyses). Second, The Life Time Dimensions Scale 
(LTDS) 21 was used to rate individual items of psychopathology longitudinally and multi-
dimensionally, coded by a single rater (JA). 
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Multivariate reduction of outcomes across domains 
Mixture Modelling using Mplus version 4 22 was carried out to identify subtypes of patients with 
shared outcome profiles (latent classes). This multivariate analysis was applied to 34 indicators 
of outcome from the standardised schedules, LCS and LTDS, chosen (a priori) to represent the 
broad range of outcomes (items presented in TABLE 2). The aim of this analysis was to identify 
the smallest number of classes, which adequately describe the observed associations seen in the 
outcomes, starting with the most parsimonious 1 class model and fitting successive models with 
increasing numbers of classes. As the LCA models with different number of classes are not 
nested, it is inappropriate to use chi squared differences to compare the fit of 2 competing mod-
els when determining the optimal solution. Therefore, the number of classes was informed by 
goodness of fit indices; the Akaike information criterion (AIC) and Bayesian information crite-
rion (BIC) (where lower values indicate better fit). As the response pattern of the outcome 
measures was large, it is unlikely that the likelihood ratio statistic would follow the theoretical 
chi squared distribution; therefore, we present boot strapped and Lo-Mendell-Rubin likelihood 
ratio test (LRT) p-values when comparing models. The Local independence assumption was 
checked by examining the bi-variate residuals and finally, standardised entropy scores were 
used to measure classification performance (higher scores indicating better classification per-
formance). 
Comparison psychopathology-derived predictive models for outcome 
A series of linear/logistic/ordinal logistic regression models were fitted for each outcome meas-
ure. First, a “full model” was generated for each outcome (as dependent/response variable) and 
regressed onto both the factor scores and diagnoses (DSM IV) (independent/ predictive vari-
ables). In order to assess the relative contribution of dimensions and diagnoses, the explanatory 
power of this full model was compared to similar models constrained by dropping the diagnoses 
and the dimensional components in turn. Statistical significance of model differences was esti-
mated using the likelihood ratio test. 
RESULTS 
Attrition at 5 years 
High quality information pertaining to the first 5 years of follow up was obtained for 379 (82%) 
of the total inception cohort. Of these, 351 (93%) had continued contact with psychiatric ser-
vices (at 5 years) and 127 (36%) had a face-to-face interview. 85 (18%) of the original cohort 
were lost at 5 years due to 56 (12%) having died and 29 (6%) having inadequate information. 
Comparison followed up / lossed to follow up (ltfu) 
There was no statistically significant difference in distribution of gender, year of presentation, 
pre-morbid social adjustment, alcohol use in the first year, cannabis use in the first year or index 
diagnosis between the two groups. However, those followed up were more likely to have 
younger age of onset (median 33 years compared to 58.5 in LFTU; t =7.4, p <0.001), be single (χ2 
= 4.49, p= 0.03), unemployed (χ2 = 4.45, p = 0.03), have a family history of schizophrenia (χ2 = 
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4.42, p=0.03) and family history of other psychiatric disorders (χ2 = 8.09, p= 0.04). This bias re-
flects the primary cause of attrition, which was death. 
Multivariate reduction of outcome measures 
Investigating fit measures for 1 to 4 class models, showed the BIC and AIC to dip at the 3 class 
solution and this was corroborated by the Lo- Mendell- Rubin LRTs becoming non significant, 
when comparing the 3 and 4 class model, though the boot strapped LRT did suggest a higher 
number of classes. Entropy was high for all models (Table 1). Overall, the most parsimonious 
model was the 3-class model which seems to be an adequate descriptor of observed variability 
of outcome and the bivariate residuals were respectable. The conditional probabilities and aver-
age class means of outcome indicators appear in Table 2. Class 1 (31% of the follow up cohort) 
tended to exhibit pervasive disability with longest time psychotic (mean 59.56 months, sd 0.32) 
and 35% probability of experiencing severe negative symptoms for more than 2 years. They 
required the highest levels of residential support (mean 18.88 months, sd 2.29) and unemploy-
ment (mean 33.22 months, sd 2.55) and had a high probability of global deterioration in func-
tioning (0.65). Class 3 (23% of the cohort) showed the best outcome with a mean time psychotic 
of 2.46 months (sd 0.25), high probability of experiencing complete remission (0.63) and low 
likelihood of significant deterioration in functioning (0.17), with on average the shortest time in 
supported residence (mean 14.30 months, sd 1.82) and lowest unemployment (mean 10.05 
months, sd 2.28). Class 2 (46% of the cohort) exhibited intermediate duration of symptoms and 
disability. There is a monotonic change in the conditional probabilities (or class means) of indi-
cators across classes for all items, with the exception of 2 severity scores, demonstrating in-
creasing severity of outcome i.e. ordinal classes. 
 
 
TABLE 1: Fit Indices for mixture modelling (LCA) of psychosis outcome 
 
Model 
 
Log likelihood BIC AIC Lo-Mendell-Rubin LRT Bootstrap 
LRT 
entropy 
1 class -10174 20557 20419 - -  
2 class -9006 18414 18149 0.32 <0.001 1 
3 class -8745 18090 17692 0.05 <0.001 0.97 
4 class -8582 17959 17431 ~1 <0.001 0.99 
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TABLE 2: Class Solution of indicators of 5 year outcome of psychosis 
 
Latent class conditional probabilities (or estimated means) for 3 class 
solution for outcome at 5 years 
 
 
CLASSES 
1.Poor 
outcome 
2.Intermediate 
outcome 
3.Best out-
come 
 
PREVALENCE 
118 
(31%) 
175 
(46%) 
86 
(23%) 
    
 
Time of longest psychotic episode (LCS) 
59.56 
(sd 0.32)
5.03 
(sd 0.42) 
2.46 
(sd 0.25) 
 
Time requiring residential support (LCS) 
18.88 
(sd 2.29)
14.30 
(sd 1.82) 
13.23 
(sd 2.58) 
 
Time unemployed or not engaged in purposeful activity (LCS) 
33.22 
(sd 2.55)
23.97 
(sd 2.27) 
10.05 
(sd 2.28) 
Over all deterioration within 5 years (LCS) 0.65 0.36 0.17 
Duration of delusions (LTDS)    
Present for delusions for days but < 2 weeks 0.01 0.32 0.30 
Present for delusions >2 months to < 2 years 0.12 0.61 0.21 
Present for delusions >=2 years 0.65 0.04 0.00 
Duration of paranoid ideation within 5 years (LTDS)    
Presence of paranoia for days but <2 weeks 0.03 0.20 0.10 
Presence of paranoia >2 months to < 2 years 0.06 0.42 0.01 
Presence of paranoia >=2 years 0.75 0.34 0.00 
Duration of any hallucinations (LTDS)    
Present for any hallucinations for days but < 2 weeks 0.11 0.32 0.19 
Presence of any hallucination >2 months to < 2 years 0.14 0.27 0.11 
Presence of any hallucination >=2 years 0.41 0.01 0.00 
Duration of formal thought disorder (FTD) (LTDS)    
Present of FTD for days but < 2 weeks  0.10 0.12 0.07 
Presence of FTD >2 months to < 2 years 0.13 0.13 0.00 
Presence of FTD >=2 years 0.12 0.01 0.00 
Severity of delusions (LTDS)    
Rated moderate and clinically relevant  0.61 0.36 0.20 
Rated severe or very severe 0.25 0.61 0.31 
Severity of Paranoid Ideation (LTDS)    
Rated moderate and clinically relevant 0.62 0.59 0.10 
Rated severe or very severe 0.22 0.38 0.02 
Severity of any hallucinations (LTDS)    
Rated moderate and clinically relevant 0.55 0.35 0.21 
Rated severe or very severe 0.10 0.26 0.09 
Severity of Formal Thought Disorder (LTDS)    
Rated moderate and clinically relevant 0.22 0.15 0.07 
Rated severe or very severe 0.12 0.11 0.00 
Presence of any Sneiderian first rank symptom, for at least 2 months 
(LTDS) 
   
Rated moderate and clinically relevant 0.31 0.20 0.10 
Rated severe or very severe 0.17 0.31 0.07 
Presence of negative symptoms (blunted affect or poverty of speech) for 
more than 2 years (LTDS) 
   
Rated moderate and clinically relevant 0.15 0.08 0.00 
Rated severe or very severe 0.35 0.06 0.04 
Type of remission (LCS)    
None 0.95 0.01 0.05 
Incomplete (residual symptoms remain) 0.02 0.43 0.32 
Complete (no residual symptoms evident) 0.03 0.60 0.63 
Characteristics of course (LCS)    
Sing episode 0.01 0.40 0.57 
Multiple episodes  0.03 0.59 0.43 
Chronic symptoms 0.97 0.01 0.00 
 113
COMPARISON OF PSYCHOPATHOLOGY-DERIVED EXPLANATORY MODELS OF 
OUTCOME 
The results comparing the predicative power of i) full model using both diagnoses and factor 
scores (symptom dimension scores) ii) factor scores only and iii) diagnoses only, are presented 
in (Table 3). Diagnoses explained an important (statistically significant) proportion of the full 
predictive model for all individual outcome measures. However, the dimensional representa-
tions added significantly to the explanatory model for time psychotic, single episode, chronic 
course, type of remission. The explanatory models using the outcome classes found the full 
model (dimensions and diagnoses) to have pseudo McFadden’s R-squared values of 0.24, while 
the model with factor scores only had a pseudo McFadden’s R-squared was 0.16 and diagnoses 
only model a McFadden’s pseudo R-squared of 0.19. However, both individual models signifi-
cantly contributed to the explanatory power of the full model (LRT statistic for: dimensions only 
model = 36.26, p value <0.001, Diagnoses only model = 63.13, p value <0.001). 
 
 
TABLE 3: Comparison of psychopathology derived predictive models with outcome 
 
Outcome R2 
Full model 
R2 
For dimen-
sional model 
LRT 
Difference full model 
with 
dimensional model 
(dropping diagnoses) 
R2 
For diagnoses 
model 
LRT 
Difference full model 
with 
Diagnoses model 
(dropping dimensions)  
Time psychotic 0.27 0.15 25.72 <0.001 0.23 59.20 <0.001 
Functional Deterioration  0.10 0.07 3.02 0.699 0.09 14.91 0.011 
Single episode 0.10 0.06 11.79 0.041 0.07 18.73 0.002 
Chronic course  0.23 0.14 23.96 <0.001 0.18 39.72 <0.001 
Type of remission 0.15 0.08 36.41 <0.001 0.10 52.27 <0.001 
Time requiring residen-
tial support 
 
0.14 
 
0.10 
 
5.13 
 
0.401 
 
0.11 
 
17.95 
 
0.003 
Time unemployed 0.22 0.16 2.12 0.835 0.20 17.17 0.004 
DISCUSSION 
Best psychopathology-derived predictive model for outcome 
Using both DSM IV diagnoses and symptom dimensions concurrently predicted 5-year outcome 
of psychosis significantly better than either diagnosis or dimensional representation on their 
own, in this (population-based) follow up of patients with first episode psychosis. DSM categori-
cal diagnosis independently explained an estimated 19% of the total variance of the overall 
measure of outcome, suggesting that the current diagnoses are relatively robust predictors of 
outcome. However factors scores (symptom dimensions) added significantly to their predictive 
power, with the combined model explaining 24% of variability of outcome. Thus, dimensions 
seem to increase the predictive power of DSM diagnoses. 
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Although there have been many studies examining the factor structure of psychosis 23, few have 
examined their association with outcome and disability 24-31, and even fewer comparing the util-
ity of dimensions and diagnoses 24, 29-31 (summarized in Table 4). Generally, these studies report 
dimensions to be more useful than categories in predicting service use and social disability 
though the difference in the competing models predictive power is small and not demonstrated 
across all outcomes. For example, categorical representation have been shown to better predict 
illness duration 27, use of support services and ‘deteriorating course’ 29, while other studies sug-
gest that neither dimensional or categorical models alone can best predict associations with out-
comes such as level of impairment during episodes, deterioration in functioning, or response to 
neuroleptic treatment 24. The lack of consistency in results may in part be consequence of the 
study design. Firstly, they study psychopathological representations generated from samples, 
which vary by ‘stage of disorder’. However, models of underlying psychopathological structure, 
derived from latent variable statistical models (e.g. exploratory factor analyses or latent class 
analyses) are highly dependent on when in the evolution of the disorder the symptoms are as-
sessed 27, 32. To overcome this problem, patients were studied using psychopathology measured 
during the first year from presentation, as this is an established validating criterion for nosologi-
cal classification 5. This methodological difference may explain in part our findings that both 
dimensions and diagnoses predict outcome over and above the other and categories have 
greater predictive power than dimensions. In previous studies, where lifetime ratings of psy-
chopathology were used, there will be accretion of symptomatic information over time and it is 
quite possible that dimensional scaling utilizes this cumulative psychopathology more effec-
tively. Secondly, few of the previous studies have used formal standardised assessment tools 
designed specifically for the measurement of course and outcome, we therefore choose to meas-
ure course and disability with the LCS, a schedule which has been used extensively in outcome 
studies and has proven reliability 33. This was supplemented with information from the LTDS, a 
scale specially designed to rate long-term symptomatic information from retrospective review of 
case notes and has proven reliability 21. In this study, one experienced clinician rated the symp-
toms over 5 years, obviating the issue of inter-rater reliability, although problems could still 
occur if the single rater scored everything erroneously. However, even if this were the case, 
there would still be no reason to suspect differential measurement error across dimensions or 
diagnoses assigned at baseline. In addition, previous papers have reported multiple individual 
indicators of outcome, with multiple statistical testing that could potentially lead to chance find-
ings. We dealt with this problem by using multivariate techniques to reduce outcome into dis-
crete classes. 
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TABLE 4: Summary of published studies of the comparative utility of diagnoses and dimensions in predicting out-
come. 
 
Study Outcome measure Estimation of predic-
tive power 
Dimensions 
 
Dimensional 
Contribution to 
prediction of 
outcome in the 
full model 
Estimation of 
predictive power 
of categorical 
(diagnoses) 
Diagnoses 
Contribution 
to prediction 
of outcome in 
the full model
OPCRIT outcome items: all 
available information 
PCA of OPCRIT life-
time psychopa-
thology 
 Clinical ascribed 
Schizophrenia or 
affective psychosis 
 
Incomplete remission  Pseudo-R sq 0.270 P <0.01 Pseudo-R sq 0.232 NSS 
Deterioration from premor-
bid level 
 
Pseudo-R sq 0.251 
 
NSS 
 
Pseudo-R sq 0.265 
NSS 
No response to neuroleptics   
Pseudo-R sq 0.085 
 
NSS 
 
Pseudo-R sq 0.060 
NSS 
Dikeos 2006 
N=191 
Mixed stage sam-
ple 
 
Course Pseudo-Rsq 0.358 P <0.001 Pseudo-R sq 0.254 NSS 
Sum scores of non standard-
ised interview (last year) 
PFA of SCAN cross 
sectional psychopa-
thology in last month
 OPCRIT generated 
Diagnoses (DSM 
IIIR)  
 
Service demand  R2 =0.085  R2 =0.069  
Use of for support services 
(sum score) 
 
R2 =0.001 
  
R2 =0.039 
 
Deteriorating course(sum 
score) 
 
R2 =0.11 
  
R2 =0.139 
 
Rosenman 2003 
N=980 
Mixed stage sam-
ple 
 
Social & occupational func-
tional score 
 
R2 =0.237 
  
R2 =0.078 
 
LCS (previous 2 years) WHO 
DAS scale 
PCFA OPCRIT 
Lifetime ratings 
 OPCRIT derived 
RDC diagnosis 
 
Social disability R2 =0.35 p <0.0005 R2 =0.26 NSS 
Unemployed thought-out  Pseudo R-sq 0.13 P< 0.05 Pseudo R-sq 0.11 NSS 
Months independent living R2 =0.11 P <0.005 R2 =0.08 NSS 
Incomplete remission no 
recovery 
 
Pseudo R-sq 0.17 
 
P <0.05 
 
Pseudo R-sq 0.20 
 
NSS 
Chronic course Pseudo R-sq 0.12 P<0.0005 Pseudo R-sq 0.06 NSS 
Van Os 1999 
N=706 
Mixed stage sam-
ple 
 
Days in hospital R2 =0.05 NSS R2 =0.07 NSS 
LCS (previous 2 years) WHO 
DAS scale 
PCA using OPCRIT 
Lifetime (<5 years 
since presentation) 
 OPCRIT derived 
DSM IIIR 
 
Negative symptoms usually 
present 
 
PPV 0.773 
 
P < 0.001 
 
PPV 0.711 
 
NSS 
Full recovery PPV 0.688 P<0.001 PPV 0.552 NSS 
Chronic course PPV 0.712 P< 0.001 PPV 0.655 NSS 
Time employed R2 =0.191 P<0.001 R2 =0.0.09 NSS 
Employed during follow up PPV 0.639 P <0.001 PPV 0.04 P <0.001 
Time as inpatient R2 =0.08 P <0.001 R2 =0.04 NSS 
Time living independently R2 =0.118 P <0.001 R2 =0.029 NSS 
Van Os 1996 
N=337 
Recent onset 
within 
5 years of presen-
tation. 
DAS score R2 =0.312 P<0.001 R2 =0.22 P <0.001 
Definitions: PCA : principal component analysis, PFA principal factor analysis, PCFA principal component factor analysis, PPV 
positive predictive value taken from classification table of logistic regression. WHO DAS (disability assessment schedule), RDC 
(research diagnostic criteria) NSS not statistically significant. 
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OUTCOME 
The application of mixture modeling techniques for data reduction purposes, on outcome at 5 
years, yields 3 ordered classes, which vary by level of outcome severity, from best to worst 
(most severe course and disability). There were clear monotonic change in means for longest 
time psychotic, time in residential support and time unemployed (or unable to carry out usual 
structured activities) and the conditional probabilities of class members endorsing all other out-
comes showed a similar gradient. The only evidence of discordance was higher probabilities of 
endorsing severe ratings for the positive psychotic symptoms of delusional thought, paranoid 
ideation and Schneiderian first rank symptoms for the intermediate class while the worst out-
come class had higher probabilities of endorsing moderate severity. These associations between 
symptom indicators and social disabilities are unlikely to be due to rater mediated information 
bias, as a different rater rated the symptom course measures than rated the social disabilities 
(i.e. independent ratings). 
Latent class analysis makes no further assumptions about the underlying latent structure of out-
come. Ordinal classes suggest a uni-dimensional outcome gradient, but are not sufficient evi-
dence. Heterogeneity within classes (indicating configurationally different classes) may occur 
even in the presence of monotonicity across classes, due to sub-class factor structures, which 
can only be explored by hybrid latent modelling. Latent classes will however, adequately reduce 
the outcome data, allowing the testing of competing psychopathology-derived models (dimen-
sions and diagnoses). The 3 class model was used in the ordinal regression analyses, however 
the 4 class, model is simply an elaborations of the model presented here, the poor outcome class 
remaining constant throughout the series of models fitted (not presented but solution can be 
provided on request). It is important to note the classes identified may be sample-specific and 
should be regarded as heuristic devices or constructs to aid our analyses and understanding, 
rather than true structures in nature. This reservation notwithstanding, the mixture model does 
suggest associations between different outcome domains at 5 years. Further research examining 
outcome using fine-grained assessment of outcomes, as they emerge would be informative. 
Methodological considerations 
The main limitation of the current study is the retrospective follow-up design. However, this 
study was carried using standardised schedules of outcome, designed to assess symptom course 
and disability retrospectively, in a region with integrated psychiatric services with low staff 
turnover, providing good longitudinal corroborative information. High quality, complete case 
notes were available, and 93% of those followed up had continued contact with at least one 
member of the community team at 5 years, so providing documentation throughout the period 
under study. At the time of assessment, patients would have different lengths of follow up de-
pending on year of presentation. This could potentially result in recall bias, however, this is 
unlikely as contemporaneous clinical notes and service-administration details informed ratings 
of outcome. Further, no association was found between index diagnoses and year of presenta-
tion. 
LTFU was primarily due to deaths in the first 5 years in patients with older age of onset psycho-
sis - this may potentially bias towards worse outcome 34, 35. The high follow up rate at 5 years 
(82%) makes it unlikely that explanatory models comparing dimensions and diagnoses will be 
compromised by differential drop-out. 
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CONCLUSION 
To the best of our knowledge, this is the first study to examine how well index diagnoses and 
dimensional representation of psychosis predict outcome as measured by standardised sched-
ules of course and disability. The best predictive model employs current DSM IV diagnoses aug-
mented with dimensional factor scores. Further work is required to examine i) differential vari-
ability of categories and dimensions predictive power across ‘phase of illness’ as perhaps dimen-
sions are more useful in predicting and therefore guiding management after the initial presenta-
tion, ii) the best method to rate dimensions in clinical settings to capitalise in this small but po-
tentially important added contribution to the explanatory power of diagnoses. 
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CHAPTER 11 
Epilogue & Future directions for Epidemiological 
Research 
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EPILOGUE & FUTURE RESEARCH DIRECTIONS 
Classical epidemiological studies of environmental risk factors: <*I*>The findings from the 
studies described and reviewed in this thesis show a number of environmental factors which are 
consistently<*I*> statistically associated<*I*> with an increased risk for the onset of schizo-
phrenia and/or other non affective psychotic disorders, but with only small to moderate effect 
sizes.  
 
TABLE 1: summary of the most often studied environmental risk factors 
Risk Factor Effect size 
(pooled) 
Dose 
Response  
Temporal Association Replicated 
& consistent finding 
Risk Factors Operating during early development 
Paternal Age OR=2 9 9 9 
Season of birth 
In Northern hemi-
sphere 
OR=1.07 ~ 9 Replicated in Northern 
Hemisphere 
9 
Pregnancy & birth 
complications 
OR=2 ~ 9 9 
Risk Factors operating during childhood and early adolescence 
Urban birth & up-
bringing 
OR=2 9 9 9 
Migration OR=2 
(1st gen) 
NA ~ 9 
Cannabis use OR=1.4 9 ~ 9(for psychotic experiences)
 
Furthermore, other environmental risk factors have been proposed and require further study to 
establish their association (prenatal infections, rhesus compatibility, prenatal maternal stress, 
stressful life events, early childhood neglect, physical brain trauma and societal organizational 
factors, taken together these studies suggest a possible environmental influence on the onset of 
schizophrenia/ psychosis. Gene environment correlation: Could the association of environ-
mental risk factor exposure and schizophrenia/psychosis be confounded by genotype? How-
ever, While contemporary epidemiological studies of environmental risk factors have substan-
tially improved designs which are likely to reduce bias and confounding from other known en-
vironmental risk factors, what cannot be adjusted for in studies designed to examine only envi-
ronmental exposure is possible confounding by genotype. That is, the relationship seen for the 
environmental factor is due directly to the effect of the genotype (non-causal gene environment 
correlation). 
 
 
 123
 
Figure 1: Gene environment correlation (non causal gene environmental correlation) 
 
This is especially a problem in studies of environmental risk factors for diseases which have a, 
significant genetic predisposition. In schizophrenia there is convincing evidence from family, 
twin and adoption studies demonstrating a high genetic predisposition with heritability esti-
mates of around 80% (derived from twin studies). On the other hand however, such heritability 
estimates do not model joint gene –environment influences, therefore it is quite possible that 
joint gene environment effects explain a substantial proportion of such estimates. Furthermore, 
to date (but perhaps this will have changed by the time of the PhD Defense!) there have been no 
genes identified which have consistently shown a moderate /strong main effect association with 
schizophrenia/psychosis, at the population level. (Craddock, O’Donovan et al. 2006). 
POSITED THEORY FOR THE ALLELIC ARCHITECTURE OF SCHIZOPHRENIA 
Polygenetic Transmission and schizophrenia 
The common disease-common variant (CD-CV) hypothesis posits that the genetic susceptibility 
to disease is largely due to alleles which have a moderate frequency in the population. This is a 
pattern of genetic transmission which is found repeatedly in nature with multiple genes influ-
encing complex traits such as psychosis (through additive or multiplicative effects of small mag-
nitude) The model suggests that genetic variation influencing disease phenotypes will follow a 
distribution in the population with many rare variants and some common variants. Even if lar-
ger effect sizes were found for rare variants, because common variants are more prevalent they 
will explain the large majority of cases within a population (i.e. the common variants will have a 
higher population attribution risk, assuming causality).If the CD-CV model approximates to the 
allelic architecture of schizophrenia, genome wide association studies (GWAS) should be a pow-
erful tool for detecting such loci of small effect, while if there is substantial allelic heterogeneity 
due to rare variants or epigenetic phenomena (low allelic identity) association mapping would 
be very much less effective, because each mutation would likely arises on an independent haplo-
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type background (therefore tending to cancel out each other’s signals) (Lander 1996; Chak-
ravarti 1999). 
SNP (single nucleotide polymorphisms.) To date, the most frequently studied CV employ SNP 
markers. Studies of variation in the human genome indicate that we all share approximately 
99.9% of our DNA sequence, while this seems like a very small difference because the human 
genome is around 3.2 billion base pairs in magnitude; this translates to you having 3 million 
base pairs which are different to mine! A site in the genome where individual members of a spe-
cies differ in a single base pair is called a SNP (“snip”). SNPs arise from mutations which are then 
inherited through allelic variants, which generally do not produce phenotypic variation. This 
results in each SNP being associated with other specific SNPs (as well as other types of genetic 
variants and alleles) present on the chromosome where the mutation occurred, this set of linked 
alleles is termed a Haplotype. SNPs within a haplotype block are physically linked and therefore 
tend to be inherited together. New haplotypes do arise from mutations but less commonly arise 
from crossing over (and the rate of crossing over is proportional to the distance between the 
genes), therefore SNPs and other variants which are physically close together on the chromo-
some will be strongly associated as haplotypes. The non random association between genetic 
variants within a haplotype is termed linkage disequilibrium. Because of their variability and 
widespread occurrence throughout the genome SNPs which are common polymorphisms (defi-
nition : occurring at >= 1% of the population) are valuable markers in linkage and association 
studies. When a SNP is physically close to a disease causing locus it will tend to be inherited 
along with the disease causing allele. People with the disease will tend to have different SNPs 
from those of non diseased people and this is the strategy used in gene fine mapping (Pierce 
2008).Genome wide Association studies using SNP have been successful in detecting strong as-
sociations in common diseases such as coronary artery disease, hypertension, rheumatoid ar-
thritis, Crohn’s disease and Type 2 Diabetes mellitus. 
CNVs Copy Number variation: Each diploid person normally possesses 2 copies of every gene; 
one inherited from their mother and the other form their father. However, studies of the human 
genome have revealed differences among people in the number of copies of large DNA se-
quences called copy-number variations (greater than 1000bp). CNVs include deletions; a person 
has a single copy or sequence, or duplications, when they have more than 2 copies of a particu-
lar gene. Data from the HapMap project indicates a relatively large number of copy number vari-
ants within the human genome. Many of these CNVs encompass large regions of DNA sequenc-
ing, often several thousand base pairs in length. This suggests that people differ not only at mil-
lions of different individual SNP regions, but also in the number of copies of many larger seg-
ments of the genome. Most CNVs contain multiple genes and potentially affect the phenotype by 
altering gene dosage and by changing the position of the sequences, which affect the regulation 
of other genes close to the altered region. Recent studies suggest that rare CNVs may be impli-
cated in some cases of schizophrenia (Kirov, Gumus et al. 2008)suggesting that the CD-CV hy-
pothesis may not account for all the genetic effects in schizophrenia but as posited earlier there 
are also rare variants with larger effects implicated. 
Microsatellite variation: Microsatellites are short DNA sequences that exist in multiple copies 
repeated in tandem. People vary in the number of copies of repeat sequences that they possess. 
Work primarily stemming from DNA fingerprinting research in forensic pathology has demon-
strated the variation in banding patterns in microsatellite sequences are inherited, with all the 
bands found in offspring also being present in the parents. This form of DNA sequence variation 
has been used to demonstrate evidence of gene environment correlation and evolutionary pres-
sure in sport hunting trophy rams and is likely to be extended into the study of human popula-
tions (Pierce 2008). 
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With ever advancing technologies for genotyping it is likely that the next decade will see the 
proliferation of GWAS studies using SNP, CNV, microsatellites, epigenetic and gene expression 
markers of genetic variation and perhaps just perhaps masses and masses of power will be 
enough to detect the genes involved in the development of schizophrenia, however it still does 
not solve the catch 22 situation: are our known environmental risk factors confounded by geno-
type or conversely are our genetic studies ignoring higher order interactions (gene-gene interac-
tions (GxG) & Gene-environment interactions (GxE)), which could be helpful in understanding 
the causes of schizophrenia? 
Genetic epidemiology: Examining the joint action of genes & environmental factors in the 
cause of schizophrenia. 
Genetic epidemiology is the study of the joint actions of genes and environmental factors in 
causing disease in human populations and their patterns of inheritance in families. Family stud-
ies are the basic approach used by genetic epidemiologists but the basic designs of classical risk 
factor epidemiology (case control studies and cohort studies) are also useful for some purposes. 
While the, statistical and laboratory techniques involved in genetic and aetiological research are 
ever evolving, the basic epidemiological principles remain useful and necessary (Thomas 2004). 
Complex genetic interactions 
Traditional genetic epidemiology has focused on the identification of genetic markers that indi-
vidually increase/decrease the occurrence of a disease (main effects). Yet for the majority of 
trait expression also depends at some level on the interaction with genes and/or environmental 
factors either where the interactions are genetically programmed or purely random. Even the 
phenotypic manifestations of conditions which have monogenetic inheritance may be the result 
of GxE e.g. phenylketanuria Schizophrenia is considered by most researchers in the field (though 
we do not know for sure) to be complex multifactorial disorder-therefore analytical strategies 
which are able to determine the cause of observed discordance between genetic susceptibility 
and phenotypic expression will be required. That is, our genetic models of disease need to take 
into consideration interactions with other genes and environmental factors and consider de-
signs to deal with genetic heterogeneity. In order to do this we require methods that simultane-
ously consider the effects of multiple genes and environmental factors. 
Gene -Gene & Gene-Environment Interactions: 
Definition of interaction The term interaction is used loosely in the current genetic and epide-
miological literature. In general one can consider GxE equivalently as either increased (or de-
creased) vulnerability to environmental exposures in carriers of a certain genotype relative to 
non-carriers, or increased (or decreased) genetic expression in exposed subjects compared to 
unexposed subjects. Effect modification (also termed interaction) occurs when the measure of 
effect varies for one variable across levels of another variable. Clearly from this definition the 
precise meaning of the interaction depends on the scale on which the effect is measured (Tho-
mas 2004). 
Therefore statistical interaction means a departure of the observed risk for some model of main 
effects for 2 or more risk factors. However statistical interaction does not necessarily imply bio-
logical interaction and vice- versa. Nevertheless such interactions are often interpreted as hav-
ing biological significance about underlying mechanisms (Ottman 1990; Yang and Khoury 1997). 
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Gene-Gene Interaction 
The polygenic model discussed above posits that multiple interacting genes are likely to influ-
ence the phenotype. However this polygenic inheritance is difficult to demonstrate in humans 
and complicates genetic mapping because no single locus is solely responsible for producing the 
trait. This means that in future research we will have to use a combination of analytical ap-
proaches to understand the complexity of the susceptibility to schizophrenia, including 1) to 
examine currently posited candidate genes which have been found to have main effects on the 
risk of developing schizophrenia for potential interactions using 2-locus linkage models or case-
control/family association tests. However, studies which aim to detect novel complex interac-
tions or replicate previously reported ones must have much larger sample sizes than studies 
designed to detect only main effects. (Smith and Day 1984). 2) Whole genome screen approach 
to identify addition loci conditional on a genotype previously shown to be of genetic risk in 
schizophrenia, these methods are powerful at finding markers with small effect that combine to 
have an important effect on the phenotype, however they do not explicitly look for GxG or GxE 
interaction. 3) exhaustive searching approaches which consider many genetic factors at once 
and use latent variable modeling techniques to identify patterns such as dimensional reduc-
tion/combinational portioning and class identification /regression trees and convergent path-
way analysis that best predict the disease phenotype from genotypic information, these methods 
seem to work best with small number of markers (<10,000) and will have to be developed to 
include explorative methods with larger marker coverage 4) ELA (ensemble learning approach) 
(Zhaogong Zhang 2008) and their extensions are being developed for this purpose. 
GENE –ENVIRONMENT INTERACTION (EXPLORATION OF MULTIFACTORIAL 
MODELS) 
”Genetic s loads the gun and the environment pulls the trigger” 
In this thesis I have discussed the indirect evidence from epidemiological studies suggesting the 
possibility of GxE interactions in the onset of psychosis. Once a major gene or environmental 
factor has been identified GxE can be explored. The examination of the candidate genes in the 
study of disease –exposure associations or GxE interactions can reveal effects of an environ-
mental factor on the risk of schizophrenia that would be concealed if genetic susceptibility was 
ignored. Furthermore, considering an established environmental risk factor may facilitate the 
Constancy of a relative risk: corresponds 
to a multiplicative model 
 
Constancy of a risk difference corresponds 
to an additive model 
 127
identification of novel genetic factors (Haines 2006). To date most models of gene-environment 
interaction are simple, and consider the effect of only one gene and one environmental risk fac-
tor. In reality the interactions are likely to be much more complex, involving multiple genes, en-
vironmental factors and will have to consider genetic heterogeneity and heterogeneity of expo-
sure. The plausible GxE models described to date however provide us with a framework for dis-
cussing potential study designs and approaches of more complex interactions which will be de-
veloped over the next decade. 
Generic heterogeneity 
Is present when a number of different mutationsÆ identical phenotypes. Or phenotypes that are 
similar enough to have been traditionally lumped together under one diagnosis. There are 2 
types of genetic heterogeneity Allelic Heterogeneity is common phenomena in nature occurs 
when different mutations at a single locus cause the same phenotype. Locus heterogeneity oc-
curs when mutations at different loci cause the same phenotype or a group of phenotypes which 
appear similar and have traditionally been classified as a single disorder/ or spectrum. Much can 
be learned from this when a distinctive phenotype is produced by alleles at more than one gene 
locus, it suggests that the gene products interact in some way or that they are necessary compo-
nents of a critical developmental or metabolic pathway –causal mechanisms. 
Potential Methodologies: Association studies including complex putative component causes 
As discussed above , the majority of GxE interaction studies have used methodologies in which 
there are only a few risk factors examined at a time, the most commonly used approaches are 
case control designs allows the examination of the joint effects of genetic and environmental 
factors on disease susceptibility while theoretically more complex models incorporating both 
GxE and GxG interactions and even higher order (GxGxE) with multiple genes and environmental 
exposures are possible using this framework , pragmatically data collection (such as genotyping 
for the controls that are likely to yield a low number of carriers may be costly), the multiplicity 
of hypothesis, and confounding by recent admixture , selection and drift between unlinked loci 
make this methodology relatively in-efficient except in the situation where linkage studies have 
identified a chromosomal region likely to be implicated i.e. the candidate gene approach. . Case-
only design can also be used to examine GxE interaction is the case only studies. This approach 
can improve the power of the study to detect interactions and is valid for rare diseases. However 
importantly it is only valid when there are strong a priori reasons to believe that the genotype 
and the environmental exposure are independent of each other in the study population. (Pie-
gorsch, Weinberg et al. 1994; Yang and Khoury 1997). Violation of this assumption has been 
shown to produce grossly inflated type 1 errors. A preliminary assessment of the independence 
of the 2 factors being studied can be performed by examining the co variation of the genotype 
and environmental exposure in a sample of people who do not have the disorder. However even 
when a test of independence is carried out in control subjects the bias may persist (Albert, Rat-
nasinghe et al. 2001).The case only approach is therefore only useful for assessing departures 
from the multiplicative interaction when there is a strong empirical evidence for the gene envi-
ronment independence. 
Family studies: case –example of parent trios: The case parent trio design has been used to 
test candidate gene associations but is also used for testing GxG and GxE interactions, under a 
weaker gene environment independence assumption than that required by the case only design. 
This model uses the genotypes on all 3 members of the trio but ONLY the environmental expo-
sure from the case (I am not really sure what a cases control comparison between the cases and 
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the parents exposure would mean anyway as you would not be comparing like for like by age, 
gender and other demographics). Basically the design stratifies the genetic relative risk esti-
mates from the case-parent trio by environmental exposure status of the case, if there is no GxE 
interaction the 2 genetic relative risks would be the same, however if an interaction is present 
their ratio will estimate the interactive relative risk (i.e. a comparison the genetic relative risk 
estimated from environmental exposed and unexposed cases). Currently we can use stratified 
analysis to control for known within family variables which may influence the risk and multi-
level analytical models are currently being developed to deal with these factors (Thomas 2004; 
Haines 2006) 
Genome wide scans and association and interaction 
The studies described above are all hampered by lack of reproducibility due to 1)too small sam-
ples with inadequate statistical power to uncover complex interactions and small effects,2) the 
biological and phenotypic complexity of schizophrenia, 3) population –specific linkage disequi-
librium, 4) effect size bias, and 5) differing population substructures (Davey Smith, Ebrahim et 
al. 2005; Crow 2007) furthermore methodological heterogeneity, such as variation in diagnostic 
criteria used to define the disease phenotype, different methods for measuring environmental 
exposure and variation in the analyses and the choice of markers chosen will only aggravate this. 
These methodological concerns in parallel with the development of high volume genotyping 
technologies (which make explorative studies of genetic variation across the entire human ge-
nome feasible) point towards GWAS (Genome wide association studies) studies as being poten-
tially useful way of identifying genetic associations with disease status. The design of such stud-
ies will be fundamentally the same as traditional genetic epidemiology, however the ambitious-
ness of such projects present a number of scientific and logistical challenges (and probably also 
political-this will require cross department cross national collaboration-good luck!) The power 
calculations suggest numbers in the thousands will be required to carry out such studies (Collins 
2004) however coordinated infra structures for genetic association studies are being con-
structed (ISC; SGENE). To be clinically relevant these genetic association studies will need to be 
placed in an epidemiological, psychiatric and public health context. However, as yet no statistical 
models or software which would allow us to concurrently look across the genome and test for 
environmental sensitivity (GxE) has been developed and this will require collaboration with 
genetic statisticians to develop appropriate analytical models to deal with such problems as 1) 
multiple comparisons which may be further accentuated if many GxG or GxE interactions are 
also considered and it may be that progress can only be made in the characterization of complex 
diseases if we consider such interactions even when only limited a priori knowledge about the 
range of exposures is minimal. A variety of data mining techniques have been proposed for this 
purpose, such as artificial neuronal networks, path & cluster analysis methods (Ritchie, Hahn et 
al. 2001; Moore, Parker et al. 2002; Moore and Williams 2002; Jansen 2003) 2) population strati-
fication 3) heterogeneity of effect due to unrecognized modifying factors either genetic or envi-
ronmental. It will be important in the reporting of such studies to consider the potential sources 
of bias and confounding and report associations that make biological sense and alleles that affect 
the gene product in a physiologically meaningful way. An anonymous editorial in Nature Genet-
ics (1999) suggested that the associations should be observed both in families and population 
based studies and the effect size should be high (for rare variants) and the population attribut-
able risk high for common variants before being reported and published. 
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Individual level characterization of environmental risk factors are not enough? 
As well as considering the joint gene and environmental risk factors effect for risk of schizo-
phrenia, as epidemiologists we will have to better characterize our environmental exposures, 
this is expensive and time consuming and furthermore will require the development of better 
more fine grained assessment tools with increased precision. To date, we have focused primarily 
on exposure at the level of the individual however increasingly studies examining complex dis-
ease epidemiology has shifted away from previous individual risk factor emphasis, to a model 
which investigates causal pathways across societal, individual and molecular levels (Susser and 
Susser 1996; Susser and Susser 1996).Chapters in this thesis have examined area level variation 
in urbanicty/migrant status and social fragmentation. Further studies are required to disentan-
gle wither these are contextual effects (mediated by perhaps social defeat or other social net-
work/integration factor, (Selten and Cantor-Graae 2007) or are simply area level proxy indica-
tors for as yet unidentified individual environmental exposures/mediating factors which are 
more prevalent in such areas (i.e. aggregate effect). This will require the development of meth-
odologies to deal with the significant heterogeneity of effect, perhaps by stratified or sub group 
sampling of certain environmental exposures. While rationally epidemiological studies have 
tended to examine exposure to outcome without integrating intermediate factors on the causal 
pathway or causal mechanisms the methods described above will facilitate the integration of 
paradigms which test the evolving pharmacological hypotheses for schizophrenia. 
What phenotype should be studied! 
The importance of case definition cannot be over emphasized and is an essential requirement 
for genetic epidemiological studies. This thesis discusses the relatively arbitrary development of 
the traditional classification systems for psychosis which have some clinical usefulness and are 
based on symptom cluster and relevance to functioning. However, understanding the complex 
genetic causes of schizophrenia will likely require phenotypic definitions which are based/ or 
are closer to pathogen tic mechanisms. Further we have to consider the possibility that not all 
clinical features are equally as important in defining phenotypes. The studies in this thesis exam-
ine the usefulness of symptom based dimensional measures generated using latent variable 
modeling techniques of exploratory factor analysis. Future studies are likely to examine both 
dimensional (factor models) and categorical (latent class) methods to better improve our classi-
fication systems, but such studies will have to more carefully consider the indicators being used 
to tap into the latent level structures. Just because a symptom is severe/ or clinically relevant 
does not mean that it is a good indicator for discriminating underlying etiologies. Minor clinical 
features which do not have important medical or functional implications may become important 
when defining our psychotic phenotypes. Many medical syndromes are defined by their patterns 
of minor features rather than major clinical features. Furthermore if in family studies we find a 
number of minor clinical features segregating with major psychosis it may suggest pleiotrophy, 
and the minor clinically trivial features may be of help in phenotypic definition. This thesis dem-
onstrates that current classification systems explain only relatively small amounts of the risk 
factor and prognosis (5 years follow up) variance, the best model using information from both 
diagnoses and dimensional models explains only 25% of the variation in outcome/risk factor 
differences. In order to develop definitions which are more aetiologically relevant intermediate 
phenotypes may be useful, e.g. neurocognitive impairment (Gottesman and Gould 2003; Green-
wood, Braff et al. 2007).and structural brain abnormalities (Boos, Aleman et al. 2007) have been 
found to aggregate in families and in some case has been found to be related to specific genetic 
 130
variants and it is likely that these profiles could be used fine tune out definition of caseness in 
aetiological studies may even be useful outcome variables. 
Psychosis evolution: a dynamic process 
That at-risk mental state, characterized by brief low grade psychotic experiences (in late child-
hood early adolescence) predict later onset of psychotic disorder is now a replicated finding. 
Over the next decade epidemiological research will model the preclinical and clinical character-
istics which influence the transition to disorder and need for health care, this will be facilitated 
with the development of powerful latent variable growth mixture models which use normal 
random effects to represent the departure of an individual’s latent growth parameters from the 
population mean growth parameters, so that class membership of possible subgroups of psycho-
sis while not being measured directly, can be inferred by their developmental courses which will 
have covariates relationships which may be useful in classification and prediction models. This 
may result in the identifying of multiple developmental pathways and the examination of envi-
ronmental and genetic co-variate effects on the different population subgroups. 
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Samenvatting  (Summary in Dutch) 
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Schizofrenie is een ernstige en vaak verzwakkende aandoening gekarakteriseerd door sympto-
men zoals hallucinaties, waanideeën, desorganisatie, verlies van doelgericht gedrag en afname in 
sociaal functioneren. Bij sommigen verloopt de ziekte relatief mild, waarbij de persoon een of 
enkele episodes doormaakt met weinig tot geen blijvende beperkingen. Echter, bij ongeveer 
47% van de patiënten is schizofrenie een levenslange aandoening, met blijvende symptomen en 
terugkerende episodes geassocieerd met een significante sociale beperking. De oorzaak van 
schizofrenie blijft echter onvindbaar. Hoewel het duidelijk is dat er een sterke familiaire kwets-
baarheid bestaat waarbij eerstegraads familieleden van patiënten een hoger risico op morbidi-
teit voor schizofrenie hebben vergeleken met familieleden van controlepersonen. Schattingen 
variëren van 2-9% vergeleken met een risico voor familieleden van controles van ongeveer 
0,5%. Tweelingstudies ondersteunen deze aanname ook met concordantie cijfers van 50% in 
monozygotische tweelingen en 4,1% in dizygotische paren, echter de genetische bijdrage blijft 
nog steeds onduidelijk en omgevingsrisicofactoren zoals het opgroeien in een stad, de leeftijd 
van de vader, cannabis gebruik hoofdzakelijk tijdens adolescentie en obstetrische complicaties 
worden ook verondersteld een rol te spelen. 
Variatie in ziekte en tijd Epidemiologische methoden vergelijken systematisch en zetten een 
verzameling ziekte patronen in populaties over TIJD, PLAATS en in verschillende PERSONEN. 
Variatie in ziekte over tijd. Dat ziektes toenemen en afnemen in bevolkingsfrequentie als ge-
volg van medische/bevolkingsgezondheid praktijken of door natuurlijke oorzaken is een van de 
axiomen van de klassieke epidemiologie. Variatie in ziekte in de bevolking vindt plaats over tijd 
doordat eigenschappen van mensen of hun omgeving veranderen. Zelfs als de sociale en fysische 
omgeving constant zouden blijven zouden patronen in het voorkomen van ziekten over tijd 
voorkomen (natuurlijk veel trager, eerder evolutionaire tijdsschalen) omdat genetische veran-
deringen onvermijdelijk zijn en deze het ontstaan en de persistentie van een ziekte beïnvloeden. 
Genetische veranderingen ontstaan door een aantal verschillende processen waaronder geneti-
sche drift, genetische mutatie en epigenetische transmutaties, die random variatie in de genfre-
quentie veroorzaken van generatie op generatie. In kleine populaties kan genetische drift tot 
belangrijke genetisch aangestuurde ziekte verschillen leiden, echter in grotere populaties blijft 
de genetische DNA (deoxyribonucleic acid) sequentie relatief stabiel over tijd. De klassieke epi-
demiologische methodologie veronderstelt dat veranderingen in het voorkomen van ziekten in 
grote bevolkingen die plaatsvinden binnen korte tijd (tientallen jaren) geheel toe te schrijven 
zijn aan omgevingsfactoren. Hoofdstuk 2 van dit proefschrift onderzoekt de trend van incidentie 
van schizofrenie over tijd in Dumfries & Galloway in de periode 1979-1989. In deze regio was er 
geen gradiënt te zien. 
Variatie van ziekte in plaats Gelijke inzichten in de etiologie kunnen bepaald worden door sys-
tematisch de variatie van ziekte cijfers te vergelijken tussen populaties met verschillende demo-
grafische en omgevingskenmerken. In Hoofdstuk 3 4 & 5 wordt deze spatiële variatie onder-
zocht en de resultaten suggereren dat in stedelijke gebieden en gebieden met lage sociale cohe-
sie eerste psychotische episoden en schizofrenie vaker voorkomen. 
Variatie in persoon (klinische epidemiologie: subgroep analysen) benut de inherente hetero-
geniteit die gezien wordt in populaties. In Hoofdstuk 6 van dit proefschrift zal ik de bestaande 
literatuur systematisch bestuderen en vinden dat, hoewel familiale kwetsbaarheid de grootste 
effecten heeft, er ook sterke bewijzen zijn dat paternale leeftijd een matig sterke invloed heeft, 
wat mogelijk wijst op het bestaan van epigenetische mechanismen dat verder onderzoek vereist. 
Bij elke epidemiologische studie staat het thema “ patiënt zijn” centraal. Hoe we een ziekte-
uitkomst definiëren bepaalt de geschatte cijfers in beschrijvende epidemiologische studies en de 
berekende effect groottes in analytische studies naar risicofactoren. Vanaf 1960 hebben psychia-
ters veel energie besteedt aan het verbeteren van de betrouwbaarheid van psychiatrische dia-
gnosen in algemeen, en speciaal van schizofrenie. Dit heeft geresulteerd in een aantal operatio-
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nele definities van schizofrenie met acceptabele betrouwbaarheid, maar allen variëren en het is 
twijfelachtig welke aangenomen moet worden. Het hoofdprobleem is dat we niet weten of het 
concept schizofrenie enige validiteit heeft, en als dat al zo is, welke operationele definitie de va-
liditeit het best reflecteert. Dat schizofrenie op zijn best een voorlopige diagnostische categorie 
is heeft serieuze gevolgen voor het opzetten van epidemiologische studies en de interpretatie 
van resultaten. In Hoofdstuk 7 8 9 & 10 van dit proefschrift onderzoek ik zowel theoretisch als 
empirisch de bruikbaarheid van categorische diagnosen in schizofrenie vergeleken met dimen-
sionale gekwantificeerde symptoomprofielen. Deze studies suggereren dat er weinig te winnen 
is met het gebruiken van dimensionale maten alleen, hoewel ze licht kunnen bijdragen aan de 
voorspellende waarschijnlijkheid in uitkomst studies als ze samen met diagnosen worden ge-
bruikt. De lijn die het onderzoek heeft gevolgd is van klassieke epidemiologische paradigma’s in 
variatie in tijd, plaats en persoon naar het exploreren van mogelijke nieuwe benaderingen in het 
onderzoek naar zowel omgevingsfactoren als ook genetische risicofactoren. In de komende tien 
jaren is het te verwachten dat de manier waarop we onze risicofactoren meten verfijnd zal wor-
den en zullen we ze bestuderen over verschillende hiërarchische/systematische niveaus (maat-
schappelijk, individueel & moleculair) in genetisch onderzoek. 
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